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Abstract
Gene expression is not only tightly regulated during differentiation, forming the basis of lineage
specification and cellular identity, but also flexible and stochastic, contributing to cellular het-
erogeneity within the organism. Monoallelic gene expression refers to the transcription of a gene
from one of its two homologous alleles, and could potentially contribute to cellular diversity,
although it has not been studied in a developmental context, nor characterised at the molecular
level. An allele-specific RNA sequencing screen was performed in clonal populations of hybrid
mouse embryonic stem cells (ESCs) and neural progenitor cells (NPCs) and identified 67 and
376 inheritable autosomal random monoallelically expressed genes respectively, a 5.6-fold in-
crease upon differentiation. While DNA methylation and nuclear positioning did not play a role
in maintaining monoallelic expression, specific histone modifications were differentially enriched
between the two alleles and are thus likely involved in preserving the monoallelic state. Inter-
estingly, transcript levels of 8% of the monoallelically expressed genes remained similar between
monoallelic and biallelic NPC clones. These results support a model in which random monoal-
lelic expression occurs stochastically during differentiation, and for some genes is compensated
for by the cell to maintain the required transcriptional output of these genes. Therefore, monoal-
lelic expression exemplifies the stochastic and plastic nature of gene expression in single cells
during development.
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Chapter 1
Introduction: gene expression
regulation and monoallelic expression
in diploid mammalian cells
1.1 Layers of gene regulation in mammalian cells:
from nucleotide to nucleus
Gene expression is the process through which the information contained in the linear DNA
sequence is transcribed into RNA. Critical to all forms of life, gene expression must be tightly
regulated throughout the lifetime of an organism to maintain homeostasis, yet flexible enough
to allow for responses to stimuli, ranging from developmental cell fate decisions to responses
to the extracellular environment. The molecular processes by which transcription takes place
in eukaryotes is well characterised biochemically: assembly of a pre-initiation complex at the
promotor leads to transcription factor mediated recruitment of RNA polymerase, initiation,
elongation and termination of RNA synthesis. However, what is of particular interest is how the
process of gene expression is regulated such that a highly similar genomic sequence can give rise
to hundreds of different cellular phenotypes, and ultimately the complexity of a multicellular
organism, such as a mouse or man. The DNA itself, contains motifs which are essential for the
proper recruitment of proteins and associated complexes to the DNA, however extra layers of
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gene regulation exist on top of the linear double-stranded DNA sequence. These range from
methylation of the cytosine nucleotide, to the composition and modifications of histone proteins
which with DNA form the basic structural unit of chromatin, the nucleosome, to how the
nucleosomes are further packaged into chromatin, and finally the interplay between different
gene regions with each other and within the three dimensional nuclear space. In this way gene
regulation in mammalian cells occurs in multiple layers, from the nucleotide to the nucleus.
1.1.1 DNA methylation
DNA methylation is perhaps one of the best studied and well characterised epigenetic modi-
fications. Essential for mammalian development, DNA methylation is present throughout the
plant, animal, fungal and prokaryotic kingdoms (Feng et al., 2010), with some notable excep-
tions including Drosophila and C. Elegans (Deaton and Bird, 2011). Cytosine methylation was
put forward as a potential inheritable modification affecting gene regulation and cellular differ-
entiation as early as the mid-1970s (Holliday and Pugh, 1975; Riggs, 1975). In mammals, DNA
methylation occurs primarily at the symmetrical CpG dinucleotide (Riggs, 1975), although non-
CpG methylation, primarily at CpA and to some extent CpT, can occur, particularly in ESCs
in which up to 25% of DNA methylation can be non-CpG (Lister et al., 2009; Ramsahoye et al.,
2000), as well as in the brain (Xie et al., 2012). The mammalian genome is generally CpG
depleted: the human genome contains approximately 28 million CpGs, of which 10% occur in
clusters known as CpG islands (Deaton and Bird, 2011). These islands are on average 1kb long,
containing approximately 1 CpG per 10 base pairs, and are often unmethylated (Deaton and
Bird, 2011). CpG islands are enriched over the transcription start sites of house keeping and
developmental genes (Larsen et al., 1992), although half of CpG islands, known as orphan CpG
islands, do not occur at annotated promoters, and may be more dynamically regulated through
development (Illingworth et al., 2010; Smith and Meissner, 2013). While 60-80% of CpGs are
methylated in somatic cells, CpG islands tend to be resistant to DNA methylation (Smith and
Meissner, 2013). In contrast to the hypermethylated genome of somatic cells, primordial germ
cells (PGCs) and blastocyst-stage embryos are hypomethylated (Seisenberger et al., 2012), a
feature which is thought to be linked to their pluripotency.
DNA methylation is inherited stably across cell divisions through the action of the DNA
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methylation maintenance machinery. The two key proteins involved are Nuclear Protein 95
(NP95, also known as UHRF1), which recognises specifically hemimethylated DNA (Bostick
et al., 2007; Sharif et al., 2007); and DNA MethylTransferase 1 (DNMT1), which catalyses
the transfer of a methyl group to the unmethylated cytosine from its substrate S-adenosyl
methionine (SAM) (Bestor and Ingram, 1983; Gruenbaum et al., 1982). NP95 and DNMT1
form a complex with Proliferating Cell Nuclear Antigen (PCNA) (Chuang et al., 1997; Sharif
et al., 2007), targeting the DNA methylation maintenance machinery to replicating DNA in S-
phase, although PCNA is not necessary for DNMT1 loading (Spada et al., 2007). Interestingly,
NP95 requires di- or tri-methylation of histone H3 lysine 9 (H3K9me2/3) to bind in S-phase
(Rothbart et al., 2012), and DNMT1 binding is inhibited by trimethylation of histone H3 lysine
4 (H3K4me3) (Ooi et al., 2007; Otani et al., 2009), coupling DNA methylation to the chromatin
state of the underlying DNA. Due to the low affinity and poor catalytic activity of DNMT1
at unmethylated DNA (Jeltsch, 2006; Song et al., 2011), de novo methylation is catalysed by
DNA MethylTransferase 3a and 3b (DNMT3a, DNMT3b) enzymes (Okano et al., 1998), which
are often found in complexes with epigenetic repressors (Smith and Meissner, 2013). Thus
promoters which are targeted by histone deacetylases, H3K9 methyltransferases, including G9a,
and chromatin remodelers such as LSH, undergo heterochromatin formation and subsequent
DNA methylation to ensure long term silencing (Ayyanathan et al., 2003; Lehnertz et al., 2003).
In this way, DNA methylation is thought to act secondary to gene inactivation as a lock to
further stabilise the silent state (Smith and Meissner, 2013).
The mechanisms by which DNA demethylation takes place are still under investigation and
likely depend on both sequence context as well as the stage of development (Seisenberger et al.,
2013; Smith and Meissner, 2013). DNA demethylation can be passive and/or active (figure 1.1
on page 18). DNA methylation can be lost passively with cell divisions if the maintenance
DNA methyltransferase Dnmt1 is not recruited to the DNA. This dilution of DNA methylation
marks requires several cell divisions and consequently has slow kinetics. There are many pro-
posed mechanisms by which active demethylation may occur. One is through the Base Excision
Repair (BER) pathway, initiated by DNA glycosylases (Jost, 1993; Jost et al., 1995) which
cleaves the bond between 5-methylcytosine base and the deoxyribose. Subsequent removal of
the deoxyribose, filling of the gap by DNA polymerase and repair by DNA ligase, results in an
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unmethylated cytosine in place of the methylated cytosine (Zhu, 2009). A slight modification
of this pathway involves prior conversion of methylated cytosine to thymine by the Activa-
tion Induced Deaminase Aid, causing a mismatch in the DNA sequence which is recognised
by the DNA glycosylases Tgd and Mbd4 (Cortellino et al., 2011), and subsequently excised
via BER pathway as above. Alternatively, 5-methylcytosine can be oxidised by members of the
ten-eleven-translocation (Tet) family of enzymes to 5-hydroxymethylcytosine (5hmC) (Tahiliani
et al., 2009). 5hmC is either then passively lost during DNA replication, or further oxidised by
the Tet enzymes to 5-formylcytosine and 5-carboxylcytosine which are then excised through the
BER pathway (Branco et al., 2011).
While DNA methylation levels remain relatively constant in adult somatic tissues, there are
two stages of development in which widespread waves of DNA demethylation occurs (figure 1.2
on page 20): during germ cell development, and in the pre-implantation embryo (reviewed
in Seisenberger et al. 2013; Smith et al. 2013). Primordial Germ Cell (PGC) development
starts at E7.25 in the epiblast, in which following an initial increase in DNA methylation levels
similar to that of the surrounding somatic cells, the PGCs undergo a wave of demethylation,
reestablishing their developmental potency (Guibert et al., 2012; Hajkova et al., 2002). Some
DNA elements, such as imprinted Differentially Methylated Regions (DMRs), and the most
active retrotransposons, such as the Intracisternal A particles (IAPs), are resistant to this wave
of demethylation (Guibert et al., 2012; Lane et al., 2003; Seisenberger et al., 2012). Classically,
it was believed that the demethylation occurs during a short time window from E11.5 to E13.5
at a similar time as imprint erasure (Hajkova et al., 2002), through the BER or TET pathways,
however recently it has been shown that demethylation may commence as early as E8.5 and
therefore passive demethylation is also a feasible mechanism by which DNA demethylation
may occur (Seisenberger et al., 2012). Following the wave of demethylation, de novo DNA
methylation commences around E14.5 to E16.5 through the action of Dnmt3a and Dnmt3b,
providing germ cell fate specification and establishing sex-specific imprints (Davis et al., 1999,
2000; Kato et al., 2007; Ueda et al., 2000). The final level of DNA methylation in gametes differs
between the sexes, with 85% methylation levels in sperm, compared to 30% in oocytes (Popp
et al., 2010; Smallwood et al., 2011; Smith et al., 2012).
The second wave of demethylation occurs in the zygote following fertilisation. Here the
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Figure 1.1: Mechanisms for removing cytosine methylation.
Cytosine is converted to 5-methylcytosine by DNA methyltransferases (DNMT). Removal of
5-methylcytosine can either occur passively (red dotted lines) or actively through either an
AID-induced thymine intermediate or TET-induced 5-hydroxymethylcytosine, 5-formylcytosine
or 5-carboxylcytosine intermediates, through either the Base Excision Repair (BER, blue line)
pathway, or passively (red dotted lines).
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two parental genomes show dramatically different demethylation kinetics: the paternal genome
undergoes a rapid global demethylation which is largely completed prior to the first cell division
(Santos et al., 2002; Wossidlo et al., 2010). The maternal genome, on the other hand, undergoes
passive demethylation over several cell cycles, partially aided by the exclusion of Dnmt1 from the
nucleus (Howell et al., 2001) and protection from the initial wave of demethylation that occurs
at the paternal genome by the maternal factor Stella (Nakamura et al., 2007; Payer et al.,
2003). At the blastocyst stage, the first lineage specifications occur. The outer trophectoderm
cells remain largely unmethylated, where as the inner cell mass, which gives rise to the embryo
proper and from which ESCs are derived, is once again largely hypermethylated (Seisenberger
et al., 2013). Interestingly, ESCs cultured conventionally in serum are hypermethylated, while
those grown in the two kinase inhibitor (2i) medium, believed to reflect the ground state of
pluripotency (Ying et al., 2008), are hypomethylated (Habibi et al., 2013), consistent with 2i
grown ESCs representing a more primal stage of development.
1.1.2 Histone modifications and variants.
Within the cell, DNA is wrapped around an octomer of histone proteins forming a complex
known as a nucleosome. While this allows packaging of the 2 meters or so of DNA into a nucleus
approximately 10μm in diameter, it also reduces the accessibility to DNA binding proteins such
as transcription factors. To circumvent this, histone modifications, variants and nucleosome
positioning alter the accessibility of the chromatin and consequently influence gene expression.
The histone octomer is comprised of two of each of the core histone proteins: H3, H4, H2A
and H2B. The proteins are encoded by large gene arrays and are highly expressed during S-
phase, coupling chromatin assembly with DNA replication. The core histones can be replaced
by non-canonical histone variants and/or undergo post-translational modifications including
methylation, acetylation, phosphorylation and ubiquitylation. These variants and modifications
correlate with different genetic elements and transcriptional activity, however whether they
directly influence gene expression or if they are a secondary correlative effect is highly debated
(Henikoff and Shilatifard, 2011; Rando, 2012).
The core histone proteins contain a characteristic structural motif known as a histone fold,
containing 3 alpha-helices and 2 loops, and a long unstructured N-terminal tail. The tail, com-
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Figure 1.2: DNA methylation dynamics throughout development.
Upon fertilisation, the paternal genome (blue) undergoes rapid active demethylation, where as
the maternal genome (red) undergoes passive demethylation. Imprinted Differentially Methy-
lated Regions (DMR, orange) are resistant to this initial first wave of demethylation. Upon
implantation and lineage specification, the embryonic genome becomes hypermethylated. At
E7.5, Primordial Germ Cells (PGCs) undergo a second wave of demethylation. Remethylation
of prospermatogonia (blue) occurs earlier in development than the growing oocytes (red). Adult
somatic cells are hypermethylated. Modified from (Auclair and Weber, 2012).
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prising up to 30% of the mass of the histone, protrudes out of the nucleosome (Luger et al.,
1997), and is where the majority of the known post-translational modifications occur. Histone
acetylation was the first modification discovered (Phillips, 1963) and shortly thereafter it was
proposed that methylation of lysine residues in the histone protein could modify RNA synthesis
(Allfrey and Mirsky, 1964; Murray, 1964). The modification of histone tails have been proposed
to alter gene transcription in two ways. First, modifications may alter the biochemical properties
of the nucleosome. For example, neutralisation of the highly positively charged histones through
acetylation or phosphorylation could result in a decrease of electrostatic interactions between
the histones and the negatively charged DNA, resulting in a decompacted and consequently
more accessible state. Indeed point mutations at lysine residues in histone tails in budding
yeast revealed that modifications of specific amino acid residues were mostly redundant, with
the exception of histone H3 lysine 14, and thus likely act by increasing overall negative charge of
the histones (Dion et al., 2005). Histone acetylation is therefore associated with transcription,
DNA replication and DNA repair: all processes which require accessibility to the DNA (Zentner
and Henikoff, 2013). However not all modifications, alter the overall charge of the histone. Some
modifications, including phosphorylation, provide protein binding sites, directing the enzymatic
activity of protein complexes to specific regions of the genome. In 2000, the first histone methyl-
transferase SUV39H1 was discovered (Rea et al., 2000), which lead to the discovery of additional
lysine methyltransferases through homology searches of the catalytic SET domain. Many hi-
stone binding proteins contain different domains that recognise specific histone modifications
including bromodomains (acetylated lysines), chromodomains (methylated histones); PHD do-
mains (methylated lysines) and Tudor domains. It is also important to note that many of the
histone modifying enzymes also have non-histone substrates, which can confound experiments
designed to show the causality between histone modifications and gene expression regulation.
With the advent of ChIP-chip and ChIP-seq technologies, distribution maps of various hi-
stone modifications have been performed genome-wide across a multitude of cell types, ex-
emplified by the efforts of the ENCODE consortium (ENCODE Project Consortium et al.,
2012). This has led to the hypothesis of the histone code, in which a unique biological out-
come could be specified by a particular combinations of histone modifications (Strahl and Allis,
2000). Although there is a clear correlation between certain genomic features and combina-
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tions of histone modifications, the causality between the two has not been conclusively shown
and is highly contested (Barth and Imhof, 2010; Henikoff and Shilatifard, 2011). Nonetheless,
chromatin can be classified into anywhere between 6 and 51 distinct states (reviewed in (Bick-
more and van Steensel, 2013)), based on the abundance of certain histone modifications, which
themselves can be in turn correlated with biochemical properties of the chromatin including
histone turnover, DNase I hypersensitivity and binding of transcription factors and chromatin
remodelers. For example, active gene promotors are characterised by an abundance of histone
H3 lysine 4 mono- di- and tri-methylation (H3K4me1/2/3) flanking the TSS and extending to
a certain extent into the gene body (figure 1.3A on page 24). Throughout the gene body of
active genes, the abundance of histone H3 lysine 79 methylation (H3K79me1/2/3), H3K9me1,
H4K20me1, H2BK5me1 and H3K27me1 decreases, where as there is an accumulation of H3 ly-
sine 36 trimethylation (H3K36me3) which peaks at the 3’ end of the gene (figure 1.3A). Active
promoters are also characterised by an increase in histone acetylation, including H3 lysine 9
acetylation (H3K9ac), which may act to help open the chromatin, providing accessibility to the
transcriptional machinery. The transcriptional start site itself, is devoid of nucleosomes, and
this nucleosome free region is often instead occupied by RNA polymerase. In contrast, inactive
promoters are marked by methylation of histone H3 lysine 9 and/or 27 (H3K9me3, H3K27me3),
and H4 lysine 20 (H4K20me3) which extends into the gene body (figure 1.3B). Of the two
major inactive-associated modifications, H3K9me3 tends to be associated with constitutive het-
erochromatin, where as H3K27me3 tends to be more dynamic and associated with facultative
heterochromatin. Interestingly, some promoters in ESCs contain both active H3K4me3 and
inactive H3K27me3 marks. These regions, known as bivalent domains, are enriched over devel-
opmental gene promoters (Bernstein et al., 2006; Mikkelsen et al., 2007).
Repetitive elements and pericentromeric heterochromatin are marked by H3K9me2/3 and
H4K20me3, where as subtelomeric regions contain H3K27me2/3, H3K9me2/3, and telomeres
contain H3K4me3 and monomethylation of lysine 5 of H2B (H2BK5me1). Enhancer elements
can be identified by a signature containing the p300 co-activator protein, acetylation of H3 lysine
27 (H3K27ac) and H3K4me1. There are over 100 different histone modifications described (Zent-
ner and Henikoff, 2013), including ADP ribosylation, glycosylation ubiquitylation and sumoy-
lation, which have half lives ranging from minutes to days (Barth and Imhof, 2010). The exact
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roles for many of these modifications remain unclear, and the interplay, or histone crosstalk,
between different marks will need to be determined. For example, binding of Heterochromatin
Protein 1 (HP1) to H3K9me3 is inhibited by phosphorylation of serine 10 (H3S10ph) on the
same histone tail (Fischle et al., 2005; Hirota et al., 2005), and ubiquitylation of lysine 123 of
histone H2B (H2BK123Ub) promotes H3K4me3 and H3K79me3 deposition during transcription
(Briggs et al., 2002). In this way, the exact functions of various histone modifications are likely
to be complex and context dependent.
In addition to the extensive post-translational modifications of histones, nucleosomes have
an added layer of complexity in that three of the four core histones have separately encoded
histone variants. Unlike the core histones, the histone variants are typically expressed through-
out the cell cycle and thus can be incorporated into chromatin in a replication-independent
manner. There are several variants of histone H3: CENP-A is a key protein at the centromeres
involved in centromere structure and stability. Histone H3.3, which differs from the core his-
tones H3.1 and H3.2 by only a few amino acids, is a characteristic component of active genes
and promotors due to its incorporation as a replacement histone following passage of RNA
polymerase II. In this way, H3.3 levels can act as a read out of the dynamics of chromatin
(Skene and Henikoff, 2013). Histone H2A also contains several variants. H2A.Z is perfectly
positioned at the +1 and -1 nucleosomes flanking the transcriptional start site (Barski et al.,
2007; Luk et al., 2010). However, its exact functions are unclear as H2A.Z is also associated
with heterochromatin, transcriptional activation and repression, transcriptional elongation and
chromosome segregation at mitosis (Skene and Henikoff, 2013). In contrast, the roles for H2A.X
are better defined. Following DNA damage, H2A.X is incorporated and rapidly phosphorylated
at it’s C-terminal generating γH2A.X, and facilitating assembly of the DNA repair machinery
at the site of DNA damage. Finally, macroH2A, a larger H2A variant, is found enriched on the
inactive X-chromosome in female cells, as well as at regulatory elements of pluripotency genes
upon differentiation (Pasque et al., 2012).
1.1.3 Nuclear structure and organisation
In addition to molecular factors, such as DNA methylation, histone modifications and variants,
the regulation of gene expression can also be influenced by the organisation of the genome within
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Figure 1.3: Typical distribution of histone modifications across active and inactive genes.
Distribution of histone modifications across active (A) and inactive (B) genes. Modified from
(Barth and Imhof, 2010).
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the three dimensional nuclear space. Nucleosomes, containing 147bp of DNA and the histone
octomer, are separated from each other by 10-80bp of DNA and associated linker histone H1.
This gives rise to a 10nm fibre, resembling “beads on a string” (Olins and Olins, 1974) (figure 1.4
on the next page). The 10nm fibre has long been proposed to fold into a 30nm fibre (reviewed in
(Grigoryev and Woodcock, 2012; Hübner et al., 2013)). However, while the 30nm fibre is readily
observed in vitro, evidence for its existence in vivo is limited (Scheffer et al., 2011; Woodcock,
1994), suggesting that chromatin organisation above the 10nm fibre may not be the prevailing
structural unit in living cells (Eltsov et al., 2008; Fussner et al., 2012; Nishino et al., 2012).
Instead, nucleosomes are proposed to be arranged in vivo into disordered interdigitated globules
(Eltsov et al., 2008; Nishino et al., 2012) which permit a more flexible and dynamic organisation
of the genome than would be possible through a static ordered structures.
The development of chromosomal conformational capture (3-C) technologies has greatly
improved our view of how chromatin is structured within the nuclear space (de Laat and Dekker,
2012). These methodologies involve formaldehyde-based cross-linking of associating regions
of DNA within the nucleus, enzymatic digestion to reduce these interactors to the minimal
regions, and ligation of the two interactors, followed by either PCR amplification or high-
throughput sequencing. There are many variations of 3C (reviewed in (de Wit and de Laat,
2012)) which either investigate a specific region of interest (3C, 4C), or take a genome-wide
view of all interactions (5C, Hi-C). This has enabled microscopy-based observations made over
many decades at individual loci through DNA Fluorescence In Situ Hybridisation (FISH), to
be generalised genome-wide. What is now apparent is that chromatin is structured into large
fractal globules (Lieberman-Aiden et al., 2009), containing between 200kb to 1Mb of DNA,
known as Topologically Associated Domains (TADs) (Dixon et al., 2012; Nora et al., 2012;
Sexton et al., 2012). Regions of DNA that are linearly separated from each other by large
distances physically associate with each other at a higher frequency than regions between TADs
(figure 1.4). The globular structures maximise packing of chromatin, while enabling any region
of interest to unfold and loop out of the globule to interact with other genomic regions or with
protein complexes or nuclear domains (Lieberman-Aiden et al., 2009). The observation that
while inter-TAD interactions change, the TADs themselves are stable and remain unchanged
upon differentiation (Dixon et al., 2012; Nora et al., 2012), suggests that TADs may be defined by
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Figure 1.4: Organisation of chromatin in the mammalian nucleus.
(A) Chromatin is resolved as a 10 nm ‘beads on a string’ fiber consisting of nucleosomes. (B)
Chromatin may form a 30 nm fiber or exist as a polymer melt, which is further organised into self-
assembling fractal globules. (C) Chromatin fibers interact (i) within a fractal globule (frequent),
(ii) between fractal globules of the same chromosome territory (rare), or (iii) between adjacent
chromosome territories (very rare). (D) These fractal globules form chromosome territories,
and fractal globules from adjacent chromosome territories can interdigitate. (E) Chromosomes
are organized in chromosome territories. Modified from Hübner, Eckersley-Maslin and Spector,
2013.
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genomic features rather than the transcriptional program of the cell. However, it is unclear what
defines the sharp TAD boundaries: while they are enriched for CTCF binding, housekeeping
gene promotors, transfer RNA genes and short interspersed element (SINE) retrotransposons
(Dixon et al., 2012), these elements are not exclusive to TAD boundaries, suggesting that other
factors are involved.
Interestingly, but perhaps not surprisingly, TADs overlap with other features of chromatin
including DNA replication timing domains and Lamin Associated Domains (LADs, discussed
below). The replication of DNA in S-phase is temporally segregated with large clusters of repli-
cation origins, several hundred kilobases to many megabases in size, firing nearly synchronously
at specific stages of S-phase (reviewed in (Rhind and Gilbert, 2013)). For approximately half
of the genome, the replication timing is dependent on cell type and usually linked to the tran-
scriptional status of the genes in that region (Hansen et al., 2010; Ryba et al., 2010; Schwaiger
et al., 2009). Early replicating domains are generally enriched for actively transcribing genes,
where as heterochromatic and silent regions of the genome replicate towards the end of S-phase
(Dimitrova and Gilbert, 1999; Hiratani et al., 2008). Interestingly some regions of the genome
replicate asynchronously, and tend to be associated with monoallelically expressed genes (Don-
ley et al., 2013; Kitsberg et al., 1993; Mostoslavsky et al., 2001). The boundaries of replication
timing domains overlap with TAD boundaries, although the converse is not always true, as
replication timing domains can contain several TADs (Dixon et al., 2012; Ryba et al., 2010). In
this way, the DNA replication timing profile is linked to the underlying chromatin structure and
state, providing a potential mechanism through which the transcriptional status of the region
can be inherited, through differential incorporation of chromatin components at different stages
of S-phase (Hiratani and Gilbert, 2009; McNairn and Gilbert, 2003).
Beyond TADs, the chromatin is further organised such that each chromosome occupies a
distinct region of the nucleus, termed chromosome territories (figure 1.4). The concept of chro-
mosome territories was first proposed over 100 years ago, by Carl Rabl in 1885 and Theodor
Boveri in 1909 (reviewed in (Cremer and Cremer, 2006)), and in 1977 the first evidence for
the existence of chromosome territories was published (Stack et al., 1977). In 1982, further
evidence for chromosome territories was provided by experiments which followed the distribu-
tion of chromatin irradiated by UV in interphase through the cell cycle (Cremer et al., 1982).
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Chromosome territories can be observed using FISH with whole chromosome composite painting
probes (Guan et al., 1993), and are now supported by the genome-wide high resolution maps
provided by the 3C-based technologies (Lieberman-Aiden et al., 2009). Chromosome paint com-
bined with exon paint depicts a picture where the exonic sequences predominantly localise to
the surface of the chromosome territory (Boyle et al., 2011), consistent with genes looping out
of their chromosome territory and potentially interacting with regions of other chromosomes.
Whether the genes move prior to activation, or if they require movement to specific regions to be
transcribed has been a topic of immense debate (Hübner et al., 2013). The observed localisation
of RNA polymerase II into foci, termed transcription factories (Jackson et al., 1993), in which
numerous transcriptionally active genes localise, often from different chromosomes, set forth the
hypothesis that genes move to these factories in order to be transcribed (Papantonis and Cook,
2010). However, recently high resolution live cell imaging of RNA polymerase II revealed that
RNA polymerase II clusters form transiently with a life time of approximately 5 seconds (Cisse
et al., 2013), arguing against stable transcription factories that genes must relocate to, and
instead supporting a model whereby clusters of RNA polymerase II form at highly transcribed
loci, which tend to be positioned outside of their chromosome territories and thus nearby other
transcribed regions of the genome.
In higher eukaryotes, the interphase nucleus is a highly ordered yet dynamic structure, con-
taining numerous specialised compartments (figure 1.5 on page 30), including the nuclear lamina,
nuclear pores, nucleoli, nuclear speckles, Cajal bodies, PML bodies and paraspeckles (reviewed
in (Mao et al., 2011; Spector, 2006; Zhao et al., 2009)). One domain in particular, the nuclear
lamina, has been extensively studied in relation to its role in transcriptional regulation. The
nuclear lamina is a meshwork of type V intermediate filament proteins called lamins, which
together with various associated proteins lines the inner nuclear membrane and interacts with
the nearby chromatin. Early electron microscopy studies first revealed a layer of heterochro-
matin at the periphery of interphase nuclei, as well as surrounding the nucleoli (reviewed in
(Moses, 1956)). This perinuclear heterochromatin tends to replicate in late S-phase (O’Keefe
et al., 1992). The recent development of DamID technology (Greil et al., 2006), which provides
genome-wide DNA-nuclear lamina interaction maps, has revealed that genes that locate to the
periphery are often, but not always, transcriptionally inactive, supporting previous observations
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made at single loci by FISH based approaches (reviewed in (Takizawa et al., 2008b)). Mam-
malian genomes contain approximately 1,100-1,400 Lamin Associated Domains (LADs), ranging
in size from 50kb to 10Mb (Peric-Hupkes and van Steensel, 2011). LADs contain approximately 2
fold less genes than inter-LADs, and typically lack RNA polymerase II and histone modifications
associated with active transcription (Guelen et al., 2008; Peric-Hupkes et al., 2010; Pickersgill
et al., 2006). Consistent with microscopy based studies (Kosak, 2002; Williams, 2006), changes
in gene transcription during differentiation correlates with changes in the nuclear localisation of
genes either towards or away from the nuclear lamina (Peric-Hupkes et al., 2010). Interestingly,
ESCs, which are reported to have a distinctive flexible and dynamic nuclear structure compared
to differentiated cells (Fisher and Fisher, 2011; Meshorer and Misteli, 2006), show a clear LAD
structure and organisation, which differs in content by only 10% from differentiated cell types
(Peric-Hupkes et al., 2010). Perhaps somewhat surprising at first, is the observation that LADs
overlap with domains of repressive chromatin that interact with the nucleolus, so called Nucle-
olar Associated Domains (NADs) (Bickmore and van Steensel, 2013; Németh et al., 2010; van
Koningsbruggen et al., 2010). The conundrum as to how chromatin domains, although similarly
repressive, can be associated both with the nuclear lamina and the nucleolus, was solved recently
by live-cell imaging of LADs in single cells (Kind et al., 2013). Not only did this study reveal
that only approximately 30% of LADs were associated with the nuclear periphery in a given
single cell, but also following mitosis there was not strict inheritance but stochastic shuﬄing
of these LADs, such that only a subset remain at the nuclear periphery and others relocate
to the nucleolar periphery (Kind et al., 2013). This demonstrates the heterogeneity of gene
expression regulation in single cells, which is often masked by high-throughput genome wide
analyses performed in populations of cells.
In addition to the nuclear lamina, the nucleus contains many other structures most of which
are less understood. The nucleolus contains the clusters of repetitive ribosomal RNA genes
which are highly transcribed by RNA polymerase I, accounting for up to 90% of RNA in the cell
(McStay and Grummt, 2008). As mentioned above, the nucleolus is surrounded by transcrip-
tionally inactive perinucleolar chromatin, which is enriched for satellite DNA as well as silent
ribosomal DNA clusters (Sullivan et al., 2001). The Cajal body contains RNAs and proteins
involved in the assembly and modification of small nuclear ribonucleoproteins (snRNPs) and
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Figure 1.5: Structure of the interphase nucleus in higher eukaryotes.
Graphical representation of the 3-dimensional nucleus showing the different nuclear compart-
ments and bodies. Figure from (Spector, 2001).
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small nucleolar ribonucleoproteins (snoRNPs) (Nizami et al., 2010). The nucleus also contains
between 30 to 50 nuclear speckles, also known as interchromatin granule clusters (IGCs), which
are enriched with splicing factors including snRNPs and SR proteins (Lamond and Spector,
2003). Identified as a satellite to nuclear speckles, the paraspeckle is less abundant and its
function poorly understood, although it is involved in retention of some A-to-I hyper-edited
mRNAs (Mao et al., 2011). Polycomb bodies contain polycomb group proteins, and are asso-
ciated with gene repression (Kerppola, 2009), where as ProMyelocytic Leukemia (PML) bodies
are associated with gene rich and transcriptionally active chromatin, including the major histo-
compatibility complex and p53 gene locus (Bernardi and Pandolfi, 2007). Correlations between
gene positioning and their associations with these, as well as potentially other as of yet uniden-
tified nuclear bodies, are abundant, however the main question remains: is nuclear positioning
a cause or consequence of gene transcription?
When considering gene positioning relative to TADs, LADs, chromosome territories, or other
nuclear structures, an important consideration is whether changes in gene positioning are a
cause or consequence of changes in gene expression (figure 1.6 on the next page). For many
examples, such as Hox gene movement from a H3K27me3 repressive domain to a permissive
H3K4me3 domain upon gene activation (Noordermeer et al., 2011), it is unknown whether the
structural changes that accompany gene activation are necessary for transcription to occur or
if they are a secondary event stabilising the gene expression program in the cell. There are
many more examples of gene movement correlating with gene expression changes (reviewed in
(Hübner et al., 2013)) performed in static cells looking at before and after snapshots in time.
What is required are live-cell systems, in which the activation and/or repression of endogenous
alleles can be followed in single cells over time, with respect to their chromosome territories
and/or nuclear structures. These types of experiments will be critical to extend our knowledge
of nuclear organisation in transcriptional regulation.
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Figure 1.6: Gene movement relative to transcriptional activation.
(a) Transcriptional activation of a gene may precede its movement within the nucleus. (b) An
inactive gene may get activated subsequent to its movement to a site that is favorable to tran-
scriptional activation. (c) Transcriptional activation and gene movement may be independent of
each other. Red, inactive gene; green, active gene. From Hübner, Eckersley-Maslin and Spector,
2013.
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1.2 Classic examples of monoallelic gene expression in diploid
cells
The majority of gene expression in diploid cells is carried out through expression of both alleles
of each gene. However, several interesting cases of monoallelic expression, in which there is
transcription from only one allele, have been documented over the last 60 years (figure 1.7 on
the following page). Well characterized and extensively studied examples include X-chromosome
inactivation, in which female mammalian cells randomly silence the vast majority of genes on
one of the two X chromosomes to compensate for the increased dosage of X-linked genes (Guidi
et al., 2004; Schulz and Heard, 2013), and genomic imprinting in which DNA methylation marks
in the gametes regulate the expression of genes from either the maternal or paternal allele in the
offspring (Bartolomei and Ferguson-Smith, 2011; McAnally and Yampolsky, 2010). Interestingly,
random monoallelic expression can also occur on autosomes independently of the parental origin
or underlying genotype (Chess, 2012b; Guo and Birchler, 1994). This has been classically studied
for large gene families in which monoallelic expression generates receptor diversity and cellular
identity. For example, the immune system utilizes monoallelic expression to ensure each B-cell
expresses a single uniquely rearranged immunoglobulin receptor (Pernis et al., 1965). Similarly,
in the nervous system, neurons express olfactory receptors in a monogenic and monoallelic
manner to provide cell-identity and aid in neural connectivity (Chess et al., 1994).
1.2.1 X-inactivation
The first case reported, and one of the best understood examples, of monoallelic expression in
mammalian cells is X-chromosome inactivation, an essential process which equalises the dosage
of genes between the autosomes and sex chromosomes within an individual, as well as the
dosage of X-linked genes between the sexes. It was first eluded to in 1949 (figure 1.7), when
Murray Barr observed the presence of a dark subnuclear structure located adjacent to the
nucleolus, specifically within the nucleus of female, but not male, cat neurons (Barr and Bertram,
1949). This ’nucleolar satellite’, which was later renamed to the Barr body in honour of it’s
discoverer, was sufficient to determine the sex of the cell, and was later discovered to contain
a single condensed X-chromosome (Ohno et al., 1959). Subsequently, Mary Lyon made the
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discovery that the Barr body was in fact an entire condensed and silent X chromosome of either
maternal or paternal origin (Lyon, 1961) (figure 1.7). Since this discovery over 50 years ago, there
has been extensive investigation into the molecular mechanisms and functional consequences
underlying X-chromosome inactivation. Different species have evolved distinct methods for
dealing with the problem of sex chromosome dosage. In Drosophila, the expression level from
the two X chromosomes in female cells is normal, and instead the single X-chromosome in male
cells is up-regulated two-fold to match autosomal levels (Conrad and Akhtar, 2011). Similarly,
the worm Caenorhabditis elegans, in contrast, increases expression levels two fold from the
single X chromosome in male cells, where as the two X chromosomes in hermaphrodites remain
expressed at normal levels (Meyer, 2010). In mammals, expression from the X-chromosome is
increased two-fold in both males and females, however one of the two X-chromosomes is silenced
in female cells, equalizing the dosage (Schulz and Heard, 2013). Marsupials show imprinted X-
inactivation in which the paternally derived X-chromosome is always silenced (Sharman, 1971),
where as in eutherian mammals the final choice of which X-chromosome to inactivate is randomly
determined, except for in the placental tissue which remains paternally imprinted.
During development, X-chromosome inactivation in eutherian mammals undergoes cycles of
silencing and reactivation (reviewed in Schulz and Heard, 2013). In the early embryo, at the 2-4
cell stage, the paternal X chromosome is inactivated. This persists until the blastocyst when cell
lineages begin to be specified. In the trophectoderm, which gives rise to the placental tissue, the
paternal X chromosome continues to remain inactive and does so throughout the development
of this tissue. It remains unclear, however, whether paternal imprinting of the X-chromosome
in placental tissue is limited to mice or if it also occurs in humans. In contrast, in the inner cell
mass the paternal X chromosome is reactivated and de novo X-chromosome inactivation takes
place, this time in a random manner so that either the paternal or the maternal X-chromosome
is inactivated. Once established, the choice of inactive X-chromosome is maintained such that
adult female mammals are mosaics.
The molecular mechanism of X-chromosome inactivation in eutherian mammals is centered
around a DNA element on the X-chromosome termed the X Inactivation Center (XIC), which
is necessary and sufficient to regulate inactivation (Brown et al., 1991). The XIC is involved
in all stages of X-chromosome inactivation, including counting the number of X-chromosomes
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in the cell, choice of which X-chromosome to inactivate, and initiation of silencing. The XIC
contains a large non-coding RNA (ncRNA), called X-Inactivation Specific Transcript (Xist)
which is expressed exclusively from the inactive X-chromosome. Deletion of this 17-20kb tran-
script results in the failure to silence the chromosome in cis (Marahrens et al., 1997; Penny
et al., 1996), and ectopic placement on autosomes leads to silencing (Jiang et al., 2013; Lee
et al., 1996; Migeon et al., 1999; Wutz et al., 2002), indicating that a central role for Xist in
X-chromosome inactivation. Furthermore, placement of Xist on one of three copies of chromo-
some 21 in induced pluripotent stem (iPS) cells from Down’s Syndrome patients, results in the
complete inactivation of the corresponding chromosome 21 and restoration of normal diploid
active chromosome dosage (Jiang et al., 2013), indicating that Xist ncRNA itself is sufficient to
induce dosage compensation, and that the molecular mechanisms of X-inactivation can be ap-
plied to any chromosome. Xist acts by binding and recruiting Polycomb Repressive Complex 2
(PRC2) (Zhao et al., 2008), the protein complex involved in H3K27me3 mediated gene silencing
(Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002; Müller et al., 2002). This occurs
initially at a nucleation center, at which YY1 binding exclusively on the future inactive X chro-
mosome bridges PRC2, Xist and the inactive X chromatin, allowing the spreading of inactive
chromatin in cis along the entire X-chromosome (Pollex and Heard, 2012). Interestingly, not
all genes on the X-chromosome are silenced. Approximately 3% of X-linked genes in mice and
15% of X-linked genes in human escape silencing. The molecular mechanisms for X-inactivation
escape remain unclear. While Xist has a central role in X-chromosome inactivation, many other
ncRNAs and protein complexes, including the antisense antagonistic ncRNA Tsix (Lee et al.,
1999), have been identified and are implicated in different stages of X-chromosome inactivation.
Furthermore, the nuclear organisation of the X-chromosomes appears to play a role, with the
two X-chromosomes coming together in the nucleus at the onset of inactivation, potentially as a
counting mechanism in the cell (Bacher et al., 2006; Masui et al., 2011). Interestingly, the Xist
ncRNA is unique to eutherian mammals and evolved only in the last 150 million years from a
protein coding gene Lnx3 (Duret et al., 2006), indicating that Xist mediated X-inactivation is
restricted to the eutherian mammals. Marsupials do not have a corresponding gene, although
they do have a different 27kb ncRNA called Rsx which also coats the inactive X-chromosome in
cis (Grant et al., 2012). It remains to be determined if Rsx acts in a similar manner to Xist or
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if an alternative mechanism for X-chromosome inactivation is involved. Nonetheless, ncRNAs
appear to play a central role in both random and imprinted X-inactivation, a feature which is
also shared by another class of monoallelically expressed genes: genomic imprinted genes.
1.2.2 Imprinting
Genomic imprinting refers to the exclusive expression of genes from either the maternal or
paternal genome. The discovery of genomic imprinting in mammals came about following nu-
clear transplantation experiments in the early 1980s (Barton et al., 1984; McGrath and Solter,
1984; Surani et al., 1984), in which diploid androgenetic (containing two paternal pronuclei)
and gynogenetic (containing two maternal pronuclei) embryos failed to develop, indicating that
both the maternal and paternal genomes were required for embryonic development (figure 1.7).
By studying different Robersonian translocations, the genomic regions responsible for these ef-
fects were mapped to distinct chromosomal regions on chromosomes, which are now known to
contain clusters of imprinted genes (reviewed in (Cattanach, 1986; Solter, 1988)). There are
approximately 150 known imprinted genes in mouse, and less in humans, although this may
be because human development has not been as extensively studied. More than 80% of the
known imprinted genes fall into 16 genomic clusters (Barlow, 2011). Each cluster spans from
80 to 4,000kb DNA (Barlow, 2011) and contains anywhere between 3 and 12 or more imprinted
genes, including usually one non-coding RNA. With few exceptions, within each cluster the im-
printed protein coding genes are mostly expressed from the same parental chromosome, where
as the imprinted ncRNA is expressed from the alternate parental chromosome (Barlow, 2011).
Many clusters also contain an Imprint Control Region (ICR), some of which also function as
Differentially Methylated Regions (DMRs), although these two features are not necessarily ex-
clusive (Lee and Bartolomei, 2013). A large proportion of imprinted genes encode for proteins
involved in growth and metabolism (Lee and Bartolomei, 2013). This, along with the higher
incidence of imprinting observed in placental tissue, suggests a role for imprinting in balancing
the growth requirements of the fetus versus the energy demands on the mother. Supporting this,
monotremes lack genomic imprinting and marsupials have fewer imprinted genes (Renfree et al.,
2013), indicating a link between the evolution of imprinting and placentation and/or viviparity.
Some genes are imprinted in a tissue-specific manner, most commonly in the placenta. One
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report suggested that thousands of genes may be imprinted in the brain (Gregg et al., 2010),
however these claims have been refuted based on technical and analytical errors in the original
study (DeVeale et al., 2012).
There are two main models describing the molecular mechanisms regarding genomic imprint-
ing: the insulator model; and the ncRNA model (figure 1.8 on the next page, reviewed in Lee
and Bartolomei, 2013). The insulator model is evolutionarily older and conserved amongst the
marsupials, and is exemplified by the H19/Igf2 imprinted cluster (figure 1.8A), containing Igf2,
the first imprinted gene discovered (DeChiara et al., 1991), and H19, the first long noncoding
RNA identified (Brannan et al., 1990). In this cluster, allele-specific methylation at the ICR
serves as an insulator element which is necessary for imprinting at the locus (Thorvaldsen et al.,
1998). When unmethylated on the maternal allele, the ICR is bound by CTCF, preventing
upstream enhancers from interacting with the downstream Igf2 gene, rendering it inactive (Bell
et al., 2010; Hark et al., 2000). In contrast, the paternal ICR is methylated, preventing CTCF
from binding and thus allowing the enhancer elements to activate transcription of Igf2 (Bell
et al., 2010; Hark et al., 2000). At the maternal allele, the enhancers loop to the H19 ncRNA
resulting in its transcription, where as at the paternal allele, the methylation of the ICR spreads
to silence the H19 ncRNA (Lee and Bartolomei, 2013).
In contrast to the insulator model, the ncRNA model is more widely used model in eutherian
mammals (Lee and Bartolomei, 2013), and was first described at the Igf2r/Airn locus (figure
1.8B). In this model, the DMR spans the promoter of the 108kb Airn ncRNA within the
gene body of Igf2r (Lyle et al., 2000). When unmethylated on the paternal allele, Airn is
transcribed, leading to silencing of the nearby Slc22a2 and Slc22a3 genes in cis (Pauler et al.,
2012). Transcription of Airn, rather than the transcript itself, is required to silence Igf2r through
preventing RNA polymerase II assembly on the overlapping Igf2r promoter (Latos et al., 2012).
In contrast, at the maternal allele, the DMR is methylated, blocking transcription of Airn,
allowing instead the expression of Slc22a2, Slc22a3 and Igf2r genes (Pauler et al., 2012). The
Kcnq1 and Snrpn imprinted domains are also proposed to function through a ncRNA model.
The insulator and ncRNA models are mutually exclusive and may both be involved in regulating
imprinted gene clusters (Lee and Bartolomei, 2013).
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Figure 1.8: Insulator and ncRNA models of genomic imprinting.
(A) Insulator model for imprinting at the H19/Igf2 locus. The maternal allele, with an un-
methylated ICR is bound by CTCF, preventing enhancer activation of downstream Igf2 gene.
Conversely the methylated paternal ICR is unbound by CTCF, allowing enhancer activation
of Igf2. (B) ncRNA model for imprinting at the Igf2r locus. The maternal allele with an un-
methylated DMR transcribes the ncRNA Airn which prevents Igf2r transcription by blocking
RNA polymerase II assembly, and coats the Slc22a2 and Slc22a3 genes. On the methylated
paternal allele, Airn is not transcribed, allowing transcription of Igf2r. Slc22a2 and Slc22a3.
Green denotes transcribed genes, grey silent genes, and orange genomic regulatory elements.
Modified from (Lee and Bartolomei, 2013).
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1.2.3 Monoallelic Expression in the Immune System: Immunoglobulins
The immunoglobulins were the first autosomal genes shown to be monoallelically expressed.
Experiments on rabbit leukocytes in the 1960s (figure 1.7) revealed that the products of different
alleles were always present in different cells (Pernis et al., 1965), a discovery made prior to the
isolation of the immunoglobulin genes themselves. One decade later, in 1976 (figure 1.7), Hozumi
and Tonegawa discovered that this allelic exclusion was due to DNA rearrangement events at
one of the two alleles (Hozumi and Tonegawa, 1976), a discovery which later won Tonegawa
the Nobel prize. There are 7 distinct antigen receptor loci in the genome: the heavy chain
locus (IgH); light chain loci (Igκ and Igλ) and T-cell receptors (TCR-α, -β, -γ and -δ); spread
over 2.5Mb of the genome, all of which undergo DNA rearrangement and are monoallelically
expressed in the respective B- and T-cells in the immune system. DNA rearrangement provides
antigen receptor diversity which could not be encoded within the genome itself, and monoallelic
expression ensures that each mature cell expresses one uniquely rearranged receptor, ensuring
the specificity of the immune system. All antigen receptor loci contains variable (V), diversity
(D) and joining (J) gene segments, each containing several segments which are recombined
together to produce the variable region of the receptor. This rearrangement is lineage restricted
and developmentally controlled, and is mediated in part by the DNA recombinase enzymes
RAG1 and RAG2 (Oettinger et al., 1990; Schatz et al., 1989).
The immunoglobulin genes, like many other examples of monoallelic expression including the
X-chromosome, imprinted genes and olfactory receptors, replicate asynchronously in S phase.
This asynchronous DNA replication, in which one allele replicates in early S-phase and one in
late S-phase, precedes and predicts the future allele which will be rearranged and expressed
(Mostoslavsky et al., 2001). Thus, rather than a probabilistic model in which there is a random
choice of alleles due to low probability of simultaneous efficient recombination, a deterministic
or instructive model is favoured in which one allele is pre-marked by its earlier replication timing
(Farago et al., 2012; Mostoslavsky et al., 2001). Upon initiation of recombination, the inactive
allele associates with pericentromeric heterochromatin, whereas the early replicating allele looses
its DNA methylation marks (Giambra et al., 2008) and gains H3 acetylation (Hesslein et al.,
2003), resulting in a change in chromosome conformation rendering it accessible to RAG1 and
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RAG2 (Chaumeil et al., 2013; Subrahmanyam and Sen, 2012). A subsequent maintenance
phase involves a feedback loop which inhibits further rearrangement. In this way, the chromatin
state and nuclear organisation of the antigen loci play a critical role in the establishment and
maintenance of monoallelic expression (reviewed in (Cedar and Bergman, 2011; Subrahmanyam
and Sen, 2012)).
Monoallelic expression occurs at another class of receptor genes in the immune system: the
Ly49 Natural Killer (NK) cell receptors. These rodent-specific receptors are a class of C-type
lectins which upon binding of host MHC class I molecules, thereby delivering inhibitory signals
to the NK cell preventing it from killing the target cell. Humans, and other primates, do
not have Ly49 receptors, instead the Killer cell Ig-like Receptor (KIR) genes are proposed to
provide a similar function, and interestingly they are also similarly monoallelically expressed
(Rouhi et al., 2006). The Ly49 genes are encoded in a 1.4Mb cluster on chromosome 6 (Held
et al., 1999; Takei et al., 2001). Each Ly49 receptor is only expressed in a subset of NK cells,
however individual NK cells may express more than one Ly49 receptor, as detected by single cell
RT-PCR analysis (Kubota et al., 1999). Expression of the Ly49 receptors is monoallelic (Held
and Kunz, 1998; Held et al., 1995), and regulated in part by promoter DNA methylation and
histone acetylation (Rouhi et al., 2006). While biallelic expression is also possible, it occurs at a
much lower frequency equal to the product of the individual frequencies (Held and Raulet, 1997).
The expression of alleles is determined independently for different Ly49 genes (Tanamachi et al.,
2001), and the rate of co-expression of two different Ly49 receptors is equal to that which is
expected if the two alleles are expressed independently (Valiante et al., 1997). This supports a
model in which low probability independent stochastic activation of each allele of each receptor
results in monoallelic expression of a small repertoire of receptors. In this way, monoallelic
expression increases the number of distinct NK clones expressing different combination of Ly49
receptors (Held et al., 1999).
1.2.4 Generating Diversity in the Nervous System: Olfactory Receptors and
Protocadherins
The olfactory receptors (OR) are the largest gene family in mammals, comprising approximately
1,400 functional genes in mice, or 350 in humans, arranged in 40 or more genomic clusters
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(Young et al., 2002). In 1991 (figure 1.7) it was first proposed that the ORs were expressed in a
monogenic manner in the main olfactory epithelium , and just a few years later (figure 1.7), the
monoallelic nature of OR expression was discovered (Chess et al., 1994). The monoallelic and
monogenic expression of the OR gene family ensures that each neuron expresses only one allele
of one olfactory receptor, providing specificity in odor recognition, and correct axon guidance
and wiring of the olfactory network. Since these original findings, extensive research into the
molecular mechanisms of the monoallelic and monogenic nature of ORs has taken place over the
last 20 years. Initially two models were proposed: deterministic and stochasticity (reviewed in
(Magklara and Lomvardas, 2013)). In the determinism model, each of the 1,400 OR genes would
be regulated by a unique combination of transcription factors acting at a unique cis regulatory
sequence in their promoters. This was supported by the observation that ORs are expressed in 4
main regions of the olfactory epithelium, and each OR is expressed overall at the same frequency.
However, experiments in which a reporter transgene placed under the control of an OR promoter
never co-expressed with the endogenous OR, provided strong evidence against a deterministic
model (Shykind, 2005). The alternative model, which is more widely accepted today, is that the
choice of OR allele to be expressed occurs stochastically in the cell, and that feedback loops act
to stabilise the initial OR allele choice and prevent additional allele activation.
How the initial selection and stabilisation of OR allele choice is made is only beginning to
be understood at a molecular level. In 2004, somatic cell nuclear transfer experiments with
post-mitotic olfactory neurons demonstrated that not only could post-mitotic cells re-enter the
cell cycle, but the OR allele choice could be re-set in the cloned animal, indicating that irre-
versible DNA alterations did not take place (Eggan et al., 2004; Li et al., 2004). This was an
important finding as it contrasted with, what was known at the time, the only other example of
autosomal monoallelic expression, the immunoglobulin and T-cell receptor genes which undergo
extensive DNA rearrangements. Next, it was proposed that the singularity of allele choice oc-
curred through specific association with a 2kb enhancer element, homology (H ), on chromosome
14 adjacent to one of the OR gene clusters (Lomvardas et al., 2006; Serizawa et al., 2003). Chro-
mosome conformation capture (3C) and RNA-DNA Fluorescence In Situ Hybridisation (FISH)
experiments clearly demonstrated co-localisation of the active OR allele with the H element
(Lomvardas et al., 2006). However, following experiments in which the H element was deleted
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in mice, had no widespread effect on OR allele allele expression and affected only the adjacent
OR genes (Fuss et al., 2007; Khan et al., 2011; Nishizumi et al., 2007). Thus association of a sin-
gle allele with a locus control region is not the mechanism resulting in monoallelic expression of
the OR genes. Instead, the current hypothesis is that the ORs are by default silent and present
as distinct, compact and inaccessible heterochromatic macrodomains in the nucleus (Clowney
et al., 2012), marked by the constitutive heterochromatic histone modifications H3K9me3 and
H4K20me3 (Magklara et al., 2011). This nuclear aggregation is regulated, in part, by the absence
of Lamin B1 Receptor (Lbr) protein as ectopic expression of Lbr causes OR gene disaggregation
(Clowney et al., 2012). Stochastic activation of a single allele by lysine specific demethylase 1
(Lsd-1), results in the allele disassociating from the heterochromatic foci, and acquisition of the
active histone modifications H3K4me3 (Magklara et al., 2011). Stabilisation of the allele choice
is made through negative feedback loops, requiring expression of full length OR coding sequence
(Fleischmann et al., 2008; Nguyen et al., 2007), in which OR induced activation of Adcy3 leads
to down-regulation of Lsd-1, preventing further OR allele activation (Lyons et al., 2013). The
mechanisms of how a single OR allele, rather than 2 or 3 OR alleles, is initially activated is yet
to be determined and will remain a future area of research in the coming years.
The clustered protocadherins are another example of a gene family which, through stochastic
monoallelic expression, represents a candidate for generating neural diversity in vertebrates.
Mammals contain approximately 50 protocadherin genes which are arranged into three tandem
clusters on chromosome 18 in mouse: Pcdh-α, Pcdh-β and Pcdh-γ. Organisation of the Pcdh-α
and Pcdh-γ clusters resemble that of the immunoglobulin and T-cell receptors, with tandem
arrays of variable (V) regions followed by a set of three constant (C) regions. Each gene has
a unique promoter and is expressed through splicing of the particular V exon to the C exons
(Tasic et al., 2002; Wang et al., 2002). In contrast, the Pcdh-β cluster contains 22 members
of unspliced single exon genes. Single-cell analysis of Purkinje cells first demonstrated that
the Pcdh-α genes were expressed monoallelically and combinatorially (Esumi et al., 2005), such
that each cell expresses approximately 2 different genes, one from each allele. The monoallelic
and combinatorial expression was then extended to include genes in the Pcdh-γ (Kaneko et al.,
2006) and Pcdh-γ (Hirano et al., 2012) clusters. As the protocadherins form heteromultimeric
protein tetramers at the cell membrane (Yagi, 2008), the estimated diversity of combinatorial
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co-expression of the three clusters would be more than 20 million combinations, more than
sufficient to distinguish the 14 million cerebellar Purkinje cells in humans, analogous to the
Drosophila Dscam1 proteins (Chen and Maniatis, 2013; Hirano et al., 2012). Regulation of the
Pcdh-α cluster involves long range cis-regulatory enhancer elements, which compete with the
individual variable exon promotors (Ribich et al., 2006), and similar DNA elements have been
identified for the Pcdh-β (Yokota et al., 2011) and Pcdh-γ clusters (Guo et al., 2012). CTCF
binding sites are present in the promoters of the Pcdh-α and Pcdh-γ clusters (Kim et al., 2007;
Xie et al., 2007) and CTCF has been implicated in mediating the enhancer activity of the
upstream cis-regulatory region of the Pcdh-α cluster (Kehayova et al., 2011). The current model
suggest that CTCF and/or cohesin mediated DNA-looping interactions of the protocadherin
promoters to the enhancers provides a means through which stochastic monoallelic expression
of different isoforms can occur in each cell (Chen and Maniatis, 2013; Guo et al., 2012).
1.3 Random autosomal monoallelic gene expression
In addition to the classic examples described in the previous section, monoallelic expression has
also been observed for autosomal genes that do not fall into any large clustered gene families.
This phenomenon of random autosomal monoallelic gene expression was initially described at
isolated examples, however in the last 7 years genome-wide studies have demonstrated that up
to 10% of the genome may be monoallelically expressed in a given cell type (figure 1.7). Despite
the identification of random monoallelically expressed genes, many unanswered questions remain
regarding the molecular mechanisms of establishing and maintaining the allelic imbalance, and
importantly, why have monoallelic gene expression for these genes at all.
1.3.1 Identification of autosomal monoallelic expression:
from isolated examples to genome wide studies
Perhaps the first example of random monoallelic expression of an autosomal gene outside of the
nervous and immune systems described, is that of albumin in hepatocytes (Michaelson, 1991,
1993). Immunofluorescence with sera raised against one of the two allelic forms of albumin, Alb-
1c provided direct evidence that most of the cells expressing albumin in the liver of heterozygous
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Alb-1axAlb-1c mice are in fact expressing only one of the two alleles (Michaelson, 1991, 1993).
Moreover, clusters of multiple adjacent cells showed clonal expression of either allele. It was
proposed that this cellular heterogeneity was due to a low probability of stochastic independent
activation of the alleles, which once established is inheritable (Michaelson, 1993). The stochastic
nature of gene expression was proposed to account for variations seen in other systems, including
coat colour variegation of autosomal genes, for example at the pink eye dilution locus, and the
globin genes (Michaelson, 1987; Searle, 1968; Silvers, 1958). Several years later, another example
of low probability stochastic gene activation resulting in random monoallelic expression was
described at the interleukin-2 (Il-2 ) locus in CD4+ T-cells (Hollander et al., 1998). Single cell
analysis in heterozygous knock-out mice revealed that half the cells produced Il-2, where as the
other half did not, and random monoallelic expression was confirmed by single-cell RT-PCR
analysis in F1 hybrid wild-type mice (Hollander et al., 1998). Similarly, monoallelic expression
has been reported for interleukin-4 (Il-4 ) (Bix and Locksley, 1998), as well as Il-3, Il-5 and Il-13
(Kelly and Locksley, 2000) and Il-10 (Calado et al., 2006). Again, the monoallelic expression of
the cytokines is likely due to stochastic low probability of expression from each allele, resulting
in a mixed population of cells with either 0, 1 or 2 expressing alleles (Guo et al., 2005). In this
case, it may not be monoallelic expression that is selected for, but the resulting low frequency
of expressing cells that can be readily expanded in response to exogenous stimuli (Paixão et al.,
2007).
Stochastic allele-specific expression was next extended to the Pax5 transcription factor,
which was initially reported to be monoallelically expressed in early progenitors and mature B
cells, but biallelically expressed in immature B cells (Nutt et al., 1999). However, unlike the
cytokines which exhibit asynchronous DNA replication timing (Ensminger and Chess, 2004; Hol-
lander et al., 1998), Pax5 replicated synchronously (Nutt et al., 1999). Furthermore, monoallelic
expression of Pax5, was not strictly inheritable, with switching of alleles occurring between 1
and 4 weeks of culturing. A follow-up study using sensitive single-cell RT-PCR analysis, as
well as FISH, confirmed monoallelic expression for the interleukins, but rejected it for Pax5
(Rhoades et al., 2000), suggesting that the observed monoallelic expression was due to the fail-
ure to adequately detect both alleles of this low abundant transcript. Additional examples of
random monoallelic expression of autosomal genes in a wide range of cell types continued to
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emerge: the cell adhesion molecule p120 catenin, identified by its asynchronous DNA replica-
tion timing profile, was reported to be monoallelically expressed in both ES cells and fibroblasts
(Gimelbrant et al., 2004); the glial fibrillary acidic protein Gfap was shown to be monoallelically
expressed in cortical astrocytes (Takizawa et al., 2008a); Igf2bp1, a zinc finger protein required
for imprinted expression of the Igf2 gene, was reported to be monoallelically expressed in B cells
(Thomas et al., 2011); and recently Cubilin, an endocytic receptor, was shown to be monoal-
lelically expressed in renal proximal tubules and small intestine (Aseem et al., 2013). What is
apparent from all of these isolated examples, is that a wide range of different types of genes can
be monoallelically expressed in a wide range of different cell types. Interestingly, in essentially
all examples, not all cells exhibit monoallelic expression, in contrast to what is observed for the
classical examples of monoallelic expression including X-chromosome inactivation and olfactory
receptor expression. Furthermore, the monoallelic expression patterns are inheritable, such that
once established, the expression patterns are maintained across successive cell generations.
Depending on the organism, there can be anywhere between 100 to 10,000 copies of ribosomal
RNA genes encoded in the genome. Mammals have approximately 400 copies of ribosomal RNA
genes arranged into 5 chromosomal clusters in humans (6 in mice) (McStay and Grummt, 2008).
Despite the large abundance of ribosomal RNA in the cell, not all the genes are transcribed by
RNA polymerase I (Grummt, 2007). Instead, the genes exist in two states that are stably
propagated through the cell cycle: an active open state that is transcribed; and an inactive
nucleosomal state (Conconi et al., 1989). In the mouse pre-implantation embryo, the rRNA
loci are biallelically expressed, which then, upon further differentiation, switch to monoallelic
expression, effectively reducing the rRNA transcript levels in the cell by half (Schlesinger et al.,
2009). Monoallelic expression is proceeded by asynchronous DNA replication timing (Li et al.,
2005; Schlesinger et al., 2009), and requires differential DNA methylation at a specific CpG
dinucleotide (Bird et al., 1981; Santoro and Grummt, 2001), histone modifications (Lawrence
and Pikaard, 2004; Santoro et al., 2002; Zhou et al., 2002) and noncoding RNAs (Mayer et al.,
2008, 2006) to maintain the differential expression between the alleles (reviewed in (McStay and
Grummt, 2008)). It has been proposed that monoallelic expression ensures 50% of the alleles
are expressed, thus providing a mechanism by which the early pre-implantation embryo can
increase transcription to meet its higher energy demands (Schlesinger et al., 2009).
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The development of high-throughput screening technologies was fundamental in enabling
random autosomal monoallelic expression to be assessed at a genome-wide level. In 2007, the
first genome-wide analysis of monoallelic expression was performed in clonal populations of
human lymphoblast cell lines, as well as WI38 fibroblasts and placental tissue, by hybridising
double-stranded cDNA to SNP arrays to determine allele-specific expression (Gimelbrant et al.,
2007). Of the 3939 assessable genes in lymphoblasts, 85 (2.2%) were monoallelically expressed
based on two or more informative SNPs, and another 286 (7.3%) based on a single informative
SNP (Gimelbrant et al., 2007). Around the same time, a second group used micro-array based
assays to detect simultaneous methylated and unmethylated DNA of a 65Mb region of mouse
chromosome 7 in the CNS (Wang et al., 2007). In addition to the olfactory receptors, 5 of the
500 assessed genes showed simultaneous methylation and unmethylation and were confirmed
as monoallelically expressed (Wang et al., 2007). Interestingly, one of the genes identified, p
(pink-eyed dilution), was predicted to be monoallelically expressed 2 decades earlier (Michaelson,
1987). A follow-up study by the same group assessing dual DNA methylation patterns genome-
wide of the entire mouse brain and identified 2,237 of 23,393 assessed genes (9.6%) marked by
simultaneous DNA methylation and unmethylation, of which 12.4% (9 out of 122 assessed) were
monoallelically expressed in clonal neural stem cells (Wang et al., 2010). The remaining genes
likely displayed the dual DNA methylation pattern as a result of cellular heterogeneity in the
brain. However, both the pilot and genome-wide screen suggest that 1-2% of genes expressed
in the CNS are monoallelically expressed (Wang et al., 2010, 2007). The lower percentage of
genes reported as monoallelically expressed in the mouse CNS compared to human cells (Gimel-
brant et al., 2007), could be due to the assumption made that monoallelic expression is marked
by allele-specific DNA methylation marks, which likely does not hold for all monoallelically
expressed genes, or differences in the criteria used to define monoallelic expression.
Very recently, four additional genome-wide assessments of monoallelic gene expression have
been reported in both mouse (Li et al., 2012b; Zwemer et al., 2012) and human (Jeffries et al.,
2012; Lin et al., 2012) cells. The first followed a similar approach to the original genome-wide
screen performed in human lymphoblasts (Gimelbrant et al., 2007), again using SNP arrays
to detect monoallelic expression in clonal populations of mouse lymphoblasts and fibroblasts
(Zwemer et al., 2012). Similar to the human, 212 of 1,358 assessed genes (15.6%) were reported
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as monoallelically expressed in lymphoblasts, however only 20 (1.5% assessed genes) contained
more than 1 informative SNP (Zwemer et al., 2012). A second study, again using array-based
technology, reported significantly less monoallelic expression in clonal human neural stem cell
lines derived from the cerebral cortex, striatum and spinal cord (Jeffries et al., 2012). In this
case approximately 2% of assessed genes were monoallelically expressed, of which half were
stochastically expressed from different alleles in different clones (Jeffries et al., 2012). Similar
frequencies were observed in the other two RNA-sequencing based genome-wide screens, also
performed in neural cell types (Li et al., 2012b; Lin et al., 2012), with 2.4% of autosomal genes
(170 of 7,198 assessed) in mouse neural stem cells exhibiting monoallelic expression (Li et al.,
2012b). Interestingly, the number of monoallelically expressed genes appears to increase upon
differentiation: 314 genes in human iPS cell lines exhibit monoallelic expression, compared
to 801 in differentiating neurons derived from the same cells (Lin et al., 2012), however overall
frequencies were not reported, and these numbers include X-linked genes, thus more investigation
into how monoallelic expression changes during differentiation is required.
1.3.2 Current understanding of monoallelic expression and outstanding ques-
tions
Despite the numerous isolated examples and handful of genome-wide screens identifying monoal-
lelically expressed genes in different cell types, very little is known about the features of these
genes, and in depth characterisation and mechanistic insights is limited. Several themes, how-
ever, have emerged regarding random autosomal monoallelic expression. To date, the majority
of monoallelically expressed genes identified are inheritable, that is once established, the allelic
expression patterns are maintained through mitosis such that clones of cells, all expressing the
same allele, are made. However, this may be simply a reflection of the methodologies used to
identify monoallelically expressed genes, particularly with the genome-wide screens. A recent
notable example of random monoallelic expression which is not strictly inheritable, is that of the
pluripotency gene Nanog in early development (Miyanari and Torres-Padilla, 2012). Random
monoallelic expression of Nanog is observed from the 2-cell stage embryo, up until formation
of the blastocysts in which it switches to biallelic expression in the naive epiblast, before re-
verting again to monoallelic expression following implantation. The switch from monoallelic
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to biallelic expression is proposed to be linked to the transition towards a ground state of
pluripotency (Miyanari and Torres-Padilla, 2012), and is reflected by observations that ESCs
cultured in serum, which gives rise to a heterogeneous mix of cells of variable pluripotency, are
predominantly monoallelic, where as those cultured in 2i medium which mimics the pluripo-
tent ground state (Ying et al., 2008), are predominantly biallelic (Miyanari and Torres-Padilla,
2012). However, the existence and physiological relevance of monoallelic expression of Nanog to
pluripotency has recently been questioned (Faddah et al., 2013; Filipczyk et al., 2013), as the
distinction between gene pulsing and unstable monoallelic expression is somewhat ambiguous.
There are several features that the inheritable random autosomal monoallelically expressed
genes identified thus far share (table 1.1 on page 51). First of all, the identified genes are
scattered throughout the genome, and do not fall into any clusters. Furthermore, there is lack
of chromosome coordination of these genes (Gimelbrant et al., 2007; Wang et al., 2007; Zwemer
et al., 2012), such that adjacent genes are not necessarily both expressed from the paternal
or maternal alleles. One exception to this feature are the interleukins, in which there is a
81% concordance of the expressed allele for the clustered IL-4, IL-13 and IL-5, however not
IL-3 which is located 450kb away (Kelly and Locksley, 2000). Secondly, the genes exhibiting
random monoallelic expression encode proteins of a wide-range of functions. While there is
a small enrichment for cell surface and transmembrane proteins in some studies (Gimelbrant
et al., 2007; Jeffries et al., 2012; Li et al., 2012b), others report no gene ontology enrichment
(Zwemer et al., 2012). Interestingly, not all cells exhibit monoallelic expression for a particular
monoallelically expressed gene. In all 7 genome-wide screens, the vast majority of monoallelic
genes showed biallelic expression in at least one of the single-cell derived clones. This feature
was also observed at individual genes including Albumin in hepatocytes (Michaelson, 1993), the
interleukins (Guo et al., 2005), p120 catenin (Gimelbrant et al., 2004), and Gfap (Takizawa
et al., 2008a). This suggests that monoallelic expression is not strictly required by the cell and
instead likely reflects independent random stochastic activation of the two alleles in the cell.
Finally, no clear rule regarding the effect of monoallelic expression on the total transcript level
in the cell can be made. While there is a general trend for monoallelically expressing cells have
less transcript levels than biallelically expressing cells (Gimelbrant et al., 2007), the reduction
is approximately 30-35% (Li et al., 2012b), not the expected 50%, suggesting that reduced
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transcript levels is not a general rule for all monoallelically expressed genes (Jeffries et al.,
2012). Therefore the functional consequences, if any, for the majority of random autosomal
monoallelically expressed genes remains unknown.
While there are some similarities between random autosomal monoallelic expressed genes
and the classic examples of monoallelic expression, there are also marked differences (table 1.2).
All types of monoallelic expression identified, with the exception of genomic imprinting and
monoallelic expression resulting from genomic cis effects, exhibit a random choice of allele ex-
pressed. Additionally, the allelic imbalance is mitotically stable, and thus is inherited across cell
division. However, random autosomal monoallelically expressed genes are not always expressed
exclusively from one allele, as is observed for X-chromosome inactivation, genomic imprint-
ing, olfactory receptors and immunoglobulins. Furthermore, the random autosomal monoallelic
genes are scattered throughout the genome and do not fall into any clusters, unlike the other
cases of monoallelic expression. While the classic examples of monoallelic expression have been
extensively studied and are fairly well understood at the molecular level, detailed characterisa-
tion and mechanistic insights into random autosomal monoallelic expression is limited. Thus
it remains unknown if many of the features associated with the classic examples of monoal-
lelic expression hold true for the random autosomal monoallelically expressed genes (table 1.2).
For example, global nuclear organisation is strongly implicated in X-chromosome inactivation
(Chow and Heard, 2010), olfactory receptors (Clowney et al., 2012; Lomvardas et al., 2006), im-
munoglobulins (Kosak, 2002; Skok et al., 2001) and to a lesser extent in imprinted genes (Krueger
et al., 2012), however to date only one study has examined the role of nuclear organisation of a
random autosomal monoallelically expressed gene (Takizawa et al., 2008a). Additionally, how
the alleles are distinguished molecularly through either DNA methylation and/or histone mod-
ifications, has not been extensively covered. While two genome-wide screens were based on
the assumption that monoallelically expressed genes show differential DNA methylation (Wang
et al., 2010, 2007), and another suggested that monoallelically expressed genes may have de-
creased CpG density and increased DNA methylation levels compared to biallelic genes (Jeffries
et al., 2012), careful examination of contribution of DNA methylation to monoallelic expression
has not been made. Furthermore, there has been only one report identifying histone modifi-
cations that are preferentially associated with monoallelically expressed genes, including a 2.9
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Table 1.1: Features of random autosomal monoallelically expressed genes.
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fold increase in H3K27me3 repressive marks and approximately a 2 fold decrease in H3K4me3,
H3K9ac and H3K9me3 (Jeffries et al., 2012), however direct evidence of preferential association
of these marks between active and inactive alleles has not been performed. Asynchronous DNA
replication timing is a distinguishing feature of classic monoallelic expression (Chess, 2012a).
While the replication timing patterns of most random autosomal monoallelically expressed genes
remain to be determined, selected examples, including the interleukins (Ensminger and Chess,
2004; Hollander et al., 1998) and the non-coding RNA Asar6 (Donley et al., 2013), exhibit
asynchronous DNA replication timing. However, asynchronous replication timing is generally
coordinated across entire chromosomes (Dutta et al., 2009; Ensminger and Chess, 2004), where
as the choice of active allele is not (Gimelbrant et al., 2007; Wang et al., 2007; Zwemer et al.,
2012), suggesting that even if monoallelically expressed genes are asynchronously replicating, the
early replicating allele may not necessarily be the active allele (Chess, 2012a). Thus replication
timing may not be the critical feature of random autosomal monoallelically expressed genes.
Finally, the dynamics of monoallelic expression during differentiation, and tissue-specificities of
the random autosomal monoallelically expressed genes remains to be determined. Increasing
our understanding of which genes undergo random monoallelic expression, and how this state
is maintained across cell divisions, will provide insights into potential functional consequences
of random autosomal monoallelic expression in mammalian cells.
1.3.3 Embryonic stem cell differentiation as a paradigm to investigate
monoallelic expression
One of the outstanding unanswered questions regarding random autosomal monoallelic expres-
sion is when and how the monoallelic state is established. For other forms of random monoallelic
expression, including X-chromosome inactivation and immunoglobulin allele-exclusion, the fu-
ture active and inactive alleles are selected in early development, around the time of implantation
from E3.5 to E8.5 (Heard et al., 1997). Embryonic stem cells (ESCs) are pluripotent cells de-
rived from the inner cell mass of the E4.5 blastocyst. They provide a useful tool for studying
this stage of early development due to their unlimited self-renewal in culture, and ability to
differentiate into any of the adult somatic cell types. ESCs have been an invaluable tool for the
X-chromosome inactivation field. From the 2-cell stage to early blastocysts, both of the two
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Table 1.2: Comparison of random autosomal monoallelic expression with other types of monoal-
lelic expression.
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X-chromosomes are active, and is believed that the lack of dosage compensation at this time
point is not lethal to the embryo as not many X-linked genes are expressed at this early stage
of development (Heard et al., 1997). Indeed, the consequences of two active X-chromosomes
is only lethal around 10 dpc (Takagi and Abe, 1990). The earliest signs of X-chromosome in-
activation is the asynchronous DNA replication timing observed at the two X-chromosomes at
E3.5 to E4.5 (Takagi et al., 1982). The silencing of one of the two X-chromosomes occurs at
the late blastocyst stage, at 5.5 to 6.5 dpc (McMahon and Monk, 1983) and is complete by
gastrulation at 6.5 dpc (Monk and Harper, 1979). Embryonic stem cells contain 2 active X-
chromosomes of which one undergoes random inactivation upon differentiation (Martin et al.,
1978; Rastan and Robertson, 1985), and thus have been essential for many of the studies in-
vestigating the molecular mechanisms of X-inactivation. Similar to the X-chromosomes (Takagi
et al., 1982), the immunoglobulin and T-cell receptor loci also replicate asynchronously in ESCs,
and it is almost always the early replicating allele that later undergoes recombination in the B
cells (Mostoslavsky et al., 2001). Additionally, other forms of random monoallelic expression,
including the interleukins and olfactory receptors, replicate asynchronously in human embryonic
stem cells (Dutta et al., 2009), again suggesting that the choice of the future active allele may be
determined at this stage of development. Embryonic stem cells have also been useful in studying
the early events of imprinted gene expression (Latos et al., 2009). In this way, embryonic stem
cells represent a good in vitro system for studying random monoallelic expression.
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Chapter 2
Embryonic Stem Cell Pluripotency and
Differentiation
Embryonic stem cells (ESCs) are derived from the inner cell mass of the blastocyst embryo
(figure 2.1A). Mouse ESCs were first derived in 1981 (Evans and Kaufman, 1981; Martin, 1981),
and human ESCs in 1998 (Thomson et al., 1998). As mentioned above, ESCs are unique in
their ability to self renew indefinitely, as well as contribute to cell types of all three embryonic
germ layers: endoderm, mesoderm and ectoderm. While embryonic development was originally
thought to irreversible, the pluripotent state can be reprogrammed in differentiated somatic cells
either by somatic cell nuclear transfer (Gurdon, 1962), in which an adult nucleus is transferred
into either an enucleated oocyte or an embryonic stem cell recipient; nuclear fusion of a somatic
cell with a pluripotent cell (Blau et al., 1983); or over-expression of a set of 4 genes: Oct4,
Sox2, Klf-4 and C-myc (Takahashi and Yamanaka, 2006). This indicates that cell fate decisions
are not irreversible, and, while the differentiated state is generally stable, it is also dynamically
controlled and can be changed (Yamanaka and Blau, 2010).
2.1 Embryonic Stem Cell culture and characterisation
Mouse ESCs are typically cultured on a feeder layer, typically mouse embryonic fibroblasts
(MEFs), and form tightly packed round colonies containing tens to hundreds of cells (figure
2.1B). These cells express the pluripotency markers Oct4 (Pou5f1) and Nanog (figure 2.1C)
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which is absent in the MEF feeder cells. Nanog expression levels are variable, a feature which
is thought to be linked to their pluripotent potential with Nanoghigh cells undergoing self-
renewal and Nanoglow cells being poised for differentiation. It has been proposed that stochastic
monoallelic expression of Nanog contributes to the two populations of cells (Miyanari and Torres-
Padilla, 2012), although this has recently been disputed (Faddah et al., 2013; Filipczyk et al.,
2013). ESCs are traditionally cultured in serum containing medium supplemented with leukemia
inhibitory factor (LIF) which keeps the cells in a pluripotent state by activating the STAT3
signaling pathway, and serum containing bone morphogenetic protein 4 (BMP4) which inhibits
the the differentiation process, and are induced to differentiate through FGF signaling. ESCs
can also be cultured in serum-free medium supplemented with small molecule inhibitors which
block Erk signaling downstream of the FGF receptor and Glycogen Synthase Kinase 3ß (Ying
et al., 2008), and represent a more homogeneous population of cells which show properties
more similar to that of the inner cell mass, including hypomethylation (Ficz et al., 2013), and
homogeneous nanog expression (Miyanari and Torres-Padilla, 2012). With the exception of
selected experiments in Chapter 3, ESCs were cultured in serum containing medium on MEF
feeder cells.
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Figure 2.1: Pluripotency of mouse embryonic stem cells.
(A) Early blastocyst-stage embryo schematic showing inner cell mass from which ESCs are
derived. (B) Light micrograph of ESCs grown on MEF feeder cells in culture. ESCs form
round colonies containing 10s to 100s of tightly compacted pluripotent cells (arrows). Scale bar
= 200μm. (C) Immunofluorescence staining of ESCs (arrows) grown on MEF feeder cells (*).
ESCs express the pluripotency markers Oct4 (green) and Nanog (red). DAPI shows DNA. Scale
bar = 50μm. Images represent single z-slice.
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2.2 Embryonic Stem Cell differentiation paradigms
ESCs can be differentiated in vitro by removing them from the MEF feeder cells and withdrawing
LIF from the medium. The process of differentiation can be sped up by addition of retinoic acid
(RA), an analogue of vitamin A which through binding to the retinoic acid receptor induces and
represses gene transcription of a large number of genes, including the HOX genes (Duester, 2008).
By day 2 of RA induced differentiation, expression levels of Nanog are absent, and Oct4 shutoff
by day 4 (figure 2.2A on the next page). In contrast markers of the three germ layers as well as
trophectoderm increase during RA induced differentiation (figure 2.2B-E), indicating that while
the ESCs have lost pluripotency and differentiated, the resulting population of differentiated cells
is very heterogeneous. In order to assess monoallelic gene expression during ESC differentiation,
a homogenous population of differentiated cells is required. Neural progenitor cells (NPCs) were
selected as the differentiated cell type for several reasons. Firstly, NPC differentiation is a fairly
well established differentiation paradigm and is used by numerous labs. Therefore the protocols
are fairly well established and reagents required readily available. Because of its wide use, there
are also a large number of genome-wide data sets comparing ESCs to NPCs for many different
features including histone-modifications (Mikkelsen et al., 2007), DNA methylation (Meissner
et al., 2008), Lamin-associated domains (Peric-Hupkes et al., 2010) and DNA replication timing
domains (Hiratani et al., 2008). Finally, monoallelic gene expression is known to exist in the
nervous system, for example at the olfactory receptor and protocadherin gene clusters, therefore
identification of potentially more autosomal monoallelically expressed genes could be of interest
in the context of cell to cell variation and unique cell identity features of the nervous system.
The ESC to NPC paradigm established was based on that from Austin Smith’s lab (Conti
et al., 2005). A complete detailed protocol is provided in appendix C.1 on page 259. ESCs are
collected and MEF feeder cells removed by soaking the cells on gelatin (figure 2.3). MEFs and
other differentiated cell types will typically adhere to gelatin within 30 minutes, whereas ESCs
take several hours. In this way the pluripotent ESCs can be isolated. Cells are then induced to
differentiate in N2B27 medium on gelatin coated plates for approximately 6 days. This medium
contains N2 and B27 supplements which contain, amongst other compounds, insulin, transferrin,
progesterone, putrescine, selenite and retinoic acid. The concentration of cells initially seeded
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Figure 2.2: Retinoic induced differentiation of ESCs.
Expression of pluripotency (A), neuroectoderm (B), endoderm (C), mesoderm (D) and trophec-
toderm (E) markers during 4 days of retinoic acid induced differentiation.
59
was found to be critical, as it varies the efficiency of differentiation. Following 6 days, cells were
collected and placed into suspension in N2 medium containing N2 supplement, EGF and FGF
but lacking B27 supplement. Over the next 3-4 days, neurosphere aggregates will form and
grow. These can be collected either by mild centrifugation or sedimentation, resuspended in
fresh medium and placed back onto gelatin coated plastic. Within a few days the NPCs will be
ready for passaging and within a few passages will represent a homogenous population of cells.
The NPCs can be cryopreserved and sub-cloned, although the efficiency of colony formation is
increased if B27 supplement is added to the medium.
The ESC derived NPCs have the typical small triangular morphology of NPCs (figure 2.3),
and appropriate growth kinetics, requiring passaging approximately every 3 days. The NPCs
lacked expression of the pluripotency markers Oct4 and Nanog, which were present in ESCs, and
gained expression of the neural markers Nestin and Blbp1 (figure 2.4). Furthermore, immunoflu-
orescence staining of the cells was performed using the neural intermediate filament marker
Nestin, which was specifically present in the NPCs, but not the pluripotent ESCs (figure 2.5).
Thus the differentiated homogenous population of cells have all the appropriate characteristics
of NPCs.
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Figure 2.3: ESC to NPC differentiation protocol.
Outline of protocol used to differentiate mouse ESCs to NPCs. Representative light micrographs
of different stages of the differentiation paradigm are shown. Scale bar = 200μm.
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Figure 2.4: Expression of lineage marker expression upon ESC differentiation to NPC.
Comparison of pluripotency (A) and neural (B) markers in ESCs (black) and NPCs (grey).
Error bars represent SEM of 3 biological replicates.
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Figure 2.5: Nestin immunofluorescence staining of ESCs and NPCs.
Immunofluorescence staining for the neural marker nestin in ESCs (top row), derived NPCs
(middle row). Bottom row represents negative control where no primary antibody was used.
Scale bar = 10μm.
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2.3 Nuclear dynamics of ESCs and differentiated cell types
ESCs are unique in their pluripotency which is reflected in a fluid and malleable nuclear struc-
ture. Indeed, live cell imaging of ESCs transiently transfected with mCherry-Lamin protein
fusions demonstrates their hyperdynamic nucleus (figure 2.6 on the next page) over very short
time scales. In contrast, differentiated MEFs have a more static and regularly shaped nucleus
which lacks the protrusions and invaginations seen in ESC nuclei. NPCs are intermediates
between the two cell types, while they still have dynamic nuclei, their shape is slightly more
regular, although not to the same extent as the MEFs. One of the major dogmas at the time of
these experiments, was that ESCs do not express Lamin A/C, one of the Lamin protein family
members, and that the absence of Lamin A/C is not only a marker for the undifferentiated state
(Constantinescu et al., 2006), but also be the reason for the dynamic nucleus and plastic chro-
matin associated with pluripotency (Mattout and Meshorer, 2010; Meshorer and Misteli, 2006).
This motivate these original live-cell imaging studies, however, the expression of Lamin A or
Lamin C in ESCs did not alter the nuclear dynamics (figure 2.6), nor did it change their gross
morphology or growth kinetics in culture. This finding led to the interesting and controversial
finding that ESCs do indeed express low levels of Lamin A/C and that the purported absence
of Lamin A/C is not an essential attribute of pluripotency (Eckersley-Maslin et al., 2013).
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Chapter 3
Lamin A/C is expressed in pluripotent
mouse embryonic stem cells
Embryonic stem cells are unique in their nuclear structure and organization, typically consisting
of a more fluid and dynamic chromatin compared to somatic cell types (Denholtz and Plath,
2012; Fisher and Fisher, 2011; Li et al., 2012a; Meister et al., 2011) (figure 2.6). It has been
widely purported that these unique features of ESCs are due to the absence of the nuclear
intermediate filament Lamin A/C protein in the cell and many models have been made linking
Lamin A/C absence to pluripotency (Li et al., 2012a; Melcer et al., 2012; Meshorer and Misteli,
2006). I was therefore interested to see what effect of expressing Lamin A/C in ESCs would
have on chromatin, gene expression and pluripotency of these cells. However, surprisingly,
Lamin A/C was clearly detected at both the mRNA and protein levels in both established and
primary ESC lines. Furthermore, I showed that Lamin A/C is also readily detected in the inner
cell mass of E3.5 blastocysts, thus refuting the dogma that lack of Lamin A/C is an essential
feature of pluripotency. These observations were published as an article in Nucleus in January
2013 (Eckersley-Maslin et al., 2013).
Author contributions to the manuscript: MAE-M and DS designed experiments and wrote
manuscript; MAE-M generated RNA-sequencing libraries and performed all Q-PCR, Western
Blotting, Immunofluorescence experiments; JHB performed RNA-sequencing data analysis; ZL
performed super-resolution OMX microscopy (not included in final manuscript).
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3.1 Abstract
The pluripotent nature of embryonic stem cells (ESC ) is associated with a dynamic open
chromatin state and an irregular nuclear shape. It has been postulated that the absence of lamin
A/C contributes to these features. However, we show that mouse ESCs express low, yet readily
detectable, amounts of lamin A/C at both the RNA and protein levels. Full-length transcripts of
both isoforms were readily detected by q-PC R and deep RNA sequencing. Additionally, protein
expression was validated in multiple primary and established ESC lines by immunoblotting using
several independent antibodies. Immunofluorescence labeling showed localization of Lamin A/C
at the nuclear periphery of all Oct4/Nanog double-positive ESC lines examined, as well as in
the inner cell mass of blastocysts. Our results demonstrate ESC s do express low levels of lamin
A/C, thus models linking pluripotency and nuclear dynamics with the absence of lamin A/C
need to be revisited.
3.2 Introduction
Embryonic stem cells (ESCs) are pluripotent cells derived from the inner cell mass of the pre-
implantation blastocyst, which are unique in their ability to self-renew indefinitely as well as dif-
ferentiate into essentially all cell types of the adult organism. ESC pluripotency is accompanied
by a unique dynamic chromatin organization and nuclear morphology (reviewed in (Denholtz
and Plath, 2012; Fisher and Fisher, 2011; Li et al., 2012a; Meister et al., 2011)). The irregular
nuclear shape of ESCs contains many invaginations and protrusions which are highly malleable
(Pajerowski et al., 2007), and the inter-membrane space of the nuclear envelope is wider and
unevenly spaced compared to differentiated cells (Smith et al., 2011). Upon differentiation, this
irregular nuclear shape transitions to a smooth and rigid form. Differentiation is further paral-
leled by changes in the association of blocks of chromatin with the nuclear periphery, including
pluripotency genes such as nanog, (Peric-Hupkes et al., 2010) suggesting a tight connection
between nuclear organization and the differentiation program.
Globally, the chromatin in ESCs is dispersed, loosely packed (Ahmed et al., 2010), with
large, poorly defined heterochromatin domains and an increased mobility of heterochromatin
proteins, such as HP1 (Meshorer et al., 2006). The chromatin is plastic and hyperdynamic,
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compared to differentiated cell types (Meshorer et al., 2006). This openness of the chromatin is
correlated with high DNAse I accessibility (Fisher and Fisher, 2011), and wide-spread transcrip-
tion of both coding regions as well as repetitive elements of the genome (Efroni et al., 2008).
Furthermore, ESCs contain extensive regions with a bivalent chromatin signature in which the
transcription-associated H3K4me3 histone modification co-exists with the polycomb-group re-
pressive H3K27me3 modification (Mikkelsen et al., 2007). These “poised” domains are largely
enriched over lineage-specific genes and become resolved to either an active (H3K4me3) or inac-
tive (H3K27me3) state during differentiation(Mikkelsen et al., 2007). The resolution of bivalent
domains to an inactive state correlates with an increase in DNA methylation at these promoters
(Mohn et al., 2008). The interconnection between the unique chromatin features and distinctive
nuclear structure is thought to have an essential role in ESC pluripotency.
The major structural component of the nucleus is the nuclear lamina, which forms di-
rectly below the inner-nuclear membrane (Dechat et al., 2008; Zhao et al., 2009). The nuclear
lamina is composed predominantly of a meshwork of type V intermediate filament proteins
called lamins, which interact with chromatin, nuclear pore complexes and lamin-associated
proteins{Wilson:2010cw}, and have important functions in gene regulation and chromatin orga-
nization (Dechat et al., 2010). The nuclear lamins can be subdivided into A- and B-types based
on sequence homology and structural features. There are two major B-type lamins in most ver-
tebrates, lamin B1 and lamin B2, which are expressed throughout development and are required
for organogenesis and proper neural development (Coffinier et al., 2011; Kim et al., 2011). The
A-type lamins are encoded by a single gene which is alternatively spliced yielding two isoforms,
lamin A and lamin C, which differ in the length of their C-terminal tail with lamin A being 74
amino acids longer. Loss of lamin proteins in vivo results in severe developmental defects (Kim
et al., 2011; Sullivan et al., 1999), and Lamin A/C mutations are associated with premature
aging in individuals with progeria (Dechat et al., 2010). Lamin A/C has been reported to be
completely absent in ESCs (Constantinescu et al., 2006), and levels increasing during embryo-
genesis (Röber et al., 1989; Schatten et al., 1985; Stewart and Burke, 1987). This purported
absence of Lamin A/C in ESCs has served as a landmark for models and hypotheses explaining
pluripotency, chromatin dynamics and ESC nuclear plasticity (Li et al., 2012a; Melcer et al.,
2012; Meshorer and Misteli, 2006).
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We sought to systematically re-investigate whether ESCs express lamin A/C. Interestingly,
we show that lamin A/C is expressed in ESCs at both the RNA and protein levels, although at
lower levels than in differentiated mouse embryonic fibroblasts (MEFs). Furthermore we show
that Lamin A/C is expressed in the inner cell mass of early blastocysts, from which ESCs are
derived. Our results show conclusively that ESCs express lamin A/C, and that its absence is
not a marker of the undifferentiated pluripotent state.
3.3 Results and Discussion
Lamin A/C is expressed in embryonic stem cells In order to examine lamin expression levels,
we performed real-time quantitative PCR on RNA derived from ESCs, neural progenitor cells
(NPCs) and mouse embryonic fibroblasts (MEFs) (figure 3.1A). ESCs were separated from the
MEF feeder cells (see materials and methods) and, as expected, expressed the pluripotency
markers oct4 and nanog (figure 3.1A). Importantly, we also detected lamin A and lamin C iso-
forms in ESCs at a similar level to NPCs, yet at a lower level than MEFs (figure 3.1A). The lmna
promoter is marked by the active-transcription associated histone H3 Lysine 4 trimethylation
(H3K4me3) mark (Mikkelsen et al., 2007) supporting gene transcription. Examination of whole
genome polyA+ RNA-sequencing data (J.H.B., M.A.E-M, D.L.S., unpublished data), as well as
published data sets from mouse (Marks et al., 2012; Mikkelsen et al., 2007) and human ESCs
(Birney et al., 2007), confirmed full length lamin A/C mRNA was generated above thresholds
used to define active gene transcription (figure 3.1B). Together, these data demonstrate that
the lmna gene is actively transcribed to yield full-length mRNA in ESCs.
To confirm that lamin A/C mRNA transcripts are being translated into protein, we per-
formed immunoblotting experiments using a series of well characterized antibodies recognizing
specifically either Lamin A/C (Moir et al., 1994) or Lamin A alone (Dechat et al., 2007). All
antibodies examined showed a clear signal in AB2.2 ESCs (figure 3.2A). Both monoclonal and
polyclonal Lamin A/C antibodies showed a doublet band, which corresponds to the two pro-
tein isoforms, whereas the Lamin A antibody specifically detected the larger Lamin A isoform.
Importantly, no signal was seen in an identically prepared lamin knock-out (lmna-/-) ESC line
(Sullivan et al., 1999), confirming antibody specificity and the purity of the ESCs from MEF
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Figure 3.1: Lamin A/C is expressed in mouse Embryonic Stem Cells.
(A) Quantitative real-time RT-PCR of the pluripotency genes oct4 and nanog, and lamin A,
lamin C and lamin B1 in ESCs (black), NPCs (grey) and MEFs (white). Error bars represent
standard deviation of three biological replicates. Data was normalized to the geometric mean
of three housekeeping genes. (B) Gene coverage plot showing expression of the full-length lmna
gene in AB2.2 ESCs by whole genome deep RNA-sequencing of polyA+ RNA.
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feeder cells (figure 3.2A, lane 2). Although this knock-out ESC line has been reported to ex-
presses a truncated Lmna protein (Jahn et al., 2012), the epitopes recognized by the antibodies
are not contained within this expressed portion. Both AB2.2 and lmna-/- ESCs expressed the
pluripotency marker Oct4 (figure 3.2A). Lamin A/C protein was also detected in 3 early-passage
ESC lines, 4 additional well-established ESC lines and an iPS cell line (figure 3.2B), confirming
that Lamin A/C expression is not limited to the AB2.2 ESC line, nor an adaptation of long-
term culturing, and is therefore a general feature of pluripotency. Furthermore, examination of
previously published proteomics screens of ESCs (Graumann et al., 2008; Gundry et al., 2010)
revealed Lamin A/C peptides. Combined, these results clearly demonstrate that lamin A/C is
expressed at both the RNA and protein levels in multiple primary and well-established ESC
lines.
Lamin A/C is correctly localized to the nuclear periphery in all cells within an ESC colony.
We next performed immunofluorescence to determine expression patterns throughout individ-
ual cells in ESC colonies cultured either with MEF feeder cells in medium supplemented with
10% serum and leukaemia inhibitory factor (LIF), or in serum-free, feeder-free 3i medium (Ying
et al., 2008) which maintains ESCs in a more uniform basal state of pluripotency. To ensure
that the ESCs remained pluripotent, the ESCs grown on MEF feeders were not separated from
the MEFs as above, but fixed on MEF feeder cells, which also serve as an internal control for
immunofluorescence labeling. ESCs can be easily distinguished morphologically from MEFs as
they grow in tight colonies, have a high nuclear to cytoplasmic ratio and have smaller and
irregularly shaped nuclei (see for example figure 3.2C fourth panel). Lamin A/C immunofluo-
rescence demonstrated correct localization to the nuclear periphery in both LIF (figure 3.2C)
and 3i medium (figure 3.2C, bottom row). Importantly, all cells within the colony displayed
Lamin A/C labeling, including the cells in the center of the colonies, confirming that Lamin A/C
expression is not limited to the peripheral cells, which may occasionally include partially dif-
ferentiated cells. The Lamin A/C positive ESCs co-expressed Oct4 and Nanog confirming their
pluripotency (figure 3.2C, arrows). ESCs grown in 3i medium show uniform Nanog expression
throughout all cells in the colony, consistent with this culture condition maintaining the cells
in a ground-state of pluripotency (Marks et al., 2012; Ying et al., 2008). As a control, lmna -/-
ESCs did not show any Lamin A/C labeling (figure 3.3, fifth row). Notably, ESCs have lower
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Figure 3.2: Lamin A/C is expressed in mouse ESCs and localizes to the nuclear periphery of
Oct4 positive ESCs.
(A) Lamin A/C protein expression is detected in AB2.2 ESCs by immunoblotting using three
independent antibodies. Monoclonal (first row) and polyclonal (second row) Lamin A/C anti-
bodies detect Lamin A (70kDa) and Lamin C (65kDa) isoforms. Lamin A/C knockout ESCs
confirm purity of ESC protein preparation and immunoblotting specificity. All cell types ex-
press lamin B1. Oct4 is used to verify pluripotency and histone H3 is used as a loading control.
(B) Extension of the immunoblotting analysis as above, in 9 independent ESC lines including
AB2.2 (lane 1), three primary ESC lines (WB6.1, CHS1, MK6, lanes 2-4 respectively), estab-
lished ESC lines (R1, ZHBTc4, v6.5, Bl6xCast, lanes 5-8 respectively), and an iPS cell line (lane
9). (C, D) Immunofluorescence was performed on ESCs grown on irradiated MEF feeder cells
(top row) or in serum-free, feeder-free 3i medium (bottom row) for Lamin A/C (first column,
green), nanog (second column, red) and Oct3/4 (third column, orange) and counterstained with
DAPI (fourth column, blue). Representative image showing a colony of AB2.2 ESCs, which
label for the pluripotency markers Nanog and Oct4 and have lamin A/C localization at the nu-
clear periphery. Arrows indicate the top of MEF nuclei. Images were taken on a Zeiss LSM710
confocal microscope. A single z-section through the center of the ESC colony is shown. Scale
bar represents 10μm.
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levels of Lamin A/C when compared to MEFs, which may explain why previous reports have
failed to detected Lamin A/C in ESCs (Constantinescu et al., 2006), as ESC staining is very
faint and could be mistaken for background staining when optimal exposures for MEF nuclei are
used. However when compared to the negative control staining in which the primary antibodies
were omitted (figure 3.3, last row), it is clear that the Lamin A/C signal observed is a bona
fide localization signal. The localization of lamin A/C to the nuclear periphery of all cells in
the ESC colony was further confirmed in other established ESC lines (figure 3.3). Immunoflu-
orescence using a different antibody specifically against Lamin A also showed clear signal at
the nuclear periphery in all cells in the colony in 5 separate ESC lines tested (figure 3.4). Our
results convincingly show that Lamin A/C is correctly localized to the nuclear periphery in all
pluripotent ESCs examined. Therefore, absence of Lamin A/C should not be used as a marker
of the undifferentiated state.
Lamin A/C is expressed in blastocysts As Lamin A/C is expressed in embryonic stem cells,
we tested whether we could detect Lamin A/C in the developing blastocyst. Examination of
published single cell RNA sequencing data-sets of 2-cell, 4-cell, 8-cell and inner cell mass of blas-
tocysts, in addition to ESCs, revealed lmna transcript was present at all developmental stages,
above the significant expression threshold cut-offs used (Tang et al., 2011). We isolated fresh
blastocysts at E3.5, and performed immunofluorescence labeling for Lamin A/C protein. We
clearly detected Lamin A/C protein at the nuclear periphery of both nanog positive and nanog
negative cells in the developing blastocyst (figure 3.5). The nanog positive cells represent the in-
ner cell mass of the blastocyst from which ESCs are derived, demonstrating that the expression
of Lamin A/C is not acquired upon ESC derivation, nor is it a cell-culture phenomenon.
Conclusion
In summary, we demonstrate that the dynamic nuclear structure of ESCs is not due to an
absence of Lamin A/C. Our results show that lamin A/C is in fact expressed at both the
RNA and protein levels in mouse ESCs as well as in the inner cell mass of the developing
blastocyst. Additionally, immunofluorescence labeling clearly shows Lamin A/C expression in
pluripotent Oct4/Nanog double positive ESC colonies, eliminating any concerns that the Lamin
A/C detected by other assays is due to contamination of partially differentiated cells or MEF
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Figure 3.3: Lamin A/C localizes to the nuclear periphery in Oct4 positive ESCs.
Immunofluorescence against Oct4 and lamin A/C was performed in R1 (top), v6.5 (second row),
ZHBTc4 (third row) and C57Bl6xCasteneous hybrid (fourth row) ESCs. The ESC colonies stain
positively for Oct4 and Lamin A/C. Lmna-/- knockout ESC (fifth row) stain positively for Oct4
but not Lamin A/C which is present in MEFs (arrow), confirming antibody specificity. The
bottom row shows a control immunofluorescence in AB2.2 ESCs in which primary antibodies
were omitted. Scale bar represents 10μm. Images were taken on a Zeiss LSM710 confocal
microscope. A single z-section through the center of the ESC colony is shown. Scale bars
represent 10μm.
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Figure 3.4: Lamin A is expressed in multiple ESC lines.
Immunofluorescence using an antibody against lamin A (first column) shows localization to the
nuclear periphery in all cells within the ESC colony in AB2.2 (top), R1 (second row), v6.5 (third
row), ZHBTc4 (fourth row) and Bl6xCast (bottom row) ESC lines. Cells are counterstained with
DAPI (second column). Images represent single 0.1μm sections through the center of ESC colony
taken on a Zeiss LSM710 confocal microscope. Scale bar represents 10μm.
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Figure 3.5: Lamin A/C is expressed in the inner cell mass of blastocysts.
Immunofluorescence labeling of E3.5 blastocyst for Lamin A/C (left), nanog (center) and coun-
terstained with DAPI (right). There is clear localization of Lamin A/C at the nuclear periphery
of nanog positive cells, representing the inner cell mass as well as more peripheral nanog negative
cells representing trophectoderm. Images were taken on a Zeiss LSM710 confocal microscope
and represents a single section. Scale bar represents 20μm.
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feeder cells.
A recent report has implicated Lamin A/C in ESC chromatin mobility (Melcer et al., 2012),
however the effects seen were very moderate and limited to heterochromatin, with euchromatin
remaining unchanged. Furthermore, overexpression of Lamin A/C did not result in any al-
terations in pluripotency gene expression nor ESC colony morphology (Melcer et al., 2012),
consistent with our observations that Lamin A/C does not contribute to the link between nu-
clear structure and pluripotency. It remains to be determined whether the lowered levels of
Lamin A/C compared to more differentiated cell types have a role in regulating the unique fluid
chromatin and pluripotency of ESCs.
Importantly, our results provide insight into the absence of a phenotype in lamin B1/B2
knock-out ESCs (Kim et al., 2011), as the presence of a low level of lamin A/C would be
sufficient to maintain cell viability and pluripotency. However, we do not rule out that total
levels and, in particular, the ratio between the different lamin proteins, may play an important
developmental role in either cell differentiation or cell fate decisions. The strong developmental
defects seen in mice upon removal of either both lamin B1 and B2 (Kim et al., 2011), or lamin
A/C (Sullivan et al., 1999), clearly demonstrate the importance of lamin proteins in coupling
nuclear architecture to the gene expression program.
It remains to be determined how the highly irregular nuclear structure of ESCs is maintained
in the presence of low levels of Lamin A/C, and how this relates to the pluripotent nature of the
cells. While the lower levels of Lamin A/C in ESCs may contribute to their pluripotency, other
nuclear envelope-associated factors may also be involved, and many are differentially expressed
between ESCs and differentiated cells (J.H.B, M.A.E-M and D.L.S., unpublished data). In
particular, Syne-1, a lamin-associated protein, has been implicated in regulating the changes in
nuclear envelope spacing that accompany ESC differentiation (Smith et al., 2011). Additionally,
ESC differentiation can be inhibited by preventing expression of the nuclear pore protein Nup210
(D’Angelo et al., 2012). How these, in addition to other protein(s) or factors, contribute to the
dynamic nuclear structure of ESCs and their pluripotency will be an exciting area of research
not only for the fields of chromatin, nuclear organization and stem cell biology, but also for
cellular reprogramming and its clinical applications.
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3.4 Materials and Methods
Cell Culture and Blastocyst Collection
ESCs were cultured using standard protocols in medium containing 1000U/ml Leukemia In-
hibitory Factor (Millipore) with irradiated MEF feeders (GlobalStem) on gelatin-coated plates.
ESCs cultured in iSTEM 3i media (Stem Cells Inc.) were passaged at least 6 times in serum-free,
feeder-free conditions on gelatin-coated plates before being analysed. For immunofluorescence
experiments, cells were grown either on gelatinized glass coverslips pre-seeded with MEF feed-
ers for +LIF experiments, or gelatinized glass coverslips alone for 3i experiments. For RNA
and protein isolation, ESCs were soaked twice for 1 hour on gelatin-coated plates to remove
MEFs, then immediately processed. AB2.2 (129/SvEvBrd-Hprtb-m2) ESC line was kindly pro-
vided by A. Mills, CSHL; R1 (129X1 x 129S1) ESC and v6.5 (C57Bl/6 x 129/Sv) by S. Kim,
CSHL; C57Bl/6 x Castaneous ESCs by C. Vakoc, CSHL; ZHBTc4 ESCs by A. Smith, Centre
for Stem Cell Research, University of Cambridge, UK (Niwa et al., 2000); lmna-/- ESCs by
C. Stewart, Institute of Molecular Biology, A*STAR, Singapore (Sullivan et al., 1999); nGFP2
iPSCs by R. Jaenisch, Whitehead Institute, MIT, USA (Wernig et al., 2008); WB6.1 (C57Bl/6
Cbrd/Cbrd/Cr), MK6 (C57B4) and CSH1 (129 x C57Bl/6) primary ESC lines were derived
in-house and experiments performed within 8 passages. NPCs were derived from AB2.2 ESCs
using a protocol adapted from (Conti et al., 2005). E3.5 blastocysts from normal female mice
were kindly isolated and provided by S. Kim, CSHL and P. Jiang, CSHL. Blastocysts were fixed
in 4% formaldehyde made fresh from paraformaldehyde and processed for immunofluorescence
within 2 hours of collection.
RNA-Sequencing
10μg of total RNA was isolated using Trizol reagent (Ambion). PolyA+ RNA was isolated
(Oligotex kit, Qiagen) and depleted of ribosomal RNA (ribominus kit). Stranded libraries were
prepared using a protocol adapted from (Parkhomchuk et al., 2009) for paired-end sequencing on
the Illumina GA IIx platform. Reads were mapped to the mouse mm9 reference genome using the
Tophat spliced-read aligner and coverage computed using BedGraph2 (bedtools suite). Coverage
tracks were uploaded to and visualized in the UCSC genome browser in BigWig format.
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Real-time RT PCR
Total RNA was isolated using Trizol reagent (Ambion), treated with amplification grade RNAse-
free DNAse I (Invitrogen) and converted to cDNA using random hexamer primers (Applied
Biosystems RT reagents) using manufacturer’s protocols. Quantitative real-time PCR was per-
formed using SYBR green reagents (Applied Biosystems). Primer sequences are available upon
request. Error bars represent standard deviation from three biological replicates normalized to
the geometric mean of beta-actin, cycloB1 and pabpc1.
Antibodies, Western Blotting and Immunofluorescence
Rabbit anti-lamin A (323-11, (Dechat et al., 2007), 1:2,000) and rabbit-anti-lamin A/C (266,
(Moir et al., 1994) 1:2,000) were kindly provided by R. Goldman, Northwestern University,
Feinberg School of Medicine; mouse anti-lamin A/C (Active Motif 39287, 1:1,000); rabbit anti-
laminB1 (abcam ab16048, 1:2,000); rabbit anti-Oct4 (Santa-Cruz sc9081, 1:2,000); rabbit anti-
histone H3 (abcam ab1791, 1:10,000) were used. Western Blots were performed using anti-
mouse or anti-rabbit secondary antibodies conjugated to HRP (1:10,000) and detected by ECL
(Perkin-Elmer). For immunofluorescence, coverslips were fixed in 4% PFA for 20 minutes at
room-temperature, permeablized in 0.5% Triton X-100 at 4 degrees for 5 minutes and blocked
for 1 hour in 3% BSA. Blastocysts were fixed in 4% PFA for 30 minutes at room-temperature,
permeabilised in 0.25% Triton X-100 for 15 minutes at room-temperature, then blocked in 10%
FBS with 0.1% Triton X-100 for 1-3 hours at room-temperature. Cells were incubated with
primary antibodies containing 1% BSA for either 1 hour at room temperature (Oct4 1:400, lamin
B1 1:400) or overnight at 4 degrees (lamin A 1:200, lamin A/C 1:200). All primary antibody
incubations for blastocysts were performed overnight. Overnight incubations are necessary
to ensure efficient antibody accessibility into the tightly packed ESC colonies. Anti-mouse,
anti-rabbit and anti-rat secondary antibodies conjugated to Alexa-488, Alexa-594 or Alexa-647
(Invitrogen) were used, and DAPI was used to counterstain DNA.
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Imaging
Immunofluorescence imaging of single sections was performed using a Zeiss LSM710 laser scan-
ning confocal microscope using a 63x 1.4N.A. oil-immersion objective using 405nm, 488nm,
594nm and 647nm lasers. Slides were mounted in antifade containing 10% glycerol and 1mg/ml
p-Phenylenediamine (Sigma). Images represent single 0.1μm sections through the center of ESC
colonies or individual blastocysts. No post-acquisition image processing was performed. Figures
show representative single z-sections.
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Chapter 4
Identification and characterisation of
monoallelically expressed genes
Bioinformatic analysis of the RNA-sequencing screen was performed through a collaboration
with David Thybert, John Marioni and Paul Flicek at European Molecular Biology Labo-
ratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cam-
bridge, CB10 1SD, United Kingdom. All other experimental results were generated by Mélanie
Eckersley-Maslin with some help from Jan Bergmann (CSHL) for NPC sub-cloning and RNA-
FISH analysis.
4.1 Allele-specific RNA-sequencing screen design
To identify in an unbiased manner monoallelically expressed genes, an allele-specific RNA-
sequencing screen was performed. Allele information was assessed using ESCs from a F1 hybrid
cross between the C57Bl/6J and CAST/EiJ mouse strains. This mouse strain has a high number
of polymorphisms, with 82% of transcripts, corresponding to 78.8% of genes, containing at
least 1 exonic single nucleotide polymorphism (SNP) and a median of 6 SNPs per transcript
(figure 4.1 on page 83). Single cells from both ESCs and NPCs were isolated and expanded
to generate 6 single-cell derived clones each. Assuming inheritance of monoallelic expression
across cell divisions, all cells within each single-cell derived clone are expected to express the
same combination of alleles. However, different clones should show random selection of alleles,
81
allowing the identification of mitotically inheritable random monoallelically expressed genes.
Figure 4.2 (page 84) shows a schematic representation of the screen design. Within each of
the 6 ESC and 6 NPC single-cell derived clones, transcripts were classified as either monoallelic
towards the C57Bl/6J allele (orange) or CAST/EiJ allele (blue), or biallelically expressed with
equal number of reads originating from both alleles (orange + blue). Transcripts could also be
classified as not-expressed or not-assessable (grey). Following classification of transcripts within
clones, transcripts were then grouped into one of three classes based on their expression patterns
across clones. Class A transcripts include the high confidence random monoallelically expressed
transcripts. Class B transcripts were of lower confidence and were subjected to additional fil-
tering to select additional high confidence monoallelic transcripts. Class C transcripts represent
non-random monoallelically expressed genes.
RNA sequencing of poly(A)+ purified RNA was performed and approximately 80 million
reads were generated per clone, which were mapped to both the C57Bl/6J and CAST/EiJ
transcriptomes using BWA (Li and Durbin, 2010), resulting in approximately 50 million mapped
reads per clone. The C57Bl/6J transcriptome, containing 87,862 transcripts, was collected from
ENSEMBL v59. The CAST/EiJ transcriptome was created by substituting the 423,197 exonic
single nucleotide polymorphisms (SNP) between the C57BL/6J and CAST/EiJ genomes (Keane
et al., 2011). A transcript was deemed expressed if it was in the top 80th percentile of the overall
expression distribution, and assessable if there were at least 5 reads covering an informative SNP.
For all expressed and assessable transcripts, the number of reads corresponding to each allele at
each SNP position was used to determine whether there was evidence of allele-specific expression.
Monoallelic expression was quantified using two metrics: a p-value calculated from a binomial
test; and a d-score representing the ratio of allele expression. The p-value was calculated using
a simple binomial distribution test, with the null hypothesis that there are equal number of
reads mapping to both alleles for all SNPs in a given transcript. The d-score was determined
by calculating the average weighted mean that each SNP within a transcript deviated from the
expected 50:50 equal distribution. In this way SNPs with a higher coverage, in which there
is less sampling noise, are given a higher weight. D-score values range between -0.5 and +0.5
with negative values corresponding to a bias towards the CAST/EiJ allele, and positive values
corresponding to a bias towards the C57Bl/6J allele. A value of 0 reflects equal number of reads
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Figure 4.1: Distributions of exonic SNPs between C57Bl/6J and CAST/EiJ genomes.
Histogram plot showing the distribution of frequency of SNPs within a transcript. 82% of
transcripts contain at least one SNP. The median number of SNPs per transcript was 6.
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ESC NPC
6 independent single-cell derived clones each
A: random monoallelic (either allele)
B: random monoallelic (one allele*)
C: non-random monoallelic
C57Bl/6J CAST/EiJ bialellic not expressed/assessable
Figure 4.2: Schematic representation of the allele-specific RNA sequencing screen.
C57Bl6/J x CAST/EiJ F1 hybrid ESCs were differentiated into NPCs and RNA from 6 single-
cell derived clones from each cell type derived sequenced. Within each clone transcripts were
classified as C57Bl/6J biased (orange), CAST/EiJ biased (blue), biallelic (orange + blue) or
not expressed/assessable (grey). Based on patterns across clones, transcripts were grouped into
three classes. Class A corresponding to random monoallelic with at least one clone biased to
C57Bl/6J and one clone biased to CAST/EiJ. Class B corresponding to random monoallelic
genes in which one clone was biased to either C57Bl/6J or CAST/EiJ. * Transcripts in this
class were further filtered to include those in which there was evidence the second allele could
be transcribed. Class C transcripts contain non-random monoallelic genes in which all clones
are biased all towards the same allele.
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from both alleles (biallelic expression). In this way, transcripts within each clone were classified
into one of 6 classes based on the p-value and d-score values (figure 4.3 on the next page):
• Monoallelic: |d-score|≥0.40, p-value ≤10-8
• Allele-biased: 0.18≤|d-score|<0.40, p-value ≤10-8
• Biallelic: |d-score|<0.18 and/or p-value>10-8
• Not expressed: expression is lower than 5.8 normalized reads per kilobase (NRPK)
• Not assessable: No SNV in the transcript with at least 5 reads coverage or the transcript
is within a genomic region filtered for aneuploidy (see below)
• Other: all remaining transcripts
To control for possible loss of heterozygosity, mouse diversity SNP arrays were run on ge-
nomic DNA from each of the 6 NPC clones. At each SNP position, a BAF value, corresponding
to the relative signal intensity of the C57Bl/6J allele versus CAST/EiJ allele, was calculated.
Each chromosome was split into 1Mb sized bins containing an average of 85.5 SNPs per bin.
The average BAF value for the bin was calculated and compared to an ESC polyclonal control
sample in which the genomic integrity had been previously confirmed by karyotype analysis.
Regions in which the distribution of BAF values differed significantly from the control were de-
fined as aneuploid and classified as non-assessable in the screen pipeline (figure 4.4 on page 87).
A total of 16 aneuploid regions were identified across the 6 NPC clones, and a subset confirmed
by karyotype analysis.
Based on the classification of transcripts into the 6 categories described above, transcripts
were assigned into one of three classes of monoallelically expressed genes. Those transcripts
which were assigned to the ’not-expressed’, ’non-assessable’ and ’other’ classes for a given clone
were not included in the classification process.
• Class A contains transcripts where at least one clone showed allele specific expression (ei-
ther monoallelic or allele-bias) of the C57Bl/6J allele and a second separate clone showed
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Figure 4.3: Classification of monoallelic transcripts.
(A) Classification of transcripts (black circles) within each clone based on d-score (x-axis) and
p-value (y-axis). Transcripts could be biallelic (middle, white), monoallelic for CAST/EiJ allele
(dark blue), allele-biased for CAST/EiJ allele (light blue), allele-biased for C57Bl/6J allele
(light orange) or monoallelic for C57Bl/6J allele (dark orange). (B) examples of transcripts
belonging to each of three classes based on transcript classification across clones. Class A
contain transcripts in which one clone is biased towards C57Bl/6J allele, and one biased towards
CAST/EiJ allele. Class B contain transcripts in which one clone is biased towards C57Bl/6J or
CAST/EiJ allele, some clones remain biallelic. Class C contain non-random monoallelic genes
in which all clones show bias towards the same allele.
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Figure 4.4: Identification of aneuploid regions with genomic SNP arrays.
Example of array data from chromosome 4 from ESC polyclonal control genomic DNA (top) and
NPC clone 3.20 genomic DNA (bottom). Red line depicts BAF value of 0.5 corresponding to
equal signal intensity coming from both C57Bl/6J and CAST/EiJ alleles. Each dot represents
one SNP between C57Bl/6J and CAST/EiJ mouse strains. Control ESC polyploid sample shows
a uniform distribution of BAF values surrounding 0.5. NPC clone 3.20 shows two aneuploid
regions. One biased towards CAST/EiJ (blue bar) and the second biased towards C57Bl/6J
(green bar). Transcripts within these regions were removed from subsequent analysis.
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allele specific expression of the CAST/EiJ allele. Some clones may also be biallelic. Tran-
scripts in this class represent high confident random monoallelic genes.
• Class B contains transcripts with at least one biallelic clone and at least one clone showing
allele specific expression (either monoallelic or allele-bias) towards either the C57Bl/6J or
CAST/EiJ allele. All clones showing allele-specific expression have the bias in the same
direction. To select high confidence monoallelic genes, class B transcripts were further
filtered using more stringent parameters to select those in which there was strong evi-
dence that the second allele was transcribed in at least one clone. Filtered class B tran-
scripts contain at least one clone with stringent allele specific expression (p-value<10-10,
|d-score|>0.35) and one clone with stringent biallelic expression (|d-score|<0.10) and rep-
resent additional high confidence random monoallelic genes.
• Class C contains transcripts in which allele specific expression was observed toward the
same allele for all clones and no biallelic clones were observed. This class contains non-
random monoallelically expressed genes, including imprinted genes and those biased due
to strong cis genetic effects. Class C transcripts were not included in subsequent analysis.
The final set of random monoallelically expressed transcripts includes class A and filtered class
B transcripts. Not all transcripts were necessarily assigned to one of the three classes above and
genes could be present in more than one class if they were represented by transcripts classified
in different classes.
4.2 Allele-specific RNA sequencing screen results
In mouse ESCs, 13,699 genes were expressed at sufficient levels and contained at least one SNP
covered by at least 5 reads. Of these assessable genes, only one was classified as high-confidence
class A (table 4.1 on page 90). An additional 66 filtered class B genes resulted in a total of 67
genes, or 74 transcripts, classified as random monoallelically expressed. This represents only
0.49% of assessable genes. Interestingly, this low number increased 5.6 fold during differentiation
to 376 genes in NPCs (table 4.2 on page 90). This included 86 genes in class A and 302 genes in
filtered class B, or 135 and 381 transcripts respectively, and represents 3.00% of assessable genes.
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This increase in monoallelic expression during differentiation suggests that the establishment of
monoallelic expression occurs upon cell-fate specification early in development. As expected, the
expressed imprinted genes were correctly classified into class C. Furthermore, 11 protocadherins
were included within the 376 NPC random monoallelically expressed genes, providing a good
internal positive control for the screen analysis.
Notably, only 4 of the 376 random monoallelically expressed genes in NPCs (Cyp7b1, Npl,
Plin2 and Rgs16 ) showed random monoallelic expression in all assessable clones. Therefore
for the remaining 98.9% of NPC monoallelically expressed genes, at least one clone was either
biallelic and/or did not express the respective gene. This contrasts with imprinted and X-
chromosome inactivated genes, where all cells exhibit strict monoallelic expression, and implies
that, rather than being tightly regulated, random monoallelic expression is likely not an active
decision required for cell survival or differentiation. Within a single clone, approximately 60%
of the monoallelically expressed genes showed biallelic expression for both ESC and NPC (fig-
ure 4.5 on page 91), supporting the hypothesis that monoallelic expression is not a requirement
for these genes but may reflect variation in gene expression regulation between two homologous
alleles. Interestingly, if an expressed transcript was not biallelic in ESCs, it was predominantly
allele-biased. In contrast, non-biallelic transcripts were predominantly monoallelically expressed
in NPCs (figure 4.5). This observation, along with the reduced frequency of inheritable monoal-
lelically expressed genes in ESCs compared to NPCs, is possibly a reflection of the increased
plasticity of pluripotent ESCs compared to the lineage committed NPCs (Mattout and Meshorer,
2010).
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Table 4.1: Summary of random monoallelically expressed genes in ESCs.
Genes Transcripts % Genes
Class A 1 1 ~
Class B 1665 2499 12.15
Class B filtered 66 73 0.48
Class C 547 721 3.99
Total Random Monoallelic (A+B filtered) 67 74 0.49
Table 4.2: Summary of random monoallelically expressed genes in NPCs.
Genes Transcripts % Genes
Class A 86 135 0.69
Class B 1874 3004 14.95
Class B filtered 302 466 2.41
Class C 276 381 2.20
Total Random Monoallelic (A+B filtered) 376 602 3.00
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Figure 4.5: Status of monoallelically expressed genes within individual clones.
Quantification of ESC and NPC monoallelic transcripts as monoallelic (dark orange), allele-
biased (light orange) or not expressed/assessable (grey). Bars represent average ± standard
deviation amongst 6 clones. ESC monoallelically expressed genes are predominantly allele-biased
whereas NPC monoallelically expressed genes are predominantly monoallelically expressed.
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4.3 Validation of monoallelically expressed genes
Three separate approaches were performed to validate the monoallelically expressed genes iden-
tified in the allele-specific RNA-sequencing screen. First, SNP-PCR, in which Sanger sequencing
of PCR products containing informative exonic SNPs was performed, provided a fast method
of verifying allele-specific expression in a population of cells. Secondly, RNA-polymerase II
Chromatin Immunoprecipitation (ChIP) allowed molecular verification as to the transcriptional
status of the alleles in a population of cells, independent of RNA analysis. Finally, combined
RNA-DNA FISH, in which both the gene locus and transcriptional activity of the respective
locus could be visualised, provided assessment of monoallelic expression at single-cell resolution.
SNP-PCR was performed on a subset of randomly selected monoallelically expressed genes
from category A, B and C in both ESCs and NPCs. Validation of genes as monoallelically
expressed through this method was invaluable in fine-tuning the p-value and d-score thresholds
used in the allele-specific RNA-sequencing screen. RNA from each of the clones was isolated,
cDNA synthesised and PCR performed to amplify exonic and/or intronic SNPs. Sanger se-
quencing was then performed on the PCR products and the expressed alleles deduced from
analysis of the sequencing traces. Primers and SNPs were confirmed either on genomic DNA
or cDNA generated from polyclonal population of cells in which both alleles are expected to
be expressed. Following analysis of the sequencing traces, clones were classified as monoallelic
or biallelic (figure 4.6 on the following page) prior to being compared to the RNA-sequencing
screen results.
A total of 82 SNP-PCR products analysing 20 separate genes were assessed (figure 4.7 on
page 95). This included 18 genes in NPCs and 2 genes in ESCs. Of the 18 NPC genes, 11 were
from class A, 2 from class B, 2 from class C, and 2 were biallelic. Both of the ESC verified
genes were from class B. For each gene, the results for the SNP-PCR and RNA-seq analysis
are shown (top and bottom rows respectively) across assessed clones. 76 of the 82 SNP-PCR
assays were in agreement with the RNA-sequencing screen, giving a 93% validation rate. Of
those that did not validate, 2 gene-clone combinations had a |d-score| very close to the cutoff
used of 0.180, resulting in them being classified as monoallelic in the RNA-sequencing screen and
biallelic by SNP-PCR analysis, or vice-versa. Nevertheless, overall there was excellent agreement
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Figure 4.6: Selected SNP-PCR validation of monoallelically expressed genes.
Example of SNP-PCR traces for four separate monoallelically expressed genes: Serpinh1, Cbr3,
Anxa6 and Cap2, showing an example of a biallelic clone (left column), C57Bl/6J monoallelic
clone (middle column) and CAST/EiJ monoallelic clone (right column). Arrows denote position
of SNP. Blue = C, green = A, red = T, black = G.
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between the RNA-sequencing results and SNP-PCR validation demonstrating the robustness of
the approach.
RNA polymerase II ChIP was used to confirm that the monoallelic expression observed
was indeed occurring at the level of transcription. Chromatin immunoprecipitation (ChIP) was
performed using the 8WG16 monoclonal antibody (Thompson et al., 1989) that detects all forms
of RNA polymerase II. Levels of RNA polymerase II pull-down were similar between monoallelic
and biallelic clones within the body of four randomly selected genes (figure 4.8, three genes are
shown). Due to informative SNPs within the amplicons, it was possible to distinguish which
alleles were associated with RNA polymerase II. Importantly, for three of four genes tested,
RNA polymerase II was specifically associated with only the active allele in monoallelic clones,
compared to both alleles in biallelic clones (figure 4.8), supporting the findings that monoallelic
expression is due to the exclusive transcription of only one of the two alleles in the cell.
Finally, monoallelically expressed genes were validated by performing combined RNA-DNA
Fluorescent In Situ Hybridisation (FISH). By using fluorescently labeled probes targeting both
exonic and intronic sequences of the target gene, the nascent RNA at the sites of transcription
could be seen microscopically as a single fluorescent spot within the nucleus (figure 4.9 on
page 97). These RNA-FISH spots co-localise with the gene locus visualized by subsequent
DNA-FISH in the same cells, confirming that they are indeed sites of transcription. 6 out of 6
separate genes were confirmed as monoallelically expressed by RNA-FISH analysis (figure 4.9).
The percentage of expressing cells exhibiting monoallelic or biallelic expression was deter-
mined by counting RNA-FISH signals across a large number of cells (n≥100) (figure 4.10 on
page 99). For example, Ror2 was detected by RNA-FISH in 83-90% of cells across experiments.
Of these expressing cells, there was expression from only 1 allele in 84.3% of cells in a monoallelic
clone, compared to only 27.0% of cells in a biallelic clone. Similarly, sites of transcription of
Acot1 were detected in 48% of cells of a monoallelic clone, of these cells, 89.6% showed tran-
scription from only one of the two alleles. Likewise, Acyp2 signal was detected by RNA-FISH
in 62% and 73% of cells in a monoallelic and biallelic clone respectively. Of these expressing
cells, 93.5% showed only 1 active allele in a monoallelic clone, confirming monoallelic expression
in these cells. In contrast 57.5% of cells in a biallelic clone showed 2 active alleles as expected.
Furthermore, expression from 1 allele was confirmed for 96.5% and 93.3% of expressing cells
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AB Gene Class Assay Clone 1 Clone 2 Clone 4
mcts2 B SNP-PCR CAST/EiJ biallelic CAST/EiJ
RNA-Seq biallelic biallelic CAST/EiJ
sema3c B SNP-PCR biallelic C57Bl/6J C57Bl/6J
RNA-Seq biallelic C57Bl/6J C57Bl/6J
biallelic
C57Bl/6J monoallelic
CAST/EiJ monoallelic
Gene Class Assay Clone 1 Clone 2 Clone 3 Clone 4 Clone 5 Clone 6
anxa6 A SNP-PCR biallelic CAST/EiJ biallelic biallelic C57Bl/6J
RNA-Seq biallelic CAST/EiJ biallelic biallelic C57Bl/6J
cap2 A SNP-PCR CAST/EiJ C57Bl/6J C57Bl/6J C57Bl/6J
RNA-Seq CAST/EiJ C57Bl/6J C57Bl/6J C57Bl/6J
cbr3 A SNP-PCR biallelic C57Bl/6J C57Bl/6J biallelic CAST/EiJ C57Bl/6J
RNA-Seq biallelic C57Bl/6J biallelic biallelic CAST/EiJ C57Bl/6J
fam111a A SNP-PCR C57Bl/6J C57Bl/6J biallelic
RNA-Seq C57Bl/6J C57Bl/6J biallelic
fkbp7 A SNP-PCR biallelic CAST/EiJ biallelic biallelic
RNA-Seq biallelic CAST/EiJ biallelic biallelic
gas6 A SNP-PCR CAST/EiJ biallelic biallelic CAST/EiJ biallelic biallelic
RNA-Seq CAST/EiJ C57Bl/6J biallelic CAST/EiJ CAST/EiJ biallelic
npl A SNP-PCR CAST/EiJ CAST/EiJ CAST/EiJ C57Bl/6J CAST/EiJ
RNA-Seq CAST/EiJ CAST/EiJ CAST/EiJ C57Bl/6J CAST/EiJ
pla2g7 A SNP-PCR CAST/EiJ C57Bl/6J CAST/EiJ CAST/EiJ C57Bl/6J
RNA-Seq CAST/EiJ C57Bl/6J CAST/EiJ CAST/EiJ C57Bl/6J
rgs16 A SNP-PCR CAST/EiJ biallelic
RNA-Seq CAST/EiJ CAST/EiJ
sgsm1 A SNP-PCR C57Bl/6J biallelic
RNA-Seq C57Bl/6J biallelic
tubb2a A SNP-PCR biallelic biallelic CAST/EiJ C57Bl/6J CAST/EiJ CAST/EiJ
RNA-Seq biallelic biallelic CAST/EiJ C57Bl/6J CAST/EiJ CAST/EiJ
scd2 B SNP-PCR biallelic biallelic biallelic biallelic biallelic CAST/EiJ
RNA-Seq biallelic biallelic biallelic biallelic biallelic CAST/EiJ
rhoj A+B SNP-PCR biallelic CAST/EiJ CAST/EiJ biallelic C57Bl/6J
RNA-Seq biallelic CAST/EiJ CAST/EiJ biallelic biallelic
serpinh1 B SNP-PCR CAST/EiJ CAST/EiJ biallelic CAST/EiJ biallelic
RNA-Seq CAST/EiJ CAST/EiJ biallelic CAST/EiJ biallelic
klhl22 C SNP-PCR C57Bl/6J C57Bl/6J
RNA-Seq C57Bl/6J C57Bl/6J
retsat C SNP-PCR CAST/EiJ CAST/EiJ CAST/EiJ CAST/EiJ CAST/EiJ CAST/EiJ
RNA-Seq CAST/EiJ CAST/EiJ CAST/EiJ CAST/EiJ CAST/EiJ CAST/EiJ
bai2 biallelic SNP-PCR biallelic biallelic
RNA-Seq biallelic biallelic
tgds biallelic SNP-PCR biallelic biallelic
RNA-Seq biallelic biallelic
Figure 4.7: Summary of SNP-PCR validation of monoallelically expressed genes.
Paired results for monoallelically expressed genes across the NPC (A) and ESC (B) clones. Top
row represents SNP-PCR result, bottom row result from RNA-sequencing screen. Only gene-
clone combinations that were assessable and expressed and had a corresponding SNP-PCR trace
are shown. Fields are colored according to the classification as biallelic (green), C57Bl/6J biased
(orange) or CAST/EiJ biased (blue). Red boxes outline discrepancies between RNA-sequencing
and SNP-PCR results. 95
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Figure 4.8: RNA polymerase II ChIP.
(A) Chromatin immunoprecipitation (ChIP) for RNA polymerase II large subunit (blue) or
control IgG (grey) for three separate gene promoter regions between monoallelic (m, dark blue),
allele-bias (ab, medium blue) or biallelic (b, light blue) clones. Error bars represent SEM of at
least 3 biological replicates. (B) Representative traces of Sanger sequencing of ChIP products
containing informative SNP (arrow) revealing associated alleles for monoallelic and biallelic
clones.
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Figure 4.9: RNA-DNA FISH validation of monoallelically expressed genes.
Representative 3D projections of RNA-FISH (left, green) and DNA-FISH (middle, red) image
stacks. Right column shows a merge of RNA- and DNA-FISH with DAPI to visualize total
DNA (blue). Arrows denote actively transcribing alleles, arrowheads inactive alleles. Scale bar
represents 5μm.
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in monoallelic clones for Pdzrn4 and Gas6 respectively. In this way, the RNA-FISH analysis
validated precisely at single cell resolution the results by RNA-sequencing analysis, SNP-PCR
and RNA polymerase II ChIP.
RNA-FISH analysis also proved valuable to understand the expression in clones exhibiting
allele-bias on a population level where a smaller contribution of expression was observed from
the second allele. Two possible interpretations could explain these allele-biased clones. Either
both alleles are expressed in every cell although at different levels, or these allele-bias clones
are a mixture of monoallelic and biallelic cells. Because the clones are derived from a founding
single cell, this second scenario would suggest that, although mitotically stable, there may be
a small frequency of reversion to biallelic expression. This reversion would be extremely rare,
however, and would need to happen at a very early stage of clone expansion, as we do not
generally observe loss of monoallelic expression, even with over 15 passages in culture. Based
on the single-cell RNA-DNA FISH analysis, allele biased clones likely result from a combination
of both processes within these clones.
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Figure 4.10: Quantification of RNA-DNA FISH analysis of monoallelically expressed genes.
Quantification of independent clones for each of the 6 genes for NPC clones that were either
biallelic, allele-biased or monoallelic for the respective gene. Percentage of expressing cells
having either 1 (dark grey) or 2 (light grey) RNA-FISH signals representing monoallelic and
biallelic cells respectively. At least 100 cells were analyzed per sample.
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4.4 Genomic characteristics of monoallelically expressed genes
Next, the genomic characteristics of the random autosomal monoallelically expressed genes
identified in the allele-specific screen were determined. First the level of expression of these
genes was examined and compared to the expression level of all assessable genes. To assess the
level of expression at the gene level, the average of expression level of all isoforms of the respective
gene across all clones was calculated. Expression levels of the random monoallelic genes were
compared to the set of assessable genes in both ESCs and in NPCs using a two-sided t-test.
Importantly, the distribution of expression levels of the monoallelically expressed genes was not
dramatically different from all assessable transcripts for both ESCs and NPCs (figure 4.11 on
the following page). While a small statistically significant difference was seen in the expression
level for NPCs, the difference is modest and unlikely to be of biological significance. There was
no statistically significant difference in the expression level for monoallelically expressed genes
versus all assessable genes in ESC, nor between ESC and NPC monoallelically expressed genes.
This indicates that monoallelic expression is not a feature limited to poorly expressed genes,
but can also occur for highly expressed genes.
The allele-specific RNA-sequencing screen used very stringent thresholds for defining whether
a gene was expressed. To control whether these stringent thresholds may have removed some
poorly expressed genes from the analysis, the expression level cutoff was varied and list of
monoallelically expressed genes compared (figure 4.12 on page 103). The original threshold
used to define whether a transcript was expressed, was 5.8 Normalised Reads Per Kilobase
(NRPK). This threshold is equal to the average expression of the 20th percentile of expression
values across all clones. Reducing the threshold to 2.14 NRPK, corresponding to the 10th per-
centile of expressed transcripts, or 1.08 NRPK, corresponding to the 5th percentile of expressed
transcripts, did not significantly change the outcome of the analysis. In ESCs, this resulted in
an increase from 67 monoallelically expressed genes to 68 genes, and in NPCs, this resulted in
an increase from 376 to 377 monoallelically expressed genes. Moreover, the proportion of all
assessable genes that are monoallelically expressed did not change significantly. The influence of
increasing the threshold to 10 NRPK, a common threshold used to define expressed transcripts,
was also examined. This resulted in a loss of 10 monoallelically expressed genes in ESCs, and
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Figure 4.11: Expression level distribution of monoallelically expressed genes.
Expression level (normalised reads per kilobase, NRPK) distribution of all assessable genes
(total) versus monoallelically expressed genes in both ESCs and NPCs. The list of assessable
genes is defined as the genes which are expressed in at least 2 clones.
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24 monoallelically expressed genes in NPCs, but again, the proportion of all assessable genes
did not change significantly. Thus, the thresholds used to define expression had no noticeable
impact on monoallelically expressed genes, and these genes are representative of all genes in
terms of their expression levels.
Other forms of monoallelic gene expression, including imprinting and olfactory receptor
allelic exclusion, occur in distinct domains or clusters in the genome. For example, more than
80% of the 144 genes imprinted in mouse are clustered into 16 distinct genomic regions containing
2 or more imprinted genes (Barlow, 2011). For these reasons, the genomic localisation of the
monoallelically expressed genes in both ESCs and NPCs was assessed using the ENSEMBL
karyotype viewer (Flicek et al., 2013). The monoallelically expressed genes were randomly
distributed throughout the genome and did not fall into any clusters, nor were they preferentially
located close to telomeres or centromeres (figure 4.13 on page 104). This is consistent with other
reports (Gimelbrant et al., 2007; Zwemer et al., 2012), and distinguishes random autosomal
monoallelic expression from other forms of monoallelic gene expression. The random autosomal
monoallelically expressed genes were also similar to all assessable genes in terms of gene features,
including the number of isoforms per gene and the number of exons (figure 4.14 on page 105). We
also assessed the CG content at the promoters of the monoallelically expressed genes (figure 4.15
on page 106). AT rich (or CG poor) promoters have been previously reported as a signature
of olfactory receptor gene promoters (Clowney et al., 2011). However there was no difference
in the CG content of monoallelically expressed gene promoters compared to all assessable gene
promoters (figure 4.15), suggesting that the AT rich promoter may be specific to olfactory
receptors and not a general feature of monoallelically expressed genes.
Gene ontology analysis was performed on the monoallelically expressed genes in NPCs (fig-
ure 4.16 on page 108) using the tool DAVID (Huang et al., 2009). Analysis was performed using
three different gene lists as a background reference, which enrichment of the monoallelically ex-
pressed genes was compared to. When the whole genome was used as background (figure 4.16A),
there was a significant enrichment for cell adhesion, biological adhesion and membrane proteins.
To control that these genes were enriched specifically in the monoallelically expressed genes and
not in NPCs in general, gene ontology analysis was also performed using either the union or
intersection of expressed genes as a background. The choice of background gave different results.
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class A 1 1 ~ 86 136 0.63
class B 1679 2529 11.04 1918 3063 14.15
class B filtered 67 74 0.44 303 468 2.24
class C 546 718 3.59 254 348 1.87
Total A+B filtered 68 75 0.45 377 604 2.78
class A 1 1 ~ 86 136 0.65
class B 1679 2529 11.35 1910 3053 14.37
class B filtered 67 74 0.45 303 468 2.28
class C 546 718 3.69 258 356 1.94
Total A+B filtered 68 75 0.46 377 604 2.84
class A 1 1 ~ 86 136 0.69
class B 1665 2499 12.15 1874 3004 14.95
class B filtered 66 73 0.48 302 466 2.41
class C 547 721 3.99 276 381 2.20
Total A+B filtered 67 74 0.49 376 602 3.00
class A 1 1 ~ 86 135 0.72
class B 1618 2424 12.66 1656 2612 13.94
class B filtered 56 61 0.44 277 427 2.33
class C 548 731 4.29 308 424 2.59
Total A+B filtered 57 62 0.45 352 562 2.96
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Figure 4.12: Effect of varying expression level thresholds on monoallelically expressed genes.
Number of monoallelically expressed transcripts and corresponding genes in ESCs and NPCs,
and percentage of all assessable genes, when four separate expression level thresholds were used.
The original threshold used corresponded to the 20thpercentile (5.8 NRPK) of expression values.
Reducing this threshold to the 10th(2.14 NRPK) or 5th(1.08 NRPK) percentile, or increasing
it to 10 reads per kb, did not significantly change the number or percentage of monoallelically
expressed genes.
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Figure 4.13: Genomic localisation of monoallelically expressed genes.
Genomic location of ESC (blue triangles) and NPC (red triangles) monoallelically expressed
genes across all chromosomes. Genes do not fall into any distinct clusters.
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Figure 4.14: Gene structure of monoallelically expressed genes.
(A) number of isoforms per gene for all assessable genes or monoallelically expressed genes in
NPCs. (B) number of exons per gene for all assessable genes or monoallelically expressed genes
in NPCs. Distributions are not statistically significant (p-value > 0.5).
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Figure 4.15: GC content of monoallelically expressed gene promoters.
Percentage of G/C nucleotides in the 1kb region surrounding the transcription start site of all
assessable, class A, class B and all monoallelically expressed genes in NPCs. The distribution
is centered around 50% and is not significantly different between the different groups of genes.
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When comparing to the union of expressed genes, that is genes which are expressed in at least
one NPC clone, cell adhesion , signal peptides and membrane were still enriched. However,
comparing with the intersection of expressed transcripts, that is genes which are expressed in all
NPC clones, cell adhesion and membrane ontologies are no longer enriched. Instead there is a
small enrichment for signal peptides, glycoproteins and disulfide bonds, although the significance
is low with false discovery rates between 0.02 and 0.03. Therefore there is a small enrichment of
cell adhesion, signal and membrane proteins, although this feature of monoallelically expressed
genes should not be over emphasised.
Interestingly, monoallelically expressed genes appear to be under less evolutionary constraint,
when compared to all assessable genes (figure 4.17A on page 109). Genomic Evolutionary Rate
Profiling (GERP) of both promoter and exonic sequences of the monoallelically expressed genes
was performed to determine the extent of evolutionary constraint of these sequences. This
measures the level of constraint at each base position by comparing the rate of nucleotide
exchange to what would occur at a neutral sequence not under selection. A higher GERP score
corresponds to a higher level of constraint. At a GERP threshold of 1.4, the exonic sequences
of monoallelically expressed genes showed significantly less constraint than all assessable genes,
indicating that they are under less evolutionary constraint, or more rapidly evolving. This was
also seen at the promoter sequences, defined as 1kb sequence surrounding the transcription
start site to a smaller yet still statistically significant extent. The difference was seen at all
GERP thresholds. However, it is unclear whether the decreased evolutionary constraint seen is
a real feature of monoallelically expressed genes, or if it is a consequence of the screen design.
The allele-specific RNA-sequencing screen requires adequate coverage of exonic SNPs to provide
allele information. A transcript with a higher number of exonic SNPs would be assigned a more
significant p-value, and thus be more likely to be classified as monoallelically expressed, than a
transcript with only one SNP, for example. Indeed, monoallelically expressed genes have a higher
number of exonic SNPs per transcript than all assessable genes (figure 4.17). Whether this is a
result of biases introduced in the allele-specific RNA-sequencing screen, or if it is a consequence
of a potential decrease in evolutionary constraint of monoallelically expressed genes in general,
cannot be resolved at this stage and requires additional analysis.
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Figure 4.16: Gene ontology analysis of NPC monoallelically expressed genes.
Gene ontology enrichment of monoallelically expressed genes in NPCs compared to (A) genome,
(B) union of expressed genes or (C) intersection of expressed genes, as background. Y-axis lists
significant categories, X-axis lists the number of genes in each category. Shade of red represents
false discovery rate (FDR) with darker colours having higher significance.
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4.5 Dynamics of monoallelic expression during differentiation
Next, the dynamics of monoallelic expression during cell differentiation was investigated. As
the number of monoallelically expressed genes increases 5.6 fold between ESCs and NPCs, the
overlap in monoallelically expressed genes between these two cell types was first compared. In-
terestingly, very few monoallelically expressed genes were found in common between the two
cell types; of the 376 monoallelically expressed genes in NPCs, only 6 genes were monoallelically
expressed in undifferentiated ESCs (figure 4.18A on page 111). In fact the majority (71.8%) of
NPC monoallelically expressed genes were biallelically expressed in ESCs (figure 4.18B, figure
4.19), with only 8.8% switching from a biallelic state in ESCs to monoallelic state in NPCs.
17.8% of NPC monoallelically expressed genes were not expressed in the pluripotent ESCs.
Likewise most (55.2%) ESC monoallelically expressed genes become biallelically expressed in
NPCs, and approximately one third are no longer expressed (figure 4.18, 4.19). There was
also notable variability in the expression biases across clones for a given transcript, with some
clones showing biallelic expression and others monoallelic expression (figure 4.19), indicating
that random autosomal monoallelic expression is not required by the cell. Furthermore, during
differentiation there is an increase in monoallelic expression, coinciding with the loss of pluripo-
tency and gain of lineage commitment. Therefore, monoallelic expression, while maintained
across cell divisions, is not maintained during differentiation.
The expression level changes of the ESC and NPC monoallelically expressed genes was also
compared during differentiation (figure 4.20 on page 114). DESeq (Anders and Huber, 2010)
was used to perform the differential expression analysis of transcripts between ESCs and NPCs.
Transcripts with a fold change ≥2 fold and a FDR<0.05 were defined as differentially expressed.
The majority of ESC monoallelically expressed genes either decreased (50%) or did not change
(32.4%) during differentiation, with only a small proportion (17.6%) increasing in expression
level upon differentiation to NPCs. This is of interest as 71.8% of ESC monoallelically expressed
genes are biallelically expressed in NPCs. Furthermore, of the NPC monoallelically expressed
genes, only 13.1% are expressed at lower levels in the NPCs compared to ESCs, despite the fact
that 55.2% switch from biallelic to monoallelic expression during differentiation. Expression
levels of approximately half of the monoallelically expressed genes remain unchanged during
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Figure 4.18: Dynamics of monoallelic expression during differentiation.
(A) Overlap of monoallelically expressed genes between ESCs and NPCs. (B) Status of the
NPC monoallelically expressed genes in ESCs. (C) Status of the ESC monoallelically expressed
genes in NPCs.
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differentiation, and another 40% increase, despite them switching to monoallelic gene expression
in NPCs. This suggests that monoallelic expression is not a mechanism for reducing transcript
levels in the cell and instead may reflect a stochastic nature of gene expression.
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Figure 4.20: Expression level changes of monoallelically expressed genes upon differentiation.
(A) Expression levels can either decrease, increase or remain unchanged during ESC to NPC
differentiation. (B) Expression level changes for ESC monoallelically expressed genes. (C)
Expression level changes for NPC monoallelically expressed genes.
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Chapter 5
Inheritance of monoallelic gene
expression
One intriguing aspect of monoallelic expression is that the transcriptional imbalance between
the active and inactive alleles is maintained across cell generations. The molecular mechanisms
describing how the active and inactive alleles are inherited through the cell cycle have not been
previously described for random autosomal monoallelically expressed genes. I therefore sought
to characterise the random autosomal monoallelically expressed genes identified in this study,
based on three potential mechanisms for inheritance: DNA methylation; histone modifications
and variants; and nuclear organisation. Additionally an epigenetic drug screen was initiated to
identify molecules which may provide insight into how the inheritance is fulfilled.
5.1 DNA methylation
DNA methylation is the most widely accepted mechanism through which the transcriptional
state of a gene can be inherited and maintained in daughter cells (reviewed in (Smith and
Meissner, 2013)). Furthermore, differences in DNA methylation at imprinting control regions are
responsible for distinguishing maternal and paternal alleles for imprinted gene clusters (reviewed
in (Kelsey and Feil, 2013)), and DNA methylation differentially marks regions of the active and
inactive X-chromosomes in female cells (reviewed in (Schulz and Heard, 2013)).
Initially, a potential role for DNA methylation in regulating random autosomal monoallel-
115
ically expressed genes was assessed bioinformatically. DNA methylation in mammals typically
occurs at symmetrical CpG dinucleotides (Gruenbaum et al., 1981; Sinsheimer, 1955). The CpG
density at the promoters of the monoallelically expressed genes was computed by calculating the
number of CpGs in a 1kb region surrounding the transcription start site. Interestingly, there
was a significant reduction in CpG density at the promoters of monoallelically expressed genes
compared to all assessable genes (figure 5.1 on the following page). This is of particular interest
as the overall CG content is similar between monoallelically expressed genes and all assessable
genes (figure 4.15 on page 106). However, as mentioned previously in the case of evolutionary
conservation of these genes 4.17 on page 109, it is unclear whether the decreased CpG density is
potentially an consequence of the selection bias of transcripts containing a higher SNP frequency
in the allele-specific screen. Further analysis is needed to determine if this is a true feature of
monoallelically expressed genes, as has been previously suggested (Jeffries et al., 2012).
Next, bisulfite analysis of the promoters of monoallelically expressed genes was performed.
Bisulfite treatment of DNA converts unmodified cytosines to uracil, which are then read out as
thymine following PCR amplification and Sanger sequencing. Methylated cytosines, as well as
hydroxymethylated cytosines, remain unaffected in the bisulfite conversion reaction, providing
a digital readout as to the methylation status of single molecules at single base resolution. If
DNA methylation was differentially marking the active and inactive alleles, one would expect
monoallelic clones to specifically contain a mixture of methylated and unmethylated CpG sites,
as is observed for imprinted genes. Biallelic clones, however, would not show this mix of two
states. The levels of DNA methylation were first compared at the promoters of 5 monoalleli-
cally expressed genes containing CpG islands at their transcription start sites. Samples included
NPC monoallelic, allele-biased and biallelic clones for the respective gene, as well as for ESCs
(figure 5.2 on page 119). The promoters in ESCs were unmethylated for 4 out of 5 genes tested,
with Cpped1 showing hypermethylation, despite being expressed in ESCs. Upon differentiation,
there was in general a gain in methylation levels at the promoters, although the extent var-
ied between genes and clones examined. Gas6 switched from an unmethylated state in ESCs
to methylated in NPCs regardless of the transcriptional status of the allele. Likewise Anxa6
was similarly methylated across the different NPC clones, although the extent of methylation
correlated with the overall transcriptional output of the clone. Cpped1, which was methylated
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Figure 5.1: Decreased CpG density at monoallelically expressed gene promoters.
Number of CpGs in 1kb sequence surrounding the transcription start site of all assessable genes
compared to monoallelically expressed genes.
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in the ESCs, remained mostly methylated in the NPC clones, with the exception of a biallelic
clone which showed a mixture of methylated and unmethylated reads, despite both alleles being
transcribed. Interestingly, methylation patterns for both Npl and Cbr3 in a monoallelic clone
showed a clear segregation between methylated and unmethylated reads. In the case of Cbr3,
the reads were able to be assigned to either the active C57Bl/6J allele or inactive CAST/EiJ
allele due to the presence of a A-T SNP within the amplicon analysed. This confirmed that
the unmethylated reads indeed corresponded to the active allele, where as the methylated reads
corresponded to the inactive allele. Both the biallelic and allele-biased clones for Cbr3 contained
unmethylated reads for both alleles, consistent with them being transcribed.
As the monoallelically expressed genes were observed to have reduced CpG density at their
promoters when compared to all assessable genes (figure 5.1), bisulfite analysis was performed for
an additional 5 genes which did not have CpG islands at their promotors (figure 5.3 on page 120).
Again, both ESCs as well as NPC clones which were biallelic, allele-biased or monoallelic for
the respective gene were analysed. Similarly to the CpG high promotors, ESCs were largely
unmethylated (figure 5.3, top row). There was an increase in DNA methylation upon differenti-
ation to NPCs at the promotor of Cacng5, such that the majority of CpGs became methylated,
regardless of the transcriptional status of the two alleles. Another gene, Rhoj, remained mostly
unmethylated in all NPC clones assessed. However, for two other genes, Serpinh1 and Fkbp7,
the monoallelic clones showed approximately 50% methylated reads and 50% unmethylated
reads. Furthermore, in the case of Fkbp7, this was only observed for the monoallelic clone, and
not for the allele-biased or biallelic clone. Therefore, of the 10 genes assayed overall, 4 showed
evidence supporting allele-specific DNA methylation correlating with transcriptional status in
the monoallelic clones.
As there were several examples supporting allele-specific DNA methylation correlating with
transcriptional output, I next tested to see whether the DNA methylation was necessary to
maintain the monoallelic state of the cells. 5-azacytidine is a small chemical analogue of the
nucleic acid cytidine, and was first synthesised as a potential chemotherapeutic agent for cancer
(Cihák, 1974). At low doses, it inhibits the activity of the DNA methyltransferases, thus treat-
ment over several cell cycles leads to passive genome wide DNA demethylation. At higher doses,
5-azacytidine incorporates into both DNA and RNA and ultimately causes cell death. First, the
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Figure 5.2: Bisulfite analysis of CpG high promotors.
Reads from bisulfite analysis performed at the promoters of CpG high monoallelically expressed
genes in ESCs (top row) and NPC clones classified as biallelic (second row), allele-biased or
monoallelic (third and fourth rows) for the respective gene. 5 separate genes were analysed.
Open circles depict unmethylated CpGs, filled circles methylated CpGs. Allele information is
noted when available. n.a. not assessable.
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Figure 5.3: Bisulfite analysis of CpG low promotors.
Reads from bisulfite analysis performed at the promoters of CpG low monoallelically expressed
genes in ESCs (top row) and NPC clones classified as biallelic (second row), allele-biased or
monoallelic (third and fourth rows) for the respective gene. 5 separate genes were analysed.
Open circles depict unmethylated CpGs, filled circles methylated CpGs. n.a. not assessable.
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dosage and duration of 5-azacytidine was determined for NPCs. Cells were treated with 10nM,
200nM, 500nM, 1μM or 5μM 5-azacytidine for 48 hours and genomic DNA collected and level of
DNA methylation assayed by bisulfite-PCR. However, following bisulfite conversion, there was
still significant levels of DNA methylation in these cells, possibly due to the short time period of
treatment. Cells were treated with either 1μM or 10μM for 5 days, with fresh medium contain-
ing 5-azacytidine changed every 2 days. During this time cells underwent several cell divisions
and were passaged at least once. Genomic DNA was collected and bisulfite converted. Analysis
of the Cbr3 promotor revealed that while 1μM was not sufficient, 10μM 5-azacytidine led to
demethylation of the inactive allele (figure 5.4 on the next page). Next, the transcriptional
output of the two alleles was assessed by SNP-PCR. However, demethylation of the inactive
allele did not lead to biallelic expression of Cbr3 (figure 5.5 on page 123). Nor did 5-azacytidine
lead to activation of the silent allele for 9 additional genes tested, including the differentially
methylated Serpinh1, Fkbp7 and Npl (figure 5.5). Based on the SNP-PCR results, there is
no evidence that DNA methylation, although in some instances correlative, directly regulates
monoallelically expressed genes. Genome-wide RNA-sequencing in several 5-azacytidine treated
clones is currently underway to determine whether this is a general feature for all monoallelically
expressed genes.
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Figure 5.4: 5-azacytidine treatment leads to demethylation of the inactive Cbr3 allele.
NPCs were treated with 10μM 5-azacytidine for 5 days, genomic DNA collected and bisulfite
analysis of the Cbr3 promotor performed. Open circles represent unmethylated CpGs, closed
circles methylated CpGs. 5-azacytidine treatment successfully led to the demethylation of the
previously methylated CAST/EiJ allele.
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Figure 5.5: Effect of 5-azacytidine treatment on monoallelic expression.
Sanger sequencing traces of 7 monoallelically expressed genes for a biallelic clone (left column),
monoallelic or allele-biased clone (middle column) and the same monoallelic clone treated for
5 days with 5-azacytidine (right column). Arrows denote SNP position. blue = C, black = G,
green = A, red = T.
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5.2 Histone modifications
While the mechanisms by which histone modifications may transmit transcriptional states
through mitosis remain unclear, the preferential association of certain marks with different ge-
nomic features has been extensively documented (reviewed in (Black et al., 2012)). Therefore,
the histone modifications at the promotors of these genes was investigated by chromatin im-
munoprecipitation (ChIP) to determine whether there were modifications specific to the active
and/or inactive alleles. First, the chromatin preparation conditions for NPCs were optimised.
Cells were fixed in 1% formaldehyde for 5 minutes at room temperature and quenched with
glycine. Nuclear lysis was verified by staining with methyl-green in which complete removal of
the cytoplasm could be observed under the light microscope. Nuclei were sonicated using the
bioruptor for 8, 12, 16 and 20 cycles of 30 seconds on the highest setting followed by 30 seconds
off. The chromatin smear was checked by loading sonicated chromatin onto a gel (figure 5.6
on the next page). Chromatin preparations should ideally contain the bulk of material at nu-
cleosomal resolution, at approximately 200bp. From the sonication time course, 20 cycles was
selected for all further histone ChIP experiments.
Allele-specific ChIP was performed by including an informative SNP in the region assayed
by ChIP-PCR. In this way, following quantitative PCR analysis of the levels of pulldown, PCR
products were subjected to Sanger sequencing and the associated alleles with the respective his-
tone modification determined. A total of 9 separate histone modifications were assayed across 4
independent NPC clones, with at least 3 biological replicates performed on separate days each.
For each pull-down, a total of 4 monoallelic gene promotors, 4 monoallelic gene bodies were
assayed by Q-PCR, as well as control regions including one biallelic gene (Gapdh1 ), one inac-
tive gene (Nanog), or previously characterised active and inactive genomic regions (Mikkelsen
et al., 2007). First, the association of histone H3 lysine 4 di- and tri-methylation (H3K4me2,
H3K4me3) were investigated at the promotors of monoallelically expressed genes. These mod-
ifications are associated with active gene promotors. As a control, H3K4me2 and H3K4me3
were both present at the promotor of Gapdh1, but not at the promotor of the transcriptionally
inactive Nanog gene (figure 5.7 on page 127). Both H3K4me2 and H3K4me3 were present at the
promotors of the 4 monoallelically expressed genes tested. In general, there was a tendency for
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Figure 5.6: Optimisation of sonication conditions for chromatin immunoprecipitation.
Nuclei were sonicated for 8, 12, 16 and 20 cycles of 30 seconds on maximum setting. Chromatin
was loaded onto an agarose gel to check size distribution of DNA. Last lane contains DNA
ladder, sizes are as marked in base pairs.
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the biallelically expressing clones to have a greater level of association with H3K4me2/3 than the
monoallelically expressing clones. Importantly, Sanger sequencing of the PCR products follow-
ing ChIP-PCR revealed that while both alleles were associated with H3K4me2/3 in the biallelic
clones, only the actively transcribing allele was marked by H3K4me2/3 in the monoallelically
expressed clones (figure 5.8 on page 128). Thus the actively transcribing allele is specifically
marked by both H3K4me2 and H3K4me3.
Next, allele-specific ChIP was performed against a panel of histone modifications gener-
ally associated with silent chromatin. H3K9me3 and H4K20me3 are typically associated with
constitutive heterochromatin, where as the Polycomb mediated H3K27me3 with facultative het-
erochromatin and bivalent domains. Also tested was another mark of constitutive heterochro-
matin H4K20me1 which is implicated in dosage compensation in mammals (Kohlmaier et al.,
2004), C. Elegans (Vielle et al., 2012) and Drosophila (Conrad and Akhtar, 2011). Association
of H3K9me3 at the promotors of inactive genes was greater in monoallelically expressed clones
compared to biallelic clones where levels were comparable to an actively transcribing control
region (figure (5.9)A on page 129). In contrast, H3K27me3 was not associated with any of the
genes tested, with the exception of Cbr3 which showed a small pulldown (figure 5.9B). Fur-
thermore, analysis of genome-wide published ChIP-chip data of H3K4me3 and H3K27me3 at
promotor regions in NPCs (Mikkelsen et al., 2007), revealed that only 1.3% of monoallelically
expressed promotors assessed were associated with H3K27me3, and another 1.3% with the bi-
valent H3K4me3/H3K27me3 signature (figure 5.9C). Instead the vast majority are marked by
H3K4me3, consistent with the findings above. H4K20me1 was expressed at similar levels across
all samples (figure 5.10A on page 130), where as H4K20me3 was not present at any of the
regions examined (figure 5.10B). Importantly, Sanger sequencing of the PCR products revealed
that H3K9me3 was specifically associated with only the inactive allele in monoallelically ex-
pressing clones (figure 5.8). H4K20me1, however, was present on both alleles at all genes tested
indicating that it was not specifically associated with the inactive allele. Therefore H3K9me3
marks the promoter of the inactive allele of monoallelically expressed genes.
Histone acetylation is generally associated with open active chromatin. Therefore, ChIP
analysis was performed using a pan-H4 acetylation antibody, as well as antibodies against
H4K16ac and H3K14ac. Levels of H4 acetylation at the promotors of the genes were simi-
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Figure 5.7: Chromatin Immunoprecipitation of H3K4me2 and H3K4me3.
Chromatin Immunoprecipitation analysis for H3K4me2 (A) and H3K4me3 (B). Analysis of re-
gions within 200bp of the transcription start site for four separate monoallelically expressed
genes are shown, in addition to transcriptionally silent Nanog and active Gapdh1 (grey). Quan-
tification of pulldown as percentage of input for individual clones which are either monoallelic
(m, dark blue), allele-bias (ab, medium blue) or biallelic (b, light blue) for the respective clone
are shown. IgG (black) shows non-specific pulldown. Error bars represent SEM of 3-4 biological
replicates.
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Figure 5.8: Sanger sequencing of ChIP-PCR products.
Representative Sanger sequencing traces of ChIP-PCR products from H3K4me2 (top), H3K4me3
(middle) and H3K9me (bottom) ChIP experiments in either a monoallelic clone or a biallelic
clone for 3 separate gene promotors. Arrows denote SNP position. blue = C, black = G, green
= A, red = T.
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Figure 5.9: Chromatin Immunoprecipitation of H3K9me3 and H3K27me3.
Chromatin Immunoprecipitation analysis for H3K9me3 (A) and H3K27me3 (B). Analysis of re-
gions within 200bp of the transcription start site for three-four separate monoallelically expressed
genes are shown, in addition to transcriptionally active and silent regions (grey). Quantifica-
tion of pulldown as percentage of input for individual clones which are either monoallelic (m,
dark red), allele-bias (ab, medium red) or biallelic (b, light red) for the respective clone are
shown. IgG (black) shows non-specific pulldown. Error bars represent SEM of 3-4 biological
replicates. (C) Genome wide analysis of H3K4me3 and H3K27me3 distribution at the promotors
of monoallelically expressed genes in NPCs.
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Figure 5.10: Chromatin Immunoprecipitation of H4K20me1 and H4K20me3.
Chromatin Immunoprecipitation analysis for H4K20me1 (A) and H4K20me3 (B). Analysis of
regions within 200bp of the transcription start site for three separate monoallelically expressed
genes are shown, in addition to transcriptionally active and silent regions (grey). Quantification
of pulldown as percentage of input for individual clones which are either monoallelic (m, dark
red), allele-bias (ab, medium red) or biallelic (b, light red) for the respective clone are shown.
IgG (black) shows non-specific pulldown. Error bars represent SEM of 3-4 biological replicates.
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lar between monoallelically and biallelically expressing clones for the four genes tested (figure
5.11A). Furthermore when Sanger sequencing was performed on the PCR products, both alleles
were found associated with this mark in the monoallelically expressed clones. Similar results
were observed for both H4K16ac (figure 5.11B) and H3K14ac (figure 5.12A), which showed
similar levels of association between different clones, and no specificity between active and in-
active alleles by Sanger sequencing analysis. I also investigated H3K36me3 at the promotors of
these genes (figure 5.12 on page 133B), which also did not show any allele-specificity. However
H3K36me3 is enriched over the gene body. Analysis of H3K36me3 association in exons of these
genes is currently in progress.
In summary, of the 10 histone modifications examined, three showed allele-specific associa-
tion (table 5.1 on page 134). Specifically H3K4me2 and H3K4me3 were present on the active
allele, and H3K9me3 on the inactive allele. Genome wide ChIP-seq analysis is currently under-
way to determine whether this is a general rule for monoallelically expressed genes. If so, it may
be possible to predict monoallelic expression based solely on chromatin marks, although dual
association of both H3K4me2/3 and H3K9me3 observed by ChIP could either be a consequence
of monoallelic expression, or result from a mixture of active and inactive cells within a popu-
lation. Whether the marks identified are actively involved in maintaining the transcriptional
bias between the alleles across cell divisions, or whether they are a secondary effect of gene
transcription, remains to be determined and will be the focus of future studies.
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Figure 5.11: Chromatin Immunoprecipitation of histone acetylation modifications.
Chromatin Immunoprecipitation analysis for panH4 acetylation (A) and H4K16ac (B). Analysis
of regions within 200bp of the transcription start site for three separate monoallelically expressed
genes are shown, in addition to transcriptionally active and silent regions (grey). Quantification
of pulldown as percentage of input for individual clones which are either monoallelic (m, dark
green), allele-bias (ab, light green) or biallelic (b, yellow) for the respective clone are shown.
IgG (black) shows non-specific pulldown. Error bars represent SEM of 1-4 biological replicates.
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Figure 5.12: Chromatin Immunoprecipitation of H3K36me3.
Chromatin Immunoprecipitation analysis for H3K14ac (A) and H3K36me3 (B). Analysis of
regions within 200bp of the transcription start site for three separate monoallelically expressed
genes are shown, in addition to transcriptionally active and silent regions (grey). Quantification
of pulldown as percentage of input for individual clones which are either monoallelic (m, dark
green), allele-bias (ab, light green) or biallelic (b, yellow) for the respective clone are shown.
IgG (black) shows non-specific pulldown. Error bars represent SEM of 1-4 biological replicates.
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Table 5.1: Summary of ChIP analysis.
Modification Active Allele Inactive Allele Comments
H3K4me2 ! % Specific for active allele
H3K4me3 ! % Specific for active allele
H3K9me3 % ! Specific for inactive allele
H3K27me3 - - Not present
panH4ac ! ! No change and present on both alleles
H4K16ac ! ! No change and present on both alleles
H4K20me1 ! ! No change and present on both alleles
H4K20me3 - - Not present
H3K14ac ! ! No change and present on both alleles
H3K36me3 ! ! No change and present on both alleles
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5.3 Nuclear organisation
The nucleus is a highly structured and dynamic organelle containing many distinct domains and
bodies, (reviewed in(Hübner et al., 2013; Spector, 2006; Zhao et al., 2009)), and the position
of genes in relation to these structures has been correlated with their transcriptional activity
(reviewed in (Hübner et al., 2013)). Monoallelically expressed genes provide a unique system
for investigating the role of nuclear organisation on gene expression, as the active and inactive
transcriptional status of an endogenous locus can be analysed simultaneously within the same
nucleus. The position of the active and inactive alleles was analysed in relation to two nuclear
structures associated with silent chromatin: the nuclear periphery and heterochromatic foci
(figure 5.13A on the following page). Combined RNA-DNA FISH was performed for a panel
of 6 monoallelically expressed genes in NPCs and three-dimensional image stacks through the
entire nucleus collected. Association with the nuclear periphery and heterochromatic foci was
determined when an allele which was touching or overlapping the structure identified by DAPI
staining. At least 30 active-inactive allele pairs were analysed for each monoallelically expressed
gene. Approximately 30% of alleles were associating with heterochromatic foci (figure 5.13B). If
the heterochromatic foci were actively involved in repressing the silent allele, a higher frequency
of association of the inactive allele with this domain would be predicted. However, there was
no clear difference in associations between the active and inactive alleles for the genes analysed,
with the exception of Acyp2, in which the active allele had reduced frequency of association,
while the inactive allele showed association frequencies similar to active alleles of other genes.
Similar results were observed for the association with the nuclear periphery (figure 5.13C). Levels
of association were similar for the active and inactive alleles of each gene, with the exception
of Ror2 in which the inactive allele showed a higher frequency of association compared to the
active allele. However this frequency was similar to that of the active allele of Acyp2 and
Pdzrn4. Biological replicates need to be performed to determine whether the small differences
observed for Acyp2 and Ror2 are real. However, in general, there was no striking evidence
for preferential positioning of the inactive allele towards heterochromatic foci nor the nuclear
periphery. Furthermore there was no evidence of for allelic pairing of the active and inactive
alleles.
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Figure 5.13: 3D nuclear position analysis of active and inactive alleles.
(A) schematic representation of measurements made in 3-D between the active and inactive alle-
les with the nuclear periphery and heterochromatic foci. (B,C) Bar graph showing the proportion
of active (light grey) and inactive (dark grey) alleles associated with either heterochromatic foci
(B) or the nuclear periphery (C) for 6 separate monoallelically expressed genes.
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To further confirm that the nuclear periphery was not involved in distinguishing the ac-
tive and inactive alleles, global analysis of the monoallelically expressed genes with respect to
Lamin Associated Domains (LADs) defined in NPCs (Peric-Hupkes et al., 2010) was performed.
Approximately 10% of monoallelically expressed genes were found within a LAD, however this
frequency was similar to what is seen for all assessable genes (figure 5.14A on the next page). To
test whether monoallelically expressed genes were positioned at LAD boundaries which hypo-
thetically could become either active or repressed upon differentiation, the distance of the gene
to the closest LAD was determined, however there was no difference between monoallelically
expressed genes and all assessable genes (figure 5.14B). These results suggest that the nuclear
lamina is not a major determinant of monoallelically expressed genes.
Finally, gross chromatin compaction of the active and inactive alleles was determined by
measuring both the volume and the intensity of the DNA-FISH signal in the RNA-DNA FISH
images. The volume of the alleles was determined in 3-D using the polygon finder tool in
Softworx software. There was no statistically significant difference in the volume of the active
and inactive alleles of Gas6 (5.15A on page 139) with approximately 50% of cells showing a
greater volume for the active allele, and the remaining 50% showing greater volume for the
inactive allele. Nor was there a difference in the signal intensity of the active and inactive alleles
(figure 5.15B) with no striking pattern seen in the pairwise comparisons of active and inactive
alleles within the same nucleus. Therefore, at the gross level of light microscopy, the active and
inactive alleles of Gas6 have similar overall chromatin compaction. These results, however, are
not of sufficient resolution to rule out local chromatin compaction differences, for example at
the promotors of these genes. Other methods, such as DNAse I hypersensitivity assays, would
be able to provide this resolution, however such types of assays cannot be performed in an allele
specific manner.
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Figure 5.14: Association of monoallelically expressed genes with Lamin Associated Domains.
(A) proportion of monoallelically expressed genes and all assessable genes located within a LAD
(black) or outside of a LAD (white). (B) minimal distance of all assessable versus monoallelically
expressed genes to the closest LAD.
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Figure 5.15: Gross chromatin compaction of active and inactive alleles.
(A) comparison of the volume of the active and inactive alleles of Gas6. Measurements were
performed in 3D using Softworx image analysis software. (B) Signal intensity of the active and
inactive alleles. Each dot represents one allele, lines connect active and inactive alleles within
the same cell. p-values are not statistically significant (paired two-tailed t-test). Dots represent
individual measurements, lines connect measurements made in the same nucleus.
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5.4 Epigenetic drug screen
In order to gain some insights into the molecular mechanisms involved in the maintenance
of monoallelic expression across cell generations, a small molecule epigenetic drug screen was
performed. This utilised a library of 69 small molecule inhibitors (Cayman Chemical 1106)
targeting a broad range of enzymes implicated in epigenetic inheritance including methyltrans-
ferases, demethylases, histone acetyltransferases, histone deacetylases and acetylated histone
binding proteins (see Appendix, page 257). A test trial was first performed by treating one of
the NPC clones with 10μM drug for 4 days in 6 well plate format, changing medium and drug
every 2 days. Morphological changes were recorded every day, and RNA collected at the end
of the 4 days. For each sample, cDNA was synthesised and SNP-PCR performed for two genes
which were known to be monoallelically expressed in that particular clone: Gas6 and Serpinh1.
Drug treatment for 12 of the 69 compounds resulted in cell death at this concentration, and
another 30 showed either slowed growth (n=20), elongated morphology (n=6) or spontaneously
formed neurospheres in suspension (n=4). Due to the lack of an internal positive control, it was
not possible to definitively conclude that a compound did not lead to activation of the silent
allele as the conditions for each compound had not been optimised. Thus a major caveat of the
epigenetic drug screen is that we cannot be sure that the compounds are active at the dosage
and time points investigated, however any positive results would provide an indication as to
a potential mechanism to pursue further. Unfortunately many sequencing traces were not of
sufficient quality to be able to assess allelic expression and so not all samples could be analysed
in each trial. However, 6 compounds resulted in a small level of expression of the silent allele
for at least one of the two genes tested (figure 5.16 on page 142). Interestingly, all 6 com-
pounds resulted in elongation of the cells, and 5 out of 6 of these compounds targeted histone
deacetylases: M 344 preferentially inhibits HDAC6 and to a lesser extent HDAC1; EX-527 is a
selective inhibitor of SIRT1; Pimelic Diphenylamide 106 is a slow tight-binding inhibitor of class
I HDACs; chidamide is a generic HDAC inhibitor; and MS275 preferentially inhibits HDAC1,
and to a lesser extent HDAC3, but not HDAC8. The 6th compound resulting in partial acti-
vation of the silent allele was decitabine. This compound is an analogue of 5-azacytidine and
thus inhibits DNA methyltransferases. As 5-azacytidine itself did not lead to allele activation
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nor to an elongated morphology both in this trial and in previous experiments (figure 5.5), it is
possible that this sample may have been switched with the adjacent sample which was treated
with JGB174, also a HDAC inhibitor.
A second trial was subsequently performed, lowering the dosage to 5μM for those compounds
that caused cell death, and increasing to 25μM those which had no noticeable effect on cell
morphology or growth rate. Additionally, a different NPC clone was used and SNP-PCR for
Cap2 was performed instead of Serpinh1, in addition to Gas6 which was assayed in both trials.
The second trial confirmed partial activation of 3 out of the 6 compounds identified in the
first trial (M 344, chidamide and MS275), as well as other compounds including the HDAC
inhibitors AGK2, CAY10603, Tenovin-1, CBHA, HNHA and CAY10433, although again the
allele activation was minimal. The top 6 candidate compounds from the two trials, all targeting
HDACs, were then tested at variable concentrations (5μM, 10μM, 20μM, 25μM and/or 40μM)
and time points (2, 4 and 8 days) in order to optimise conditions to achieve maximal reactivation.
However, in this third trial, no activation was observed for any of the drugs for any of the
conditions tested. New compounds were ordered from an alternative source for 4 separate
HDAC inhibitors (M344, pimelic diphenylamide 106, valproic acid and SAHA) and treatment
was repeated. Unfortunately, only 1 of the 4 compounds at 1 condition (M-344 for 4 days
at 10μM) lead to partial activation of the silent allele. Furthermore, treatment with HDAC
inhibitors for 20 or 60 minutes, did not lead to activation of the silent allele of Pla2g7 for all
4 compounds tested. Due to the small level of activation and lack of reproducibility of results
between trials, the small molecule inhibitor screen was no longer pursued. In the future, use
of a reporter system, such as a knock-in GFP at one of the two alleles, would provide a useful
system for high throughput screening of epigenetic modifiers involved in the maintenance of the
inactive allele, either through small molecule inhibitor libraries or through shRNA libraries.
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Figure 5.16: Selected results from epigenetic drug screen.
Drug structures and Gas6 SNP-PCR sequencing traces for 6 compounds from the epigenetic
drug screen which led to partial activation of the silent allele (arrows). Untreated sample is
shown as a reference. All compounds, except for decitabine, target histone deacetylases.
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Chapter 6
Transcriptional Consequences of
Monoallelic Gene Expression
One of the potential functional consequences of monoallelic gene expression would be to alter the
total transcript levels of the particular gene product. By halving the number of active alleles in
the cell, it could be expected that the total transcript levels would also be halved. Alternatively,
the cell may respond to the altered gene dosage such that the total mRNA levels approach those
of biallelic cells. Previous genome-wide assessments of monoallelic expression have reported
an overall reduction in transcript levels of monoallelically versus biallelically expressing cells,
however rather than the expected 50%, this reduction was only 30-35% (Gimelbrant et al.,
2007; Jeffries et al., 2012; Li et al., 2012b). Therefore it is possible that while others are
dosage sensitive with expression levels correlating with the number of active alleles, some genes
compensate transcriptionally to match biallelic expression levels.
6.1 Identification of transcriptionally compensating monoalleli-
cally expressed genes
First, the expression levels of NPC clones across the range of d-scores was assessed (figure 6.1 on
page 145). It is possible for transcripts not classified as monoallelically expressed to have clone(s)
with a |d-score| greater than the 0.18 cutoff if they fall into either category C, in which all clones
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biased towards same allele, or did not pass the additional filtering in category B. Additionally,
transcripts could have a high |d-score| yet not pass the p-value significance threshold. In this
way, comparisons between the monoallelically expressed genes and all assessable genes can be
made across the entire range of d-scores. At low d-scores, representing equal transcription of
the two alleles, expression levels between all assessable transcripts and monoallelically expressed
transcripts are similar (figure 6.1). However, at higher d-score values, representing biased or
exclusive transcription from only one of the two alleles, transcript levels of the monoallelically
expressed genes are greater than that of all assessable genes. Furthermore, while transcript
levels for all assessable genes at high d-scores are approximately half of those at low d-scores,
the monoallelically expressed genes show a smaller reduction, suggesting that there is not a clear
1:1 correlation between the number of active alleles and transcript levels for the monoallelically
expressed genes.
Next, the behaviour of the monoallelically expressed genes was investigated more closely.
For each of the monoallelically expressed genes, the clone with the highest and lowest d-scores
were selected, and the difference in d-scores, Δd-score=|d − scoremax| − |d − scoremin|. The
majority (531 out of 602 or 88%) of monoallelically expressed transcripts have a Δd-score of 0.3
or greater. Next the ratio of expression for the two clones was calculated. As expected, genes
in which there was not a large variation in the extent of monoallelic expression, that is have
a Δd-score<0.1, had the same level of expression in both the clones (expression ratio = 1, so
log2(expression ratio) = 0). If the level of transcript in the cell followed the number of active
alleles, then those genes with |Δd-score|>0.4 would be predicted to have an expression ratio of
0.5 (figure 6.2A, red line). However, there was a shift in the distribution of expression ratios
away from 1 towards, but not centered around 0.5 (figure 6.2A, blue line). This suggests that
there is a range in the transcriptional response of genes to monoallelic expression, with some
genes showing dosage sensitivity and others dosage compensation. Importantly, this effect was
not influenced by low abundant transcripts, as the same analysis performed on highly expressed
transcripts with FPK>50 showed similar results (figure 6.2B). Note that the results of genes
with Δd-score from 0.1-0.2 should not be over-interpreted as this bin contains only 10 genes.
Next, linear regression analysis was used to compare expression levels across clones with
different extents of allelic imbalance. This allowed for the identification of the random monoal-
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Figure 6.1: Influence of d-score on transcript levels.
Expression levels of transcripts of individual NPC clones placed into different arbitrarily sized
bins based on the |d-score| ranging from 0 to 0.5. Blue represents all assessable transcripts, red
represents monoallelically expressed transcripts.
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Figure 6.2: Transcript expression ratio between biallelic and monoallelic clones.
Expression ratios of monoallelically expressed transcripts between the clone with the largest
and smallest |d-score|. Transcripts are binned based on this difference between the largest
and smallest |d-score| (Δd-score). An expression ratio of 1 (red line) denotes equal expression
between the two clones, where as an expression ratio of 0.5 (blue line) denotes a 50% reduction,
predicted if the expression level of the gene follows the allele dosage. (A) all monoallelically
expressed transcripts, (B) Highly expressed monoallelically expressed transcripts with FPK>50.
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lelically expressed transcripts showing transcriptional compensation versus dosage sensitivity.
Through linear regression analysis, estimates of the slope (a) and the y-intercept (b) were cal-
culated and the ratio a−b calculated. Compensating transcripts in which the expression level is
similar across all clones will have a ratio close to 0 (figure 6.3A, red line), while those which are
dosage sensitive will have a ratio close to 1 (figure 6.3A, blue line). Ratios were calculated for all
602 monoallelically expressed transcripts in NPCs (figure 6.3B), and arbitrarily defined thresh-
olds were used to classify transcripts as either compensating (−0.35 < a−b < 0.35), dosage sen-
sitive (0.75 < a−b < 1.25), intermediate (0.35 <
a
−b < 0.75), over-compensating (
a
−b < −0.35),
or over-sensitive (1.25 < a−b) (figure 6.3B). Of the 74 monoallelically expressed transcripts in
ESCs, 18 transcripts corresponding to 18 genes were classified as compensating, and another 13
transcripts or 11 genes were classified as dosage-sensitive, corresponding to 24.3% and 17.6%
of transcripts respectively (figure 6.4A on page 149). Interestingly, in NPCs, there were only
62 transcripts, or 30 genes, corresponding to 10.3% or 8% of monoallelically expressed tran-
scripts or genes respectively. This is approximately 2 fold less than in the pluripotent ESCs.
Instead, there were more transcripts which were dosage sensitive (140 transcripts or 23.3%) or
over-sensitive (223 transcripts or 36.9%). Examples of transcripts which are over-compensating
(figure 6.4B), compensating ((figure 6.4C), intermediate (figure 6.4D), dosage-sensitive (figure
6.4E) or over-sensitive (figure 6.4F) are shown. Interestingly, the genes that exhibited transcrip-
tional compensation were enriched for DNA binding proteins and transcription factor activity,
although the confidence of enrichment was low (p-value 0.037). There was no enrichment for
the genes that undergo transcriptional compensation in ESCs, although this could be due to
the limited power of gene ontology analysis with low number of genes.
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Figure 6.3: Defining transcripts which undergo transcriptional compensation.
Linear regression analysis was performed to identify transcripts that undergo transcriptional
compensation (red) or are dosage-sensitive (blue). (A) hypothetical example showing a com-
pensating transcript (red), in which there is equal expression levels across all clones of variable
|d-score|, and a dosage-sensitive transcript (blue), in which the monoallelic clone (|d-score|=0.5),
has half the expression level as a biallelic clone (|d-score|=0). The ratio of the slope (a) over the
y-intercept (-b) was computed and used to classify the transcripts. (B) histogram showing the
distribution of NPC monoallelically expressed transcripts across the spectrum of (a/-b) ratios.
Those with a ratio between -0.35 and +0.35 were classified as compensating (red), and those
with a ratio between 0.75 and 1.25 as dosage-sensitive (blue). Transcripts were also classified
as intermediate (0.35 < a/ − b < 0.75), over-compensating (a/ − b < −0.35), or over-sensitive
(1.25 < a/− b).
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Figure 6.4: Linear regression analysis of transcript expression levels.
(A) summary of results from the linear regression analysis of expression levels versus d-scores.
Examples of NPC monoallelically expressed transcripts which are over-compensating (B), com-
pensating (C), intermediate (D), dosage-sensitive (E) and over-sensitive (F) are shown.
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6.2 Validation of transcriptional compensators and dosage-sensitive
transcripts
One of the major caveats in the approach used to classify transcripts as compensating or dosage-
sensitive is that there are only 6 data-points used for the linear regression analysis, as only 6
clones were analysed. Furthermore RNA-seq expression data for only one replicate per clone
was available for analysis. Therefore the amount of variation in expression levels of a given
transcript is unknown, which makes interpreting a potential 50% reduction in transcript levels
across 6 samples difficult. For these reasons, the RNA-seq analysis was independently validated
by quantitative RT-PCR for 20 different genes. For each of the 6 clones, 3 biological replicates
representing different passages were analysed. All data was normalised to the geometric mean
of at least 3 housekeeping genes. Of the 20 genes assessed, 12 were in agreement with the linear
regression analysis. This included 10 genes classified by linear regression analysis as transcrip-
tional compensators, of which 6 were validated by Q-RT-PCR (figure 6.5A). The remaining 4
genes classified as compensators by RNA-seq analysis, were either dosage sensitive (Fkbp7, Ttc4
and Ptgr1 ) or over-compensated (Pcsk6 ) by Q-PCR analysis (figure 6.5B). Another 3 genes
were classified as dosage-sensitive by RNA-seq analysis (figure 6.6A), of which one (Pla2g7 ) was
validated by Q-PCR, and the other two genes (Acyp2 and Pdzrn4 ) represent false-negatives as
they were transcriptional compensators by Q-PCR analysis. There was another 3 genes (Rhoj,
Acot1 and Cap2 ) which were over-sensitive by both RNA-seq analysis and Q-PCR analysis
(figure 6.6B), and four genes which were over-compensating by RNA-seq analysis (figure 6.6C),
of which two were compensating by Q-PCR (Thrsp and Gas6 ), and two were dosage-sensitive
(Rgs16 and Serpinh1 ). In summary, there was a 60% validation rate of the linear regression
analysis by Q-RT-PCR, with 4 false-positive and 2 false-negative transcriptional compensators.
Therefore, while there are some caveats of the RNA-seq based linear regression analysis, the
fact that some genes exhibit transcriptional compensation is validated. Future experiments
looking at a larger number of clones and replicates by high-throughput microfluidic-based Q-
PCR technologies, would enable a more accurate assessment of transcriptional compensation of
the monoallelically expressed genes.
Next, I examined whether the transcriptional compensation was reflected in the levels of
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Figure 6.5: Validation of transcriptional compensation by Q-RT-PCR.
Q-RT_PCR validation of RNA-seq linear regression analysis for transcripts classified as tran-
scriptional compensators showing those which (A) validated and (B) did not validate. Blue
circles represent Q-RT-PCR data (mean +/- SD of 3 biological replicates), red crosses represent
RNA-seq data.
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Figure 6.6: Validation of RNA-seq linear regression analysis by Q-RT-PCR.
Q-RT-PCR validation of RNA-seq linear regression analysis for transcripts classified as (A)
dosage-sensitive, (B) dosage-oversensitive and (C) over-compensating. Blue circles represent
Q-RT-PCR data (mean +/- SD of 3 biological replicates), red crosses represent RNA-seq data.
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protein in the cell. Western blotting experiments was performed to compare the levels of
monoallelically expressed genes across clones and a non-clonal population of cells (figure 6.7
on the following pageA, B). Quantification of the Western blots was performed by determining
the ratio of the band’s signal intensity between the gene of interest and a control gene such as
Lamin B1 (figure 6.7C, D). Antibodies for two genes (Cbr3 and Rgs16 ) gave clear and consistent
signals in NPC clones. Cbr3 was classified as a transcriptional compensator by both RNA-seq
and Q-PCR analysis (figure 6.5A). This was reflected in the protein levels in the clones as
monoallelically expressing, allele-biased and biallelic clones showed similar levels of protein as
the non-clonal control sample (figure 6.7A, C). Rgs16 was classified as over-compensating by
RNA-seq linear regression analysis, and over-sensitive by Q-PCR analysis (figure 6.6C). Protein
levels in the monoallelically expressing clone were similar to the non-clonal sample, yet higher
than in an allele-biased clone (figure 6.7B, D). Therefore it is likely that for Rgs16, the exact
levels of protein are not critical for the cell, and instead there is a high degree of variability in
expression levels both of the mRNA and the protein across samples.
Finally, compensation was confirmed at the level of mRNA transcription in single cells by
RNA-FISH analysis. Cells from monoallelic and biallelic clones were mixed together in equal
amounts, and seeded onto coverslips for RNA-FISH analysis. This enabled control for any
differences in hybridization efficiency or imaging biases introduced by preparing samples inde-
pendently. For each site of transcription, visualized as an RNA-FISH spot, the z-slice containing
the maximum signal intensity was identified. The total signal intensity for the individual allele
in that slice was then measured (figure 6.8A on page 156), and the background signal intensity
subtracted. The normalized signal intensity between single alleles was then compared between
monoallelic and biallelic cells (figure 6.8B). There was a statistically significant 2-fold increase
in the signal intensity of alleles in monoallelic cells when compared to biallelic cells for two sepa-
rate monoallelic candidates (figure 6.8B). Gas6 was identified as over-compensating by RNA-Seq
analysis and compensating by Q-PCR analysis (figure 6.6C), and RNA-FISH analysis confirmed
that this observed compensation was due to a two-fold upregulation of the single active allele
in monoallelically expressing cells, such that overall transcript levels are comparable to bialleli-
cally expressing cells (figure 6.8). The other gene which showed transcriptional upregulation by
RNA-FISH analysis was Cap2, a gene identified as dosage-sensitive by both RNA-sequencing
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Figure 6.7: Validation of transcriptional compensation by Western blotting.
Western blotting analysis for two monoallelically expressed genes Cbr3 (A) and Rgs16 (B) across
different NPC clones and non-clonal control. Lamin B1 is used as loading control. Quantification
of western blots for Cbr3 (C) and Rgs16 (D) relative to Lamin B1 control is shown.
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and Q-PCR analysis. This discrepancy between the two assays could be due to having only 4
clones that were assessable for the RNA-sequencing and Q-PCR analysis, some of which showed
high variation in expression levels for this gene (figure 6.6B). In fact, removal of the clone
with |d-score| of 0.5 would completely change the results to either compensation (RNA-seq) or
over-compensation (Q-PCR), again illustrating the main caveat of the linear regression analysis.
Finally, Ror2, the third gene assayed by RNA-FISH, showed equal transcription coming from
a single allele in both monoallelically and biallelically expressing cells (figure 6.8B). Consistent
with these findings, Ror2 was identified as dosage-sensitive by RNA-sequencing linear regression
analysis. In this way the total amount of Ror2 mRNA in the cell follows the number of equally
expressing alleles.
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Figure 6.8: Validation of transcriptional compensation by RNA-FISH.
(A) Measurements of transcriptional outputs of single alleles was performed by calculating the
maximum signal intensity of the RNA-FISH hybridisation signal in a single slice for monoal-
lelically and biallelically expressing cells. Signal intensity was normalised to the mean of three
nucleoplasmic control measurements. Three genes were tested, Gas6 (B) and Cap2 (C) show a
two fold increased output of the single active allele in monoallelically expressing cells compared
to a single allele in a biallelically expressing cell, while transcriptional output was similar for
alleles of Ror2 (D). Error bars represent standard error of the mean, n=30. ** p<0.01, ***
p<0.001, Mann-Whitney two-tailed t-test.
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Chapter 7
Conclusions and Perspectives
7.1 Summary
Identification of random inheritable monoallelic expression during differentiation of mouse em-
bryonic stem cells (ESCs) to neural progenitor cells (NPCs) was performed through an allele-
specific RNA sequencing screen. While just 67 genes were monoallelically expressed in ESCs,
this increased 5.6 fold to 376 genes in NPCs, representing 3.0% of the assessable transcriptome,
indicating that the establishment of monoallelic expression occurs during early development.
There was little to no overlap between monoallelically expressed genes in ESCs and NPCs,
supporting cell-type specificity of monoallelic expression. Furthermore, 72% of NPC monoal-
lelically expressed genes switched from biallelic expression in ESCs to monoallelic expression
during differentiation. DNA methylation was not sufficient to explain the mitotic inheritance
of monoallelically expressed genes, nor was there evidence for differential nuclear positioning
of the active versus inactive alleles. However, histone modifications differentially marking the
two alleles not only provide an epigenetic signature of monoallelic expression, but could also
provide a mechanism through which monoallelic expression could be maintained across cell di-
visions. Interestingly, overal transcript levels of only a subset of monoallelically expressed genes
followed active allele dosage. In contrast, for 8% of monoallelically expressed genes, transcript
levels remained similar between monoallelic and biallelic states. For these genes the single active
allele is up-regulated to preserve the biallelic levels of the respective mRNA in the cell. This
supports a model where stochastic gene regulation during dynamic ESC differentiation results
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in monoallelic expression, and for some genes, the cell is able to compensate transcriptionally
to maintain the required level of expression of these genes.
7.2 Discussion
I propose that random monoallelic expression exemplifies a stochastic aspect of gene regulation
that takes place upon the initiation of specific differentiation programs, that result in global
changes in gene expression and chromatin condensation. If the probability of gene activation
is less than 1, this would result in a mixed population of cells containing 0, 1, or 2 active
alleles. Once established, if not detrimental to the cell, these allele expression patterns could
become set epigenetically, and the transcriptional states subsequently maintained across cell
divisions and propagated clonally (figure 7.1 on the following page). Probabilistic models of
random monoallelic expression have been proposed for other examples of monoallelic expression,
including Albumin in hepatocytes (Michaelson, 1993), the interleukin genes in T cells (Guo
et al., 2005), and Ly49 receptors in NK cells (Held and Raulet, 1997). In all cases, the two
alleles are independently regulated with a low activation probability, possibly due to limiting
quantities of key activating factors. One consequence of this independent regulation is that it
generates both monoallelic and biallelic cells in a mixed population. Indeed, at least one biallelic
clone is observed for almost all monoallelically expressed genes, consistent with an independent
stochastic regulation model. As monoallelic expression is stochastic, it is likely that genes have
different propensities to become monoallelic, depending on the cell type. Consistent with this,
screens performed in neuronal cell types (Jeffries et al., 2012; Li et al., 2012b; Lin et al., 2012;
Wang et al., 2010) have a higher degree of overlap with our study than those performed in
more distant cell types, such as lymphoblasts and fibroblasts (Gimelbrant et al., 2007; Zwemer
et al., 2012). The outcome of monoallelic expression for some genes may be unfavorable if the
cell requires a specific level of transcript that cannot be accommodated for by the single active
allele, thus resulting in cell death. However, for those genes for which either the exact level of
transcript is not critical, there are functional redundancies with other genes, or for those that
are able to compensate transcriptionally, monoallelic expression represents a viable outcome for
the cell.
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Figure 7.1: Model for random monoallelic gene expression during differentiation.
Differentiation of ESCs to NPCs involves dramatic changes to the gene expression program. For
those genes in which the probability of gene activation is less than 1, potentially due to limited
accessibility or availability of chromatin remodelers (purple pentagons), histone modifying en-
zymes (blue diamonds) or the transcriptional machinery (green stars), three outcomes exist in
the differentiated cell types. Either no alleles are activated (no expression), 1 allele is active and
one remains inactive (monoallelic expression) or both alleles are active (biallelic expression). If
these states are viable for the cell, either through transcriptional compensation of the monoallel-
ically expressed genes, redundancies with other gene products or due to flexible transcriptional
requirements of the cell, these states may become mitotically stable, such that they are propa-
gated across cell divisions in a clonal manner, potentially through the acquisition of either active
H3K4me/2 (green circles) or inactive H3K9me3 (red triangles) histone modifications.
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The results in this study both support and add significantly to the findings of previously
published genome-wide screens (table 7.1 on the next page). By performing an RNA-sequencing
based screen, the number of assessable genes is substantially greater than for those screens
performed using microarray technologies in which only 1,358 (Zwemer et al., 2012) to 3,939
genes (Gimelbrant et al., 2007) were able to be assessed. This is in contrast to the approximately
14,000 genes that were able to be assessed in this study. Therefore in this way, RNA-sequencing
based approaches enable a more complete global picture of random monoallelic gene expression.
This study identified a similar frequency of random monoallelic expression to that of other RNA-
sequencing based approaches in neural cell types (Li et al., 2012b; Lin et al., 2012), however
it was substantially less than that reported using microarray based approaches in human and
mouse lymphoblasts and fibroblasts (Gimelbrant et al., 2007; Zwemer et al., 2012). This is likely
not due to the technology platform used, as another microarray based approach in neural stem
cells reported similar frequencies (Jeffries et al., 2012) to the 3% of assessable genes identified
in this study. Instead it likely represents differences in the stringency thresholds and criteria
used to define random monoallelic expression. Our approach has been very stringent in order
to minimise the number of false-positives, but in this way likely underestimates the number of
monoallelically expressed genes. For example, the vast majority of monoallelically expressed
genes identified by Gimelbrant et al. and Zwemer et al. (78% and 91% respectively) were
called using only 1 available SNP. As these studies only required 1 biased clone for a gene to be
classified as monoallelically expressed, they likely have a higher rate of false positives in their
screens (Gimelbrant et al., 2007; Zwemer et al., 2012). In contrast, my screen required adequate
coverages (at least 5 reads) per SNP for a transcript to be assessable, and there was on average
6 SNPs per transcript (see section 4.1 on page 81), increasing the robustness of the screen.
However, this may have led to a higher rate of false negatives in the screen. An alternative
possibility for the observed differences in frequencies, although unlikely, is that there are more
monoallelically expressed genes in fibroblasts and lymphoblasts compared to neural progenitor
cells. Additional screens across different cell types, both in vivo and in cell culture systems, are
required to gain further insight into how random autosomal monoallelic gene expression changes
both during development and between cell types.
Consistent with previous findings, we see no genomic clustering of the random monoalleli-
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Table 7.1: Comparison of features of monoallelically expressed genes identified with previously
published screens.
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cally expressed genes, nor any coordination in expression biases along the chromosomes (table
7.1). There is an enrichment for signaling proteins and glycoproteins, similar to that observed
in previously observed (Gimelbrant et al., 2007; Jeffries et al., 2012; Li et al., 2012b), how-
ever this enrichment is small and likely not of great biological significance. Importantly, less
than 1% of the random autosomal monoallelically expressed genes identified demonstrated strict
monoallelic expression in every single clone assessed. That is, for the vast majority of monoal-
lelically expressed genes, at least 1 clone was biallelically expressed. This is consistent with
previous findings and supports a model in which random autosomal monoallelic expression is a
consequence of stochastic low probability gene expression. Finally, this study has advanced our
understanding of monoallelic expression beyond the published literature by providing substantial
advancements into the understanding of both the mitotic inheritance of the allelic imbalance,
but also the consequences on expression levels at these genes.
One key finding of this study is that there is significantly less monoallelic expression in
pluripotent ESCs compared to lineage committed NPCs, supporting the original hypothesis
that the establishment of random autosomal monoallelic expression occurs during early devel-
opment. ESCs are unique in their developmental plasticity which is reflected in a more open and
dynamic chromatin and promiscuous gene expression profiles (reviewed in (Fisher and Fisher,
2011; Mattout and Meshorer, 2010; Meshorer and Misteli, 2006)). The ESC colonies are highly
heterogeneous both in terms of transcriptional profiles, but also in developmental potentials
(Huang, 2011; Martinez Arias and Brickman, 2011). Their genome is in general transcrip-
tionally hyperactive, with low level expression of lineage-specific genes and normally silenced
repetitive elements, which become repressed upon differentiation (Efroni et al., 2008). Within a
population of ESCs, cell states range from pure unrestricted pluripotent potential, to a poised
state in which the cell has commenced to proceed towards a specific differentiation pathway.
This heterogeneity is hypothesised to reflect properties of the pluripotent state (Martinez Arias
and Brickman, 2011), rather than being a feature of stem cells in culture, as similar hetero-
geneities exist in the preimplantation embryo (Guo et al., 2010; Plusa et al., 2008). In this
way, these heterogeneities may reflect trapped transition states, that is, intermediates during
cell fate decision in which a cell exhibits a mixture between the state of origin and the state of
destination (Arias et al., 2013). As the ESCs within the colony cycle between these different
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states of developmental potential (Canham et al., 2010), it is therefore not surprising that there
is significantly less stably inheritable random monoallelic expression in ESCs compared to more
static differentiated cell types. While the initial frequency of random monoallelic expression
resulting from stochastic gene expression may be similar to that of differentiated cell types,
these allelic imbalances would not be clonally propagated and maintained as efficiently in ESCs
given the dynamics in transcriptional profiles and developmental potential. It would be of in-
terest to determine whether the initial frequency of random monoallelic expression, while not
necessarily maintained, is similar in ESCs compared to other cell types, an experiment which
will become more feasible with the advances made in single-cell RNA sequencing technologies.
Furthermore, it will be of interest to study how monoallelic expression changes not only during
mouse development, but also across both closely related and distant organisms, and how, given
the potentially lowered evolutionary constraint of these genes, monoallelic expression may play
a role in speciation, not only of mammals (Keverne, 2009; Renfree et al., 2013) but also for
other species (Georgy and Widdicombe, 2002).
Although DNA methylation is perhaps the best understood mechanism by which tran-
scriptional states can be inherited (reviewed in (Smith and Meissner, 2013)), and has been
demonstrated to be important for other examples of monoallelic expression, including genomic
imprinting (reviewed in (Kelsey and Feil, 2013)), a global role for DNA methylation in main-
taining monoallelic expression for the genes identified in this study was not observed. However,
it does remain possible that selected genes are regulated in this way. While allele-specific DNA
methylation has been previously reported in the mouse CNS (Wang et al., 2007) and used to
identify monoallelically expressed genes, including Thrsp which was also identified in this screen,
it has never been demonstrated that DNA methylation drives monoallelic expression. My obser-
vations are consistent with a recent report that DNA methylation is not involved in maintaining
active and inactive alleles of the monoallelically expressed Cubilin gene in kidney and intestinal
cell lines (Aseem et al., 2013). Additionally, a recent genome-wide analysis of the interplay
between genetic variation, DNA methylation and gene expression, did not find any evidence for
allele-specific DNA methylation driving monoallelic expression in human cells in the absence of
DNA sequence variation effects (Gutierrez-Arcelus et al., 2013). Therefore DNA methylation
likely does not regulate random autosomal monoallelic expression.
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However, I did observe that the active and inactive alleles were associated with differ-
ent histone modifications: the active allele marked by H3K4me2/3 and the inactive allele by
H3K9me3. Histone modifications have been shown to mark other examples of monoallelically
expressed genes, consistent with our results. For example X-inactivated genes and imprinted
genes are marked by promoter-restricted H3K4me2 (Rougeulle, 2003), and olfactory receptors
by H3K9me3 and H4K20me3 (Magklara and Lomvardas, 2013). Interestingly, we did not see
evidence for the Polycomb-associated H3K27me3 repressive mark at the promoters of inactive
alleles of monoallelically expressed genes, whereas H3K9me3 was present. It remains to be
determined whether these histone modifications are actively involved in the inheritance of the
transcriptional state or if they are a byproduct of the respective state. Additionally, there may
be yet undetected characteristics that distinguish the active and inactive alleles of monoalleli-
cally expressed genes that may also play a role in maintaining the difference in transcriptional
state across cell divisions. The position and organization of alleles within the three-dimensional
nucleus has been linked to transcriptional output (reviewed in (Hübner et al., 2013)), and while
small differences in nuclear positioning between the active and inactive alleles has been observed
for monoallelically expressed GFAP in astrocytes (Takizawa et al., 2008a), and nuclear organi-
zation has been implicated in regulating both olfactory receptor genes (Clowney et al., 2012)
and immunoglobulins (Skok et al., 2001), I did not observe any difference in the position of
active versus inactive alleles with respect to the nuclear periphery or heterochromatin. Thus,
it is unlikely that nuclear organization is critical for maintaining the expression bias of the
monoallelically expressed genes examined in this study.
One would predict that decreasing the gene dosage would lead to decreased expression levels
of the particular gene. Therefore the observation of transcriptional compensation for some of the
monoallelically expressed genes was surprising, albeit not without precedent. Transcriptional
compensation has also been observed for examples of aneuploidy in non-mammalian systems,
including Drosophila (McAnally and Yampolsky, 2010) and Maize (Guo and Birchler, 1994) in
which mRNA levels do not strictly follow the dosage of the gene. Examples of transcriptional
compensation can also been seen when comparing heterozygous knockout mice to their wild-type
counterparts. For example, two genes we identified as monoallelically expressed in NPCs, Mks1
(Wheway et al., 2013) and Bag3 (Homma et al., 2006), both show comparable levels of protein
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between wild-type and heterozygous knock-out mice. There are, however, examples of genes
in which the heterozygous mice have reduced transcript levels, including the monoallelically
expressed genes Cth (Kaasik et al., 2007) and Cstb (Ishii et al., 2010). Therefore, it is likely
that transcriptional upregulation is not only gene specific but also cell type specific. For those
genes that do not compensate, the precise level of gene product may not be critical for normal
cell viability. Thus, in some cases, the cell is able to tune the transcriptional output of the
respective allele in response to either genetic or epigenetic inactivation of the second allele to
maintain overall expression levels (figure 7.2 on the next page). This has important implications,
especially in the interpretation of copy number variants, as these may not necessarily result in
a change of transcript and protein product.
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Figure 7.2: Transcriptional compensation of monoallelically expressed genes.
Schematic showing the effect of number of active alleles of a transcriptionally compensating
gene. (A) In biallelically expressing cells, transcriptional output is similar between the two
alleles which are both marked by the active-associated histone modifications H3K4me2/3 (green
circles). (B) In contrast, monoallelically expressed cells show expression from only one of the
two alleles. This expressing allele has similar levels of H3K4me2/3 however is now expressing
at twice the level of a single allele compared to the biallelic cell. In contrast, the inactive allele
has lost the H3K4me2/3 modifications and gained the repressive H3K9me3 modification (red
triangle).
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7.3 Perspectives and future directions
At the outset of this thesis work, there were many unanswered questions regarding the character-
istics, inheritance and significance of random autosomal monoallelic gene expression (table 1.1
on page 51). Many of these questions have now been resolved in this study (table 7.2 on
page 169). One of the major questions in the field is how monoallelic gene expression is main-
tained mitotically through cell divisions. I have found that unlike most other examples of classic
monoallelic expression, DNA methylation is not involved in the inheritance of the active and
inactive alleles, although it may distinguish between the alleles. Nor is there a role for nuclear
organisation of these genes, also in contrast to the classical examples of monoallelic expression.
Instead H3K4me2/3 and H3K9me3 differentially mark the two alleles and are likely candidates
for the maintenance of monoallelic expression. There was no enrichment for non-coding RNAs
surrounding these genes, nor did they fall into clusters, further distinguishing them from the
classical monoallelically expressed genes. Thus I propose that random autosomal monoallelic
expression results from very different processes and for very different reasons from that which
occurs at X-chromosome inactivation, imprinted genes, immunoglobulins and olfactory recep-
tors. Rather than being an active process in the cell to either control gene dosage or generate
receptor diversity, random autosomal monoallelic expression is a consequence of the stochas-
tic nature of gene expression regulation. Low probability of gene activation may be due to a
number of different reasons, such as limited transcription factor accessibility and/or availability,
and has been described for a number of different genes such as the interleukins (Paixão et al.,
2007). This low probability of activation results in a mixed population of cells, some of which
express only from one allele, others are biallelic and some not expressing at all. Indeed single
cell RNA-sequencing and Q-PCR analysis is generating a picture of high variability of gene
expression levels in an otherwise seemingly homogeneous population of cells (Bengtsson, 2005;
Kalisky et al., 2011; Raj and van Oudenaarden, 2009; Shalek et al., 2013). This variation in
gene expression levels within single cells can be tolerated in several ways. First, the genes in-
volved may have functional redundancies such that the exact levels of the genes are not critical.
Alternatively, and what we see, there may exist tight feedback loops that act to ensure the
critical level of the genes are reached. Furthermore, rather than being noise in the system, this
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variability in gene expression levels may have important roles during development in cell fate
decisions (Zernicka-Goetz and Huang, 2010).
Now that a comprehensive set of genes that are monoallelically expressed in both ESCs and
NPCs has been identified, there are many exciting future directions that could now be taken
with this project. It would be interesting to determine how extensive and similar monoallelic
gene expression is in other developmental contexts. This could be performed either using a
similar approach to that in this thesis, that is allele-specific RNA sequencing of single-cell
derived clones, or alternatively as single-cell RNA sequencing technology becomes more sensitive,
monoallelic expression could be assessed at the single cell level, both in cell culture as well
as in tissues. By examining monoallelic expression in neighboring cells one could distinguish
inheritable monoallelic expression versus transcriptional pulsing. It would also be interesting
to perform time-course experiments during the course of differentiation to follow the kinetics of
monoallelic expression. Again, this could be performed by allele-specific RNA-sequencing based
approaches, or alternatively the dynamics of a specific monoallelically expressed gene of interest
could be studied using a live-cell reporter system. In such a system, knock-in at the endogenous
alleles of repeats of the 19 base pair MS2 stem loop sequence into the 3’UTR of the gene would
allow visualisation of the site of transcription of that allele in single cells, through expression
of the MS2-coat protein fused to a fluorescent reporter (Bertrand et al., 1998; Chubb et al.,
2006; Janicki et al., 2004; Lionnet et al., 2011; Yunger et al., 2010). Insertion of different RNA
stem-loop motifs, which would be recognised by different proteins, into the second allele would
allow direct visualisation of transcription of the two alleles through the cell cycle, across cell
divisions and during differentiation.
While I ruled out DNA methylation and nuclear organisation, it is not definite that the his-
tone modifications identified play a causal role in maintaining monoallelic expression. Therefore
future experiments are required to determine whether these marks are the cause or consequence
of the transcriptional status of the allele. While siRNA mediated knock-down of the relevant
histone methyltransferases could be performed, such an approach will have widespread effects
on the overall transcriptional program of the cell which will confound any results making a
direct causal link hard to establish. Instead targeting of the relevant histone methyltransferases
or demethylases to the alleles could be performed by fusing these proteins to sequence specific
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Table 7.2: Contribution of this work to understanding the features of random monoallelically
expressed genes.
Contributions to the understanding of monoallelic expression in this thesis are highlighted in red.
X-inactivation Genomic Imprinting Immuoglobulins Olfactory Receptors Random Autosomal
Genomic distribution X-chromosome Autosome, clusters Autosome Autosome, clusters Autosome, dispersed
Choice of allele random parental random random random
Mitotic inheritance yes yes yes n.a. yes
Number of genes ~1,000 ~150 7 ~1400 100s - 1,000s
DNA methylation yes yes yes yes no
Histone modifications yes yes yes yes H3K4me2/3 and H3K9me3
Nuclear organisation yes yes yes yes no
DNA replication timing asynchronous asynchronous asynchronous asynchronous ?
Non-coding RNAs Xist, Tsix… Airn, Kcnq1ot1… no no none annotated
Function dosage compensation parental conflict hypothesis receptor diversity receptor diversity
consequence of 
stochastic gene 
expression
Mechanism sotchastic deterministic deterministic stochastic stochastic
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DNA binding proteins such as TAL effectors (Boch et al., 2009; Moscou and Bogdanove, 2009)
or through use of the CRISPR system (Gilbert et al., 2013; Jinek et al., 2012). This will en-
able direct evidence for these marks in the maintenance of the monoallelic state. Furthermore,
establishment of TALE- or CRISPR-based targeting of an activator could enable additional
experiments in which the silent allele is induced, and the response to the cell investigated over
time. TALE-activators targeting the monoallelically expressed Gas6 gene were designed and
successfully generated during the course of this study, however there were issues in transfection
efficiencies in NPCs of these plasmids due to their large size. For these, as well as other tech-
nical reasons, a CRISPR based system is now being pursued in order to perform these types of
endogenous locus manipulation experiments.
In order to determine whether there are other factors involved in the maintenance of monoal-
lelic expression, a fluorescent-protein knock-in reporter line could be established to enable high-
throughput screens to be performed. This system would ideally involve insertion of a fluorescent
reporter protein within the 3’UTR of the monoallelically expressed gene at only one of the two
alleles. Clones in which this fluorescent reporter is not expressed could be picked and used
to screen for expression of the fluorescent protein, against either small molecule inhibitor li-
braries, such as was used for the pilot screen in this thesis, or through shRNA libraries targeting
chromatin modifying enzymes.
Finally, for those genes that exhibit compensation, it will be of interest to determine the
mechanisms by which transcriptional compensation maintains the total level of mRNA in the
cell. One possibility is that the levels and accessibility of specific transcription factors themselves
are critical in determining the frequency of gene transcription at the respective alleles. Alterna-
tively, there may be feedback loops in which the levels of mRNA and/or protein can be sensed in
the cell. For example, the tumor suppressor Ini1 compensates transcriptionally in heterozygous
cells (Guidi et al., 2004). This transcriptional compensation was shown to be dependent on
the levels of Ini1 mRNA in the cell, as expression of a transgene led to down-regulation of the
endogenous alleles (Guidi et al., 2004). Additionally, Brn3a, which is not expressed in NPCs,
has been shown to compensate transcriptionally through autoregulation (Trieu et al., 2003). An
alternative possibility is that there is transcription factor feedback to regulate the activity of the
upregulated allele. Experiments are currently underway to examine the effect of over-expression
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of a transgene on the endogenous gene expression levels of those monoallelically expressed genes
which exhibit transcriptional compensation.
7.4 Concluding remarks
This study provides the first in depth analysis of random autosomal monoallelic expression
during the course of ESC differentiation. There are few monoallelically expressed genes in
pluripotent ESCs, likely due to their highly dynamic chromatin and extensive expression profiles.
Upon lineage commitment, as cells become more restricted in their expression, there is a random
and stochastic activation or repression of alleles, which in some cases results in allelic-imbalance.
This cell-type specific monoallelic expression is subsequently maintained epigenetically across
cell divisions, likely through histone modifications that differentially mark the two alleles. For
the majority of monoallelically expressed genes, the inactivation of one allele results in a decrease
in gene product, however some genes are able to upregulate the single active allele to compensate
for the allelic-imbalance. In this way, random monoallelic expression illustrates the remarkable
plasticity and robustness of gene regulation in mammalian cells.
In conclusion, monoallelic expression represents an interesting consequence of stochastic
gene expression for which in some situations, the cell is able to compensate for, demonstrating
the remarkable plasticity of the cell in response to initiating developmental programs including
changes in gene expression, chromatin structure and chromatin compaction. These findings have
very important biological significance, not only when considering how gene regulation is carried
out in single cells, but also in relation to heterozygous mutations and copy number variations
involved in disease.
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Chapter 8
Extended Materials and Methods
8.1 Cell culture
Mouse ESC lines (Table 8.1 on page 174) were grown on irradiated Mouse Embryonic Fibroblast
(MEF) feeder cells pre-seeded for at least 24 hours on gelatin coated plates to give a confluent
monolayer of cells (approximately 1.5 x 106cells per 10cm plate) in MEF medium (DMEM high
glucose, 10% FBS, 1x P/S). ESCs were grown in ESC medium (500ml medium contains 425ml
Knockout DMEM, 75ml FBS, 5ml NEAA, 5ml PSG, 500μl LIF (ESGRO 106units) and 7μl
β-mercaptoethanol) and require passaging approximately every 2-3 days before colonies come
into contact with each other and start to differentiate. Prior to RNA or protein isolation, ESCs
were soaked 1-2 times for 1 hour each on gelatin coated dishes to remove MEF feeder cells
which typically adhere faster than ESCs. The non-adherent cells, containing predominantly
pluripotent ESCs, can then be collected for subsequent analysis. ESCs cultured in 3i medium
(GlobalStem) were passaged at least 6 times in the absence of MEFs prior to experiments being
conducted.
ESC differentiation time courses were performed by plating soaked pluripotent ESCs onto
gelatin coated plates in differentiation medium (for 500ml mediummix 450ml DMEM-GlutaMax,
50ml FBS, 5ml 100xNEAA, 5ml PSG, 7μl β-mercaptoethanol). This -LIF differentiation pro-
tocol differentiates the ESCs into all lineages. For a faster more directed differentiation, 1μl
of 1mM retinoic acid (RA) can be added per 10ml differentiation medium. This will select for
cells in the neuronal lineages, however all other lineages will still be present, albeit at lower
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proportions.
Detailed NPC differentiation protocol can be found in appendix C.1 on page 259. Briefly,
NPC differentiation was performed by culturing ESCs in the absence of MEF feeders in 50:50
DMEM/F12:Neurobasal medium (Gibco) supplemented with 1x N2 (Gibco), 1x B27 (Gibco),
40mg/L insulin (Sigma), 25μg/ml BSA Fraction V (Gibco) at 0.5x106 - 2.0x106 cells per 10cm
plate for 6 days. Cells were then resuspended in N2 expansion medium (DMEM/F12, 50μg/ml
BSA fraction V, 10ng/ml EGF (Preprotech), 10ng/ml FGF (Preprotech), 1μg/ml laminin (In-
vitrogen), 1x N2) and plated onto uncoated T75 flasks to allow for neurosphere outgrowth.
Following 4 days, neurospheres were collected by mild centrifugation and plated onto gelatin-
coated plates in N2 expansion medium. Following 2-3 passages, cells represent a homogeneous
population of NPCs, which can be seeded to expand single-cell derived clones. 0.5x to 1x B27
supplement can be added to medium to aid in single-cell colony expansion or to help rescue a
poorly growing culture.
Cell lines can be routinely frozen and stored in liquid nitrogen by resuspending cells in
freezing medium (regular medium supplemented with 10% FBS, 10% DMSO), slow cooling
at -80°C for 1-3 days, then transferring to liquid nitrogen. Thawing cells should be performed
quickly by placing frozen vials in 37°C water bath and transferring immediately to fresh medium
to minimise cell death.
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Table 8.1: Cell lines used in this work
Name Cell Type Species Genetic Background Source Notes
AB2.2 Embryonic Stem
Cell
mouse 129/SvEvBrd-Hprtb-m2 A. Mills, CSHL
Bl6 x CAST Embryonic Stem
Cell
mouse C57Bl6/J x CAST/EiJ C. Vakoc
CSH1 Primary
Embryonic Stem
Cell
mouse 129 x C57Bl/6 derived by S. Kim, CSHL
lmna-/- Embryonic Stem
Cell
mouse C. Stewart, A*STAR LmnA/C knockout (Sullivan
et al., 1999)
GM12878 lymphoblast human GM12878-16XiMat Coriell one of cell lines used in
(Gimelbrant et al., 2007)
MEF Mouse Embryonic
Fibroblast
mouse CF-1 GlobalStem, Rockville, MD,
USA
Irradiated for ESC culture
MK6 Primary
Embryonic Stem
Cell
mouse C57B4 derived by S. Kim, CSHL
NE4C Neural Stem Cell mouse C57Bl x Sv129 ATCC CRL-2925 cell line is triploid
nGFP2 iPS Induced
Pluripotent Stem
Cell
mouse ROSA26-rtTA/pgk-puro;
Nanog-GFPiresPuro
R. Jaenisch, Whitehead
Institute, MIT
contain doxycycline
inducible Yamanaka factors
and Nanog-GFP reporter
(Wernig et al., 2008)
R1 Embryonic Stem
Cell
mouse 129X1 x 129S1 S. Kim, CSHL
v6.5 Embryonic Stem
Cell
mouse C57Bl/6 x 129/Sv S. Kim, CSHL
WB6.1 Primary
Embryonic Stem
Cell
mouse C57Bl6 Cbrd/Cbrd/Cr derived by S. Kim, CSHL
Ts65Dn (5-1c) Euploid
Embryonic Stem
Cell
mouse female, Ts65Dn x
C57Bl/6EiJ/C3H/HeSnJ
U. Hochgeschwender, Duke
University
euploid control for Ts65Dn
(7-5) line (Reeves et al.,
1995)
Ts65Dn (7-5) Trisomic
Embryonic Stem
Cell
mouse female, Ts65Dn x
C57Bl/6EiJ/C3H/HeSnJ
U. Hochgeschwender, Duke
University
trisomic for region between
Mrpl39 and Znf295
(Reeves et al., 1995)
Ts1Cje (line 2) Trisomic
Embryonic Stem
Cell
mouse male,
B6EiC3Sn-Ts(16C-tel)1Cje
x C57Bl6/Ei/C3H/HeSnJ
U. Hochgeschwender, Duke
University
trisomic for region between
Sod1 and Mx1. Sod1
inserted copy contains
neomycin resistance cassette
(Sago et al., 1998)
Ts1Cje (line 9) Euploid
Embryonic Stem
Cell
mouse male,
B6EiC3Sn-Ts(16C-tel)1Cje
x C57Bl6/Ei/C3H/HeSn
U. Hochgeschwender, Duke
University
euploid control for Ts1Cje
(line 2)
(Sago et al., 1998)
ZHBTc4 Embryonic Stem
Cell
mouse A. Smith, University of
Cambridge
Pou5f1+/-tetracycline
regulated transactivator
tTA and tTA-responsive
Oct3/4 transgene (Niwa
et al., 2000)
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8.2 RNA isolation and cDNA synthesis
Total RNA was isolated using Trizol reagent (Ambion). Cells were resuspended in 1ml Trizol
reagent and either stored at -80°C or processed immediately. 0.2ml of chloroform was added per
1ml Trizol used. Samples were shaken vigorously, incubated for 2-3 minutes at room temperature
then centrifuged at 12,000g for 15 minutes at 4°C. Following centrifugation, the upper aqueous
phase containing RNA was transferred to a new tube, and 0.5ml isopropanol added, gently
mixed, incubated at room temperature for 10 minutes, then centrifuged at 12,000g for 10 minutes
at 4°C. Following centrifugation, the RNA forms a small white pellet which was washed once in
1ml 75% ethanol, air dried for 10 minutes and resuspended in 10-30μl water. RNA concentration
was measured using nanodrop, only samples with OD260/280 and OD260/230 ratios above 1.6
were used for subsequent experiments.
cDNA synthesis was performed using 1μg total RNA. RNA was first treated with DNAse
I (Invitrogen) to remove any potential contaminating genomic DNA for 15 minutes at 25°C.
DNAse I enzyme was then inactivated by adding 1μl EDTA and heating to 70°C for 10 min-
utes. Following DNAse I treatment, reverse transcriptase reaction was performed using TaqMan
RT reagents from Applied Biosystems (#N808-024), using either oligodT or random hexamer
primers and a reaction time of 30 minutes at 48°C.
8.3 RNA-sequencing library preparation
Two protocols were utilised to generate libraries from 4-10μg total RNA isolated using Trizol as
in section 8.2 for deep sequencing analysis. The first is a 5-day protocol utilised by ENCODE
and was used to generate all libraries in the initial RNA-sequencing screen, as well as libraries
analysed in the Lamin A/C manuscript (Chapter 3). Subsequent libraries were generated using
Illumina TruSeq mRNA library preparation kit, and typically take 2-3 days to generate. Prior
to library construction, the quality of RNA was verified by running an Agilent RNA nano
ChIP. Only samples with RNA Integrity Number (RIN) > 9.0 were used for library preparation.
Detailed ENCODE RNA-seq protocol can be found in the appendix C.2 on page 262. Illumina
TruSeq libraries were prepared as per manufacturers instructions. Paired-end libraries prepared
with the ENCODE RNA-seq protocol were sequenced on the Illumina genome analyser (GA) IIx
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platform. Paired-end libraries generated using the Illumina TruSeq mRNA library preparation
kit were pooled and sequenced on the Illumina HiSeq platform.
8.4 Allele-specific RNA-sequencing analysis
8.4.1 C57Bl/6J and CAST/EiJ transcriptome and read mapping
The C57Bl/6J transcriptome was collected from ENSEMBL v59. The transcriptome of Mus
castaneus (CAST/EiJ) was created by substituting the 423,197 exonic single nucleotide variants
(SNV) between C57BL/6J and CAST/EiJ (Keane et al., 2011). In total 82.8% of transcripts
have at least 1 SNV between CAST/EiJ and C57BL/6J. RNA-seq libraries with ~80 million
reads per clonal sample were mapped to both the C57BL/6J and the CAST/EiJ transcriptomes
using BWA (Li and Durbin, 2010) with default parameters, resulting in ~50 million mapped
reads per sample.
8.4.2 Definition of expressed transcripts and genes
Overall, transcript expression levels were determined by calculating the union of raw reads
mapped to both the C57BL/6J and the CAST/EiJ transcriptome files and were normalized
by library size using DESeq (Anders and Huber, 2010). Expression levels are reported as the
number of Normalized Reads Per Kilobase (NRPK), by dividing the normalized read count
by the transcript length. In each clone, a transcript was defined as not expressed when its
expression level was below a threshold of 5.8 NRPK. This threshold is equal to the average of
the expression of the 20th percentile of expression values across all clones. The set of assessable
transcripts used as a background for all subsequent analysis was defined as the transcripts that
were expressed in at least two clones. The set of assessable genes used as a background was
defined as the genes containing at least one transcript in the set of assessable transcripts.
8.4.3 Identification of monoallelically expressed transcripts within each clone
To identify monoallelically expressed transcripts, we exploited the SNVs between C57BL/6J and
CAST/EiJ present in each transcript. At each SNV position we first determined the total read
count at the respective SNV position in both the C57BL/6J and the CAST/EiJ transcriptomes.
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Reads that mapped equally well to both transcriptomes were only counted once. Subsequent
analysis was performed on the 72,754 transcripts (82.8% of all transcripts) that contained at
least one exonic SNV between C57BL/6J and CAST/EiJ. A read was then assigned to the
C57BL/6J (or CAST/EiJ) allele if it contained the nucleotide variant associated with C57BL/6J
(or CAST/EiJ) at the particular SNV position. Transcripts in each clone were classified into
one of six categories defined below based on both a p-value generated from a binomial test (see
below), and a d-score representing the ratio of expression between the two alleles and hence the
strength of allelic imbalance (see below):
Monoallelic: |d-score|≥0.40, p-value ≤10-8
Allele-biased: 0.18≤|d-score|<0.40, p-value ≤10-8
Biallelic: |d-score|<0.18 and/or p-value>10-8
Not-expressed: expression is lower than 5.8 normalized reads per kilobase (NRPK)
Non-assessable: No SNV in the transcript with at least 5 reads coverage or the transcript is
within a genomic region filtered for aneuploidy
Other: all remaining transcripts P-value calculation
For each transcript, we assessed whether there was evidence of allele specific expression by
considering the set of k SNVs between C57BL/6J and CAST/EiJ. For SNVi(i = 1, . . . , k) let
Xi denote the number of reads mapped to C57BL/6J allele, ni denote the number of reads
mapped across both alleles, and p be the probability that a read carries the C57BL/6J allele.
Subsequently, we assume that Xi Bi(ni, p) where Bi(N, p) denotes a binomial distribution with
parameters N and p. For each transcript, we then assess the following hypotheses: H0 : p = 1/2
H1 : p 6= 1/2 by calculating a likelihood-ratio test statistic before computing a p-value to test
whether there is evidence to reject the null hypothesis by comparing the likelihood-ratio to the
quantiles of a chi-squared distribution with one degree of freedom.
d-score calculation: To calculate a d-score for each transcript, we first di as di = Xini − 12
where Xi and ni are as above. The d-score, d, of a transcript is calculated as the weighted
mean of each di of the transcript: d =
∑
(i=1...k)widi where wi = ni⁄N with N being the total
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number of reads that map over all positions i in the transcript. This gives less weight to SNV
positions with fewer mapped reads, since they will have more sampling noise and are thus less
representative of the overall d-score of the transcript. The d-score takes values between -0.5 to
0.5, where negative values correspond to a bias toward the CAST/EiJ allele and positive values
to the C57BL/6J.
8.4.4 Classification of monoallelically expressed transcripts across clones
Based on the classification of transcripts into the 6 categories described in the previous section,
we further assigned transcripts into one of three classes of monoallelically expressed genes.
Transcripts assigned to the not-expressed, non-assessable clones and other classes for a given
clone were ignored in the classification process.
ClassA: transcripts where at least one clone showed allele specific expression (either monoal-
lelic or allele-bias, defined above) of the BC57Bl/6J allele and a different clone
showed allele specific expression of the CAST/EiJ allele. Some clones may also be
biallelic. Transcripts in this class represent high confident random monoallelic genes.
ClassB: transcripts with at least one biallelic clone and at least one clone showing allele
specific expression (either monoallelic or allele-bias) towards either the C57Bl/6J
or CAST/EiJ allele. All clones showing allele-specific expression have the bias in
the same direction. Class B transcripts were further filtered using more stringent
parameters to select those in which there was strong evidence that the second allele
was transcribed in at least one clone. Filtered class B transcripts contain at least
one clone with stringent allele specific expression (p-value<10-10, |d-score|>0.35) and
one clone with stringent biallelic expression (|d-score|<0.10).
ClassC: transcripts in which allele specific expression was observed toward the same allele
for all clones and no biallelic clones were observed. This class contains non-random
monoallelically expressed genes, including imprinted genes or those biased due to
strong cis genetic effects. Class C transcripts were not included in subsequent anal-
ysis.
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Not all transcripts were necessarily assigned to one of the three classes above. Genes were
assigned to a class if at least one corresponding transcript was in the class. Consequently, genes
could be present in more than one class. The final set of random monoallelically expressed
transcripts includes class A and filtered class B transcripts.
8.4.5 Identification of genes showing transcriptional upregulation
Linear regression analysis was used to compare expression levels across clones with different
extents of allelic imbalance. For each gene the model assumes a linear relation between its ex-
pression level in a given clone and the degree of allelic imbalance (defined by the |d-score|) in the
same clone. In other words, a transcript expressed in a monoallelic clone (|d-score|=0.5) would
have half of the expression of the same transcript expressed in a biallelic clone (|d-score|=0). In a
given clone, the relation between expression level and d-score is: yc = −ExpBiall×|d|c+ExpBiall
where yc is the expression level of the transcript in clone c, |d|cis the d-score of clone c for this
transcript and ExpBiall is the expression of this transcript in the biallelic state. To test whether
this relationship holds for monoallelically expressed genes we regressed yc upon |d|c and ob-
tained maximum likelihood estimates of the slope a and the intercept b. We then calculated the
ratio r = | a−b | If r is close to 0, then the expression level is similar when the transcript is both
biallelically or monoallelically expressed. Genes with a transcript with a ratio r < 0.35 were
defined as upregulated and investigated further.
8.5 Genomic DNA isolation
Genomic DNA was isolated using Trizol reagent (Ambion). Cells were resuspended in 1ml Trizol
reagent and either stored at -80°C or processed immediately. 0.2ml of chloroform was added
per 1ml Trizol used. Samples were shaken vigorously, incubated for 2-3 minutes at room tem-
perature then centrifuged at 12,000g for 15 minutes at 4°C. Following centrifugation, the white
interphase can be seen containing genomic DNA. The upper aqueous phase containing RNA is
completely removed, and 0.3ml 100% ethanol added to the DNA interphase sample. Samples
were mixed by inversion, incubated at room temperature for 2-3 minutes, then centrifuged at
2,000g for 5 minutes at 4°C. Following centrifugation, the pellet is washed twice in 0.1M sodium
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citrate in 10% ethanol by incubating at room temperature for 30 minutes with periodic mixing
followed by centrifugation at 2,000rpm for 5 minutes at 4°C. The pellet is then air dried for 15
minutes at room temperature, and resuspended in 300-600μl 8mM NaOH then centrifuged at
12,000g for 10 minutes at 4°C to remove insoluble material including membranes. The DNA
solution is transferred to a new vial, and the high pH is adjusted by adding HEPES such that
it is lowered to pH7-8. Genomic DNA is subsequently purified by phenol chloroform extraction.
Equal volumes of phenol is added to the sample. Samples are vigorously mixed, centrifuged
and the upper phase transferred to a new vial. Next the DNA is purified by one round of phe-
nol:chloroform:isoamylalcohol extraction and one round of chloroform:isoamylalcohol extraction.
DNA is precipitated by adding 0.1 volumes of 3M NaOAc and 1.1 volumes of isopropanol, incu-
bating at -80°C for 30-60 minutes, centrifuging at 12,000g for 30 minutes at 4°C, washing once
in 75% ethanol, air drying the pellet, and resuspending in water. Sample concentration was
measured using the nanodrop.
8.6 Mouse diversity SNP arrays
To control for any variation in DNA copy number that may result in identification of false-
positive random monoallelically expressed genes, copy number was assessed using SNP arrays.
Mouse Diversity Arrays (Affymetrix) containing probes for over 600,000 SNPs, were run using
5μg purified genomic DNA per sample by The Jackson Laboratory, Bar Harbor, Main, USA.
The library MouseDivGeno from JAX lab was used to normalise the signal from raw data in
CEL format, keeping only the SNPs present between C57BL/6J and CAST/EiJ mouse strains
for analysis. For each SNP we calculated a BAF value, BAF = B(A+B) , where A and B are the
signal value for the A and B alleles respectively. Each chromosome was split into bins of 1Mb
in size with an average of 85.5 SNPs per bin. Average BAF values from the ESC SNP array
were used to determine the background for each chromosome. Bins with a distribution of BAF
values that differed from the background were defined as aneuploid (Kolmogorov-Smirnov test,
p-value<10-8). A total of 16 aneuploid regions were identified across the 6 NPC clones, and a
subset were confirmed by karyotype analysis (Molecular Cytogenetics Core Facility, Memorial
Sloan Kettering Cancer Center, NY, USA). Transcripts within aneuploid regions were defined
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as non-assessable and removed from further analysis.
8.7 SNP-PCR
Exonic SNPs were identified in the Mouse Phenome Database hosted at The Jackson Laboratory
(http://www.phenome.jax.org/). Primers spanning the SNP were designed using NCBI’s online
primer design tool (http://www.ncbi.nlm.nih.gov/) ensuring that SNPS were positioned at least
20 base pairs from both primers (table 8.3 on the following page). SNPs were verified using
either genomic DNA or cDNA from non-clonal samples. PCR was performed using Phusion
polymerase (Finnzymes) which has proofreading capabilities. Products were either gel purified
or reactions were cleaned up using PCR purification spin columns (Qiagen). Samples were
sent to Molecular Cloning Laboratory (MCLAB, South San Francisco, CA, USA), or Genscript
(Piscataway, NJ, USA) for Sanger sequencing with either forward or reverse primers used for
PCR reaction. Sequencing traces were analysed using MacVector software (MacVector Inc.) or
4Peaks (Mekentosj).
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8.8 Quantitative RT-PCR
Quantitative RT-PCR was performed using 2μl of cDNA (see section 8.2 on page 175) using
primers amplifying a maximum of 300bp (table 8.8 on page 193) using SYBR green reagents
(Applied Biosciences). At least 3 biological replicates for each sample were used in each exper-
iment, and values normalised to the geometric mean of at least 3 separate housekeeping genes.
Data was analysed using Excel (Microsoft) and graphing performed using Prism (GraphPad).
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Table 8.4: Primers used for quantitative RT-PCR for mouse genes.
Gene Forward Reverse
18S GGGCCCGAAGCGTTTACTTT CGCCGGTCCAAGAATTTCAC
Acan GCACAGCGGGCTTGCCTACA CAGCCAGCCTGCATCGCACT
Actin-beta GCAGCTCCTTCGTTGCCGGT TACAGCCCGGGGAGCATCGT
Acyp2 CTGGTTGGCTGGGTGAAGAA AACCTTTTCTTCGGGGCCTT
Airn CTCATTGGGAGCCTGTGATT TCTGTGCAGCTCATTTCACC
Acot1 CATCACCTTTGGAGGGGAGC TGTACCTTTCCCCAACCTCC
Adamts1 CCGTGCCCGAGGAGGAGTCA AGGCCACTGGTTCCGGGTGT
Anxa6 CCGCCGTGACCTGACCAAGC GTCCAACCCCACCCCTTGCG
Anxa6 (intron) ACCACTGCCCCTTTAGCATC ATTCACCAGCATCCACCCTG
App GGTGGCCCACGCAGGATCAC CGGCGTTGCCATCAGTGGGT
Blbp TCATGTGCAGAAGTGGGATGGCA AGCTGGCTAACTCTGGGACTCCA
Brachyury (T) TGGCGGGAGGATGAGCTCGC CAGTTCGCGTTCGGTGGGGT
Cap2 TGGCTCCAAGCTGGTCACCG CGGGCGTCGGGGCTATGGTA
Cap2 (intron) TCCCTCGTGATCCCCATTCT TGACTAACTGCCGGGGTAGA
Capn5 ACACGTCAGAGGAATGGCAG GGATGCTCAGGTAGGACGTG
Cbr3 GTCCCTCTGACATGTCGTCC CGTTAAGTCCCCCGTACTCC
Cbr3 (intron) CCTTGGAACTTTCAGCTGCG TGATGAGCTTGACAAGGCGT
Cdx2 GCGGCTGCTACGGCGAACTT GCTGTAGCCCATAGCGGCGG
Chaf1b GCCAAATCCACAGCCCAATAGC CCATCACCAGCCTTCGAGCTTTG
Cpne8 ACCCTCACCCCTTCCCGTCG TCCACTCGTGTGGCGGGGAT
Cth CTTTGCATCGGGTCTTGCTG CAGATGCCACCCTCCTGAAG
CycloB1 GACAGACAGCCGGGACAAGC GGGGATTGACAGGACCCACA
Dscam AGCATGGAAGGCTCACAGGCA TGAGGGACGGATGGGCAAGTGA
Dio3 GCCTCGTGCCTCGTGCTGTT ATTGAGCACCAACGGGCGGG
Dlk1 AGCTGGCGGTCAATATCATC AGCTCTAAGGAACCCCGGTA
Ebf1 ATCCAGCCCCACCATGGCCT TCGCTTGCAGGCTGTTCCCG
Emerin AACACCGCTTCCAGGTGCCG GTCCACGGCGGCTGAATCCAA
Eomes GGGAGGCCGTGGCGCTTATC ACCCCGGAGTCGCTGGAGTC
Fgf5 GCTGTGTCTCAGGGGATTGTAGGA GCCACGTACCACTCTCGGCC
Fkbp7 ACTTGGCTAAAGACGGCTCC TGGAATCTTGCCTTCTGCGT
Foxd3 GGTGCGGCGTGGAGAAACCT GCTCCGCGAACTCTTGCGGT
Gabp1 GGGGCGTTTGTGCCTCGTGA CCCTTCCCGTGGAATCGGCG
Gapdh1 GGTGGTGAAGCAGGCATCTG CGGCATCGAAGGTGGAAGAG
Gas6 CGTGAGGCGGCGCAGTTTCT CCTCCTCCACGCACTCCCGT
Gas6 (intron) GTCACCCACACCATGTTTGC GCCAGGAATGAAGCTGACCT
Gata4 TGACAGTTCCGCACACCCGC GGCCACCTGCTTCGTAGGCG
Gfap AGGGCCAAAGCCTCAAGGAGGA TGGTGCTTTTGCCCCCTCGGATC
Gtl2 AGCCTCGCGGTCTCTTCGGT TGTGTCCAGGGTCCCACGCA
Gpc5 GCCGGATGCTTGCCGTGTCT CCGCGGCTTCACCTGCAAGA
Gpn3 ACTACAGCATGGTCCGCTTC CCCGTACTGAATGGCGAAGT
H19 GGCAGCAGTGGGCAGGTGAG GTCGCCAATGGTCCCCCAGC
Igf2bp1 CCCGCTCCTAGAGCCCATGTGA CACCCCAAGTCTTTCCTAAGCGC
Jam2 CGGGCGAAGTGCTGGGAGAC TTGGGGGCTCCTCGCCATCT
Kcnq5 AGCGGCTCTCGAGGCAGTCA GAAAGCAGCCTCCCCCGCAG
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Table 8.4 continued from page 184.
Gene Forward Reverse
Lamin A GCCTTCGCACCGCTCTCATCA TGCGTGAGCGCAGGTTGTACT
Lamin B1 AGCGCGCCAAGCTCCAGATC GTAGCCAGCGCCGCATCCTT
Lamin A/C GGCTGTGGGAGCAGCCTTCG GGCTGCCACTCACACGGTGG
Lamin B receptor GTGTCAAGTGGCTGTGCCCGT CTGTGGCACTGTCCGCCCTT
Me1 TGCCGCCCTGCATCATCAGC TCAGGGCCTCTGACTCGCCG
Mrpl39 TGTGGACGGACAACCGTGGGA TCCGGTGCTCTGACCAGGCT
Myo1e CTCTATGGCCCGCCCACCCT GGCCGGCTGCTCGTTTGTCT
Nanog CCTCGCCATCACACTGACATGAGT GCAGGTCTTCAGAGGAAGGGCG
Necdin CTGGTGCAGAAGGCGCACGA GCTCCTCTGGGCTGAGGGCT
Nespas CGGCGTCGGCAGGAGCTATG ACAGCCCTGGGGGAGCAACT
Nestin CATGAGGGCAGCCATGCCCC CAGTCCCAGCTTCCGGCTGC
Nurim TGTACCGCGGCTGTGCTTCC GGGAGCCCTGAGTCAACCCGA
Oct4 GACCGCCCCAATGCCGTGAA TGGTCTGGCTGAACACCTTTCCA
Pabpc1 GCCGGGCTGAACTTCTCGTA CGCACTCGCTCTCCTCCTCT
Pcsk6 ACAGGAAGTGTGTGAGCGAG GATAGAACCCACGGCGACAA
P4ha3 ATGCTACGTCGCCCAGCAGC ACCATCCCCCTCTCCGCTCC
Pla2g7 CAACCGGAGGAGGGGAGGGTC GAGCGCAGCAATGCCACCAGA
Ptgr1 CCCTACGGACGGTAACTTCG CTGTCGCCCTCCTTCAGTTT
Ptk2 TCGCTGGTGCTCCTGAGCCT TGGCAACGCCCGTTCACCTT
Rcan CGACACTCGGTGAACATTTG GGTTTGGAGAACATCAACC
Rgs16 CACGAGACCCGAGAACTGAC GACTTGAGGAAGCGCGGATA
Rhoj GGCCACTCTCTTACCCCAAC GAGGCATGCAGTCCTTCAGT
Serpinh1 CAGTGGAGTTGCTGAGGGAG AGCTAAGTTCCAAGGCGACC
Snrpn GGCAATGCAGCAACCAAGCTGT CTGGACCTCGACCTCGGGCA
Sox1 CAGTGGGAGTGCCAACGCGA CAAGGCAGAGAAGAGAGTGTTTGCA
Sox2 CAAGGCAGAGAAGAGAGTGTTTGCA GCCGCCGCGATTGTTGTGAT
Sox7 ACTGGAGTGTCCCGCCCTGG GCGTTGTGCAGGTCCGGGTT
Sox17 TGCATTCTGGACCCGCTACTGTT GCCTCTCAGAAGCAGGGACGC
Thrsp GTGCAGCTGAGTGGGCCTGG AGCGTCGTTCTCAGCCTCGC
Ttc4 GACTGAAGCGCCGAAGTTG CCATGGAAGCGTCCTCTGTA
Twist GCAGAGCGACGAGCTGGACT GGTGGGGAGCTCCGCTGCTA
Xrcc3 CTTGGCATCACCTGGGCTAA CCACTGACTGTGTAGCAGCA
.
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8.9 Bisulfite analysis
Bisulfite conversion was performed on 500ng of purified genomic DNA using reagents from the
EZ DNA Methylation-Gold Kit (Zymo Research, D5005). The bisulfite conversion reaction was
performed at 64°C for 2.5 hours, samples were subsequently purified using spin columns with an
addition desulphonation step for 20 minutes at room temperature between washes. Samples were
eluted from the columns in 10μl H2O and stored at -20°C. PCR amplification of bisulfite treated
DNA was performed using OneTaq Hot Start DNA polymerase (NEB, M0481). Using a hot start
polymerase is crucial to amplify bisulfite treated DNA. Primers were designed to amplify regions
within 500bp of the transcription start site using MethPrimer (Li and Dahiya, 2002) online tool
(http://www.urogene.org/methprimer/). Where possible, primers were designed to include an
A-T SNP between the C57Bl/6J and CAST/EiJ mouse strains. Only A-T SNPs were possible
due to loss of information occurring at cytosines during bisulfite conversion, and consequently
guanines during the PCR amplification steps. Primer sequences are listed in table 8.5. PCR
was performed using an initial denaturation at 95°C for 5 minutes, followed by 45 cycles of
95°C for 30 seconds, 52°C for 30 seconds and extension between 68°C and 72°C for 60 seconds,
then a final extension phase at 72°C for 60 seconds. 4μl of gel-purified PCR products were
cloned into pCR4-TOPO-TA vector using the TOPO-TA cloning kit (Life Technologies) and
transformed into competent Mach1 E. coli (Life Technologies). Single colonies were picked and
expanded in LB overnight. DNA purification was either performed using the Qiagen miniprep
kit reagents, or rolling circle amplification was performed directly on bacterial cultures prior
to Sanger sequencing by Molecular Cloning Laboratory (MCLAB, South San Francisco, CA,
USA). Sanger sequencing was performed using the M13 F (-20) universal primer and sequencing
traces analysed manually for the SNP allele information, and using the BiQ_Analyzer software
for bisulfite analysis (Bock et al., 2005).
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8.10 Western blotting
Protein extracts were made by resuspending cell pellets in 1x protein sample buffer, 10% β-
mercaptoethanol (100ml of 3x protein sample buffer contains 15ml 1M Tris-HCl pH6.8, 45g
sucrose, 6ml 0.1M EDTA pH7.4, 45ml 20% SDS, 0.1g Bromophenol Blue), boiling for 10 minutes
at 100°C and filtering through a needle and syringe. 10μl of protein extract was loaded onto
8-15% SDS-PAGE gels and run for 2 hours at 90V until the gel front reached the end of the gel.
Transfer to nitrocellulose membranes was performed overnight at 4°C at 15V. Membranes were
blocked in 5% skim milk, 0.1% Triton X-100, 1xPBS for at least 3 hours at room temperature
with gentle rocking. Primary antibodies were incubated with the membranes in 5% skim milk
powder, 0.1% Triton X-100, 1xPBS for 2-4 hours at room temperature at concentrations listed
in table 8.6. Membranes were washed at least 3 times for 10 minutes each in 0.1% Triton X-100
prior and subsequent to secondary antibody incubation. Secondary antibodies conjugated to
HRP were diluted 1:10,000 in 5% skim milk, 0.1% Triton X-100, 1xPBS and incubated with
membrane for 30-60 minutes at room temperature with gentle rocking. Membranes were subject
to ECL (Perkin-Elmer) exposure for 1 minute the immediately exposed to film.
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8.11 Chromatin immunoprecipitation
Cells were fixed in 1% molecular biology grade formaldehyde (Calbiochem) at 1x106 cells/ml for
5 minutes before being quenched with 2M glycine. Cells were lysed on ice for 10 minutes (10mM
Tris-HCl, 10mM NaCl, 0.5% NP-40, pH8.0) in the presence of protease inhibitors (cOmplete
Mini cocktail tablets, Roche and 1mM PMSF), and nuclei snap frozen and stored at -80°C. For
histone ChIP, nuclei were sonicated using Bioruptor (Diagenode) for 20 cycles of 30 seconds
each in dilution buffer (50mM Tris-HCl, 2mM EDTA, 0.2% SDS, 134mM NaCl, 0.88% Triton
X-100, 0.088% Na-deoxycholate, pH8.0) in an ice slurry with water exchanged every 4 cycles.
Chromatin size was confirmed by agarose gel electrophoresis for each preparation. 2mg antibody
(table 8.7 on the next page) were pre-incubated with 40μl Dynabeads anti-mouse or anti-rabbit
magnetic beads (Invitrogen) per reaction for 4 hours at 4 degrees centigrade. Chromatin was
incubated with bead-antibody mix for 16-20 hours at 4 degrees centigrade. Bound chromatin
was eluted with 10mM Tris-HCl, 1mM EDTA, 1% SDS, pH8.0 at 65°C. Reverse crosslinking
was performed for 16 hours at 65°C in 10mM Tris-HCl, 5mM EDTA, 0.5% SDS, 300mM NaCl,
pH8.0. Following treatment with 50μg/ml RNase A (Invitrogen), and 250μg/ml proteinase K
(Viagen), DNA was purified using Qiaquick PCR purification kit (Qiagen). For full protocol see
appendix on page 271.
For RNA polymerase II ChIP, frozen nuclei were resuspended in sonication buffer (50mM
Tris-HCl, pH7.5, 140mMNaCl, 1mM EDTA, 1mM EGTA, 1% Triton X-100, 0.1% Na-deoxycholate,
0.1% SDS) for 16 cycles of 30 seconds each using Bioruptor (Diagenode). Antibody was bound
to 40μl anti-mouse magnetic beads (Invitrogen) at 4°C for 4 hours. Chromatin was incubated
with bead-antibody mix for 16-20 hours at 4°C. Chromatin bound to the beads was washed
three times in sonication buffer, once in sonication buffer containing 500mM NaCl, once in
LiCl wash (20mM Tris pH8.0, 1mM EDTA, 250mM LiCl, 0.5% NP40, 0.5% Na-deoxycholate)
and once in TE. Bound chromatin was eluted with 50mM Tris-HCl, pH8.0, 10mM EDTA, 1%
SDS. Reverse crosslinking was performed for 16 hours at 65 degrees centigrade in 10mM Tris-
HCl, 5mM EDTA, 0.5% SDS, 300mM NaCl, pH8.0. Following treatment with 50μg/ml RNase
A (Invitrogen), and 250μg/ml proteinase K (Viagen), DNA was purified using Qiaquick PCR
purification kit (Qiagen). For full protocol see appendix on page 276.
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Table 8.7: Antibodies used for chromatin immunoprecipitation.
Antigen Source Species
H3K4me2 Millipore 07-030 rabbit
H3K4me3 Abcam ab8580 rabbit
H3K9me3 Abcam ab8898 rabbit
H4K16ac Millipore 07-329 rabbit
panH4ac Millipore 06-866 rabbit
H3K27me3 Active Motif 39155 rabbit
H4K20me1 Abcam ab9051 rabbit
H4K20me3 Millipore 07-463 rabbit
H3K36me3 Abcam ab9050 rabbit
RNApII (8WG16) Abcam ab817 mouse
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Quantitative PCR was performed using 2μl ChIP DNA per sample with 2 technical repli-
cates per sample. Standard curves were performed using serial 1:10 dilutions of input DNA.
Primers were designed to contain an informative SNP and were located within 1kb of the tran-
scription start site for promotors, or within exonic sequences, and are listed in table 8.8 on the
following page. Analysis was performed in Excel (Microsoft) and graphs generated using Prism6
(GraphPad).
ChIP-seq libraries were performed in a similar manner to ChIP-PCR with a few changes.
Cells were fixed and nuclei lysed as above. Sonication was performed for 24 cycles of 30 seconds
each on highest setting. 107 cells were used per IP, with 4mg antibody pre-bound to 80μl beads.
Washes and elution were performed as above. Purified immunoprecipitated DNA was run on a
high sensitive DNA chip to verify pulldown and sufficient DNA within 200-600 base pairs. At
least 10ng of DNA in the correct size range is required to proceed with library preparation. Li-
braries were generated using reagents from the Illumina mRNA TruSeq preparation kit, starting
at the end-repair step, followed by A-tailing and adapter ligation, as per kit protocol. Prior to
PCR amplification, samples were run on a 2% agarose gel for 2 hours at 90V and DNA at 200bp
gel purified. PCR was performed for 15 cycles, amplified libraries were purified, verified using
the bioanalyser, pooled and sent for single-end 36 base pair sequencing using Illumina HiSeq
platform. At least 20 million reads per sample is required for proper analysis. 3 biological
replicates per sample were generated, as well as input controls. For full detailed protocol see
appendix C.5 on page 281.
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8.12 Electroporations and transfections
Overexpression experiments performed in ESCs were conducted by electroporation using 25μg of
phenol-chloroform purified plasmid DNA. For stable cell lines, plasmid DNA must be linearised
to allow genomic integration. ESCs were fed 2-4 hours prior to harvesting, resuspended at 1.1
x107 cells/ml, and 0.9ml cells used per electroporation. Cells and DNA were mixed together,
placed into electroporation cuvettes and electroporated using Biorad GenePulser at 250V, 500μF.
Time constants should range between 5.6 and 8.0. Following electroporation, cells were plated
onto drug-resistant MEF feeder cells and if necessary, appropriate drug selection commenced
after 24 hours.
The best method for transfecting NPCs is through calcium phosphate transfections, although
Fugene 6 transfection reagent (Roche) also works. Optimal results are made with cesium chloride
purified DNA, although endo-free purification (Qiagen) can also be performed. For one well of
a 6 well plate at 60-70% confluency, 4μg plasmid DNA is mixed with 12.4μl of 2M CaCl2
(reagents from CalPhos Mammalian Transfection Kit, Clontech) and made up to 100μl with
sterile H2O. To this mix, 100μl of 2x HBS is slowly added while gently vortexing. The combined
mix is incubated at room temperature for 30 minutes, then added dropwise to the cells. Cells
are incubated for 2-3 hours, then washed 1x for 15 minutes at 37°C in 5% CO2with acidified
medium pre-incubated at 10% CO2 for at least 15 minutes. Medium is then replaced and cells
returned to the incubator and assessed the following day.
8.13 Immunofluorescence staining
Immunofluorescence of adherent cells was performed by growing cells on glass coverslips which
were then fixed for 15-20 minutes at room temperature in 4% freshly prepared formaldehyde in
1x PBS. Cells were subsequently permeabilised in ice-cold 0.1% Triton X-100 in 1x PBS for 5
minutes on ice, and washed at least 3 times in 1xPBS. Coverslips could be stored at 4°C for up
to 2 days in 1xPBS, however best results are obtained with freshly prepared cells. Cells were
blocked in 3% BSA for 1 hour at room temperature, then incubated with primary antibodies
(table 8.9 on page 196) for either 1 hour at room temperature or overnight at 4°C in 1% BSA, 1x
PBS. Cells were washed 3 times in 1xPBS, then incubated with appropriate secondary antibodies
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conjugated to Alexa-488, Alexa-594 or Alexa-647 (Invitrogen) diluted 1:1,000 in 1% BSA, 1x
PBS for 30-60 minutes at room temperature. Cells were washed again 3 times in 1x PBS,
counterstained with DAPI (1:10,000) and mounted in antifade containing 10% glycerol and 1
mg/ml p-Phenylenedi- amine (Sigma).
Blastocysts were fixed in freshly prepared 4% formaldehyde for 30 min at room-temperature,
permeabilised in 0.25% Triton X-100 for 15 min at room-temperature, then blocked in 10% FBS
with 0.1% Triton X-100 for 1–3 h at room-temperature. Cells were incubated with primary an-
tibodies containing 1% BSA overnight at 4°C. Secondary incubations and DAPI counterstaining
was performed as per adherent cells.
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8.14 RNA-DNA Fluorescence In Situ Hybridisation
Probes for both RNA and DNA FISH were generated from BAC or fosmid DNA (see Ap-
pendix C.6 on page 287 for detailed protocol) by Nick Translation (Abbott Molecular Inc.)
with red or green fluorescently conjugated d-UTP nucleotides (Enzo Life Sciences) for 10 hours
at 15 degrees. Probe size was verified by agarose gel electrophoresis to be 50-400nt. Probes
were mixed with competitor DNA, lyophilized and resuspended in 50% deionized formamide,
2x SSC and 10% dextran sulfate. Cells were grown on coverslips, fixed in freshly prepared
4% formaldehyde for 15 minutes and permeabilized in 0.1% Triton for 5 minutes on ice in the
presence of 5mM vanadyl ribonucleoside complex (NEB). Full protocol for RNA-DNA FISH is
present in Appendix C.7 on page 289.
Briefly, RNA FISH was performed by hybridizing prepared denatured probes on coverslips
overnight at 40 degrees centigrade. DNA FISH required prior treatment with 0.1mg/ml RNase
A (Invitrogen) for 1 hour at 37 degrees centigrade, followed by heat denaturation in 70% for-
mamide, 2x SSC for 5 minutes at 80 degrees centigrade, and hybridization with denatured probe
overnight at 37 degrees centigrade. Following hybridization, cells were washed in 2xSSC/50%
formamide, 2xSSX then 1xSSX at 37 degrees, counterstained with DAPI and mounted in an-
tifade containing 10% glycerol and 1mg/ml p-Phenylenediamine (Sigma). RNA-DNA FISH was
performed sequentially with separate images taken for both RNA-FISH and DNA-FISH.
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Table 8.10: BAC and fosmids used for FISH probes.
Target ID Chr Start Stop Size (kb) Gene specific Entire gene
Abcg1 RP24-108E21 17 31164093 31311286 147 no yes
Acan RP24-308C23 7 86129664 86297666 168 no
Acot1 WI1-2795P12 12 85334811 85372727 38 yes yes
Acyp2 RP23-405O2 11 30375678 30562420 187 yes yes
Adarb1 CH29-574B03 10 76740613 76906667 166 yes
Anxa6 WI1-0992J09 11 54797616 54836918 39 yes no
App RP23-424A20 16 84924341 85121213 197 no
Bag3 WI1-0675I05 7 135665920 135703160 37 yes yes
Cap2 RP23-105K14 13 46579015 46764554 186 yes yes
Cbr3 WI1-1329N21 16 93671074 93708521 37 yes yes
Chaf1b RP23-290C6 16 93880797 94040198 159 no yes
Col18a1 WI1-0204H24 10 76532609 76578562 46 yes no
Col4a1 WI1-1996G17 8 11235581 11272563 37 yes no
Cpne8 RP24-180J16 15 90333195 90490125 157 no
Cpped1 WI1-2354D17 16 11868258 11909617 41 yes no
Crip1/2 RP23-313C4 12 114259856 114431973 170 no
Dscam RP23-46N2 16 96812588 97069668 257 no no
En2 WI1-2728F04 5 28477913 28517563 40 yes yes
Enf1 RP24-140K14 11 44486728 44728495 242 no
Ets2 RP24-372P3 16 95909494 96049560 140 yes yes
Evc WI1-2255C20 5 37688862 37727984 39 yes no
Fam111a WI1-0083C22 19 12632378 12670899 39 yes no
Farp1 RP23-91P8 14 121441409 121675164 234 yes no
Gas2 WI1-663M1 7 59134904 59175563 41 yes no
Gas6 RP24-203O11 8 13381191 13539259 158 no yes
Gas6 WI1-0153N19 8 13474615 13517192 43 yes no
Gpc5 RP24-144L17 14 115509075 115741582 233 no
Gucy1b3 WI1-1386D05 3 81838650 81879656 41 yes no
HoxD cluster RP24-398B4 2 74484615 74609972 126 no
Igf2bp1 RP23-383D10 11 95758900 95942277 186 no
Kcne1 RP23-204P24 16 92345613 92544377 199 no yes
Kcnq5 RP23-209O20 1 21444460 21719510 275 no
Me1 RP23-304B9 9 86473026 86670829 198 no
Mrpl39 RP23-201L12 16 84602500 84758422 156 yes yes
Myh9 RP24-127K7 15 77590338 77749554 159 no yes
Myo1e RP24-400C15 9 70078194 70202876 125 no
Npl RP24-146M18 1 155336674 155494008 157 no yes
Npl WI1-2769H07 1 155350845 155392555 42 yes no
Oca2 RP23-290P10 7 63521994 63692267 170 yes
P4ha3 RP24-343C20 7 107360776 107518336 158 no yes
Pdzrn4 RP23-322L18 15 92356026 92579506 223 yes no
Pla2g6 WI1-2275J10 15 79130927 79169069 38 yes no
Rfx4 RP24-342J16 10 84201615 84357496 156 yes no
Rgs16 RP23-91E22 1 155546928 155679601 133 no yes
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Table 8.10, continued from page 198.
Target ID Chr Start Stop Size (kb) Gene specific Entire gene
Rhoj RP23-67B14 12 76390736 76504993 114 yes yes
Ror2 RP23-280O5 13 53207914 53383775 176 yes yes
Serpinh1 RP23-86E4 7 106411402 106565864 154 no yes
Serpinh1 WI1-1903D04 7 106486433 106524944 39 yes yes
Skap2 RP23-261L24 6 51765049 5196949 204 yes
Slc25a30 WI1-2250C21 14 76162005 76200862 39 yes yes
Stmn2 RP23-245F10 3 8432176 8623501 191 no
Thrsp RP23-63G13 7 104542422 104760155 218 no yes
Trim12 RP23-325P21 7 111427313 111495378 68 no yes
Tubb2a RP24-307M23 13 34048502 34192157 144 no yes
Twist1 WI1-1685D03 12 34619710 34657218 38 yes yes
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8.15 Microscopy
Immunofluorescence imaging of single sections for images in Chapter 3 was performed using a
Zeiss LSM710 laser scanning confocal micro- scope using a 63 × 1.4N.A. oil-immersion objec-
tive using 405 nm, 488 nm, 594 nm and 647 nm lasers. Images represent single 0.1 μm sections
through the center of ESC colonies or individual blastocysts. No post- acquisition image pro-
cessing was performed. Figures show representative single z-sections.
All other fixed cell microscopy was performed using an Applied Precision DeltaVision Core
wide-field fluorescence microscope system (GE Healthcare, Issaquah, WA) equipped with a
PlanApo 60x 1.40 numerical aperture objective lens (Olympus America). Image stacks were
taken at 0.2nm intervals throughout the entire cell and deconvolved using Applied Precision
SoftWoRx software version 4.2.1. with default parameters. Separate projections of RNA-
FISH/DAPI and DNA-FISH/DAPI images were overlayed in Photoshop using heterochromatin
foci as a guide. Image analysis was performed manually using Applied Precision SoftWoRx
software.
Live-cell imaging was performed using an Applied Precision DeltaVision Core wide-field
fluorescence microscope system equipped with PlanApo 60x 1.40 numerical aperture objective
lens (Olympus America). For live cell imaging, cells were seeded onto MatTek glass-bottomed
microwells. During imaging cells were cultured in DMEM medium without phenol red (Invitro-
gen), supplemented with 30% FBS (Clontech) and 1000U/ml LIF (Millipore) in an environmen-
tal chamber equilibrated at 37°C and 5% CO2. Cells were monitored using wide-field images
to verify cell viability. Image stacks (25 slices x 0.8μm, 2x2 binning) were taken at 5 minute
intervals over 4 hours. Ultraviolet wavelengths were filtered out using a sharp cutoff (long-pass)
filer (~420nm) to minimize phototoxicity. Blastocyst images were deconvolved using Applied
Precision SoftWoRx software version 4.2.1. with default parameters.
Super-resolution microscopy was performed using an Applied Precision OMX (Optical Mi-
croscope eXperimental) system equipped with 405, 457, 488, 514 and 593 nm solid-state lasers,
a UPlanS Apochromat 100x/1.4 NA objective lens (Olympus) and 4 EMCCD cameras (Cascade
II 512, Photometrics). Images were collected in three-dimensional structured illumination mode
and reconstructed using SoftWoRx 4.5.0 software (Applied Precision).
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Appendix A
List of random autosomal
monoallelically expressed genes
A.1 List of monoallelically expressed genes in ESCs
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Gene ID Gene Name Class
ENSMUSG00000078184 B020018G12Rik A
ENSMUSG00000032666 1700025G04Rik B
ENSMUSG00000074635 3110070M22Rik B
ENSMUSG00000021185 9030617O03Rik B
ENSMUSG00000029695 Aass B
ENSMUSG00000028127 Abcd3 B
ENSMUSG00000087439 AC118260.5 B
ENSMUSG00000086294 AC142101.1 B
ENSMUSG00000086627 AC164431.1 B
ENSMUSG00000078445 AC168276.1 B
ENSMUSG00000022477 Aco2 B
ENSMUSG00000022229 Atp12a B
ENSMUSG00000034112 Atp2c2 B
ENSMUSG00000036905 C1qb B
ENSMUSG00000053819 Camk2d B
ENSMUSG00000040189 Ccdc114 B
ENSMUSG00000068547 Clca6 B
ENSMUSG00000001119 Col6a1 B
ENSMUSG00000054196 Cthrc1 B
ENSMUSG00000004267 Eno2 B
ENSMUSG00000038776 Ephx1 B
ENSMUSG00000033373 Fntb B
ENSMUSG00000031714 Gab1 B
ENSMUSG00000037280 Galnt6 B
ENSMUSG00000069170 Gpr98 B
ENSMUSG00000020176 Grb10 B
ENSMUSG00000054128 H2-T3 B
ENSMUSG00000059447 Hadhb B
ENSMUSG00000024423 Impact B
ENSMUSG00000025825 Iscu B
ENSMUSG00000018362 Kpna2 B
ENSMUSG00000036853 Mcoln3 B
ENSMUSG00000042814 Mcts2 B
ENSMUSG00000051855 Mest B
ENSMUSG00000031647 Mfap3l B
ENSMUSG00000003948 Mmd B
ENSMUSG00000023939 Mrpl14 B
ENSMUSG00000034422 Parp14 B
ENSMUSG00000029231 Pdgfra B
ENSMUSG00000006494 Pdk1 B
ENSMUSG00000019817 Plagl1 B
ENSMUSG00000027695 Pld1 B
ENSMUSG00000027750 Postn B
ENSMUSG00000010609 Psen2 B
ENSMUSG00000036858 Ptcra B
ENSMUSG00000070953 Rabepk B
ENSMUSG00000004952 Rasa4 B
ENSMUSG00000005774 Rfx5 B
ENSMUSG00000086391 RP23-119N24.3 B
ENSMUSG00000080989 RP23-136C22.3 B
ENSMUSG00000086730 RP23-13C17.5 B
ENSMUSG00000084291 RP23-158O11.5 B
ENSMUSG00000045464 RP23-16O15.2 B
ENSMUSG00000044751 RP23-173F16.2 B
ENSMUSG00000075276 RP23-263O6.4 B
ENSMUSG00000078640 RP23-57F11.1 B
ENSMUSG00000022032 Scara5 B
ENSMUSG00000028780 Sema3c B
ENSMUSG00000025020 Slit1 B
ENSMUSG00000020409 Slu7 B
ENSMUSG00000051111 Sv2c B
ENSMUSG00000020059 Sycp3 B
ENSMUSG00000056130 Ticam2 B
ENSMUSG00000029810 Tmem176b B
ENSMUSG00000027656 Wisp2 B
ENSMUSG00000021287 Xrcc3 B
ENSMUSG00000027514 Zbp1 B
A.2 List of monoallelically expressed genes in NPCs
246
Gene ID Gene Name Class
ENSMUSG00000006931 1110036O03Rik A
ENSMUSG00000045107 1810063B07Rik A
ENSMUSG00000038059 2010002N04Rik A
ENSMUSG00000031851 2310079N02Rik A
ENSMUSG00000021747 4930452B06Rik A
ENSMUSG00000073755 5730409E04Rik A
ENSMUSG00000021792 5730469M10Rik A
ENSMUSG00000073858 AC122912.1 A
ENSMUSG00000072949 Acot1 A
ENSMUSG00000060923 Acyp2 A
ENSMUSG00000018340 Anxa6 A
ENSMUSG00000042082 Arsb A
ENSMUSG00000030847 Bag3 A
ENSMUSG00000008999 Bmp7 A
ENSMUSG00000022440 C1qtnf6 A
ENSMUSG00000073418 C4b A
ENSMUSG00000040373 Cacng5 A
ENSMUSG00000021373 Cap2 A
ENSMUSG00000022947 Cbr3 A
ENSMUSG00000027435 Cd93 A
ENSMUSG00000024769 Cdc42bpg A
ENSMUSG00000044303 Cdkn2a A
ENSMUSG00000026042 Col5a2 A
ENSMUSG00000031825 Crispld2 A
ENSMUSG00000016256 Ctsz A
ENSMUSG00000040327 Cul9 A
ENSMUSG00000039519 Cyp7b1 A
ENSMUSG00000073609 D2hgdh A
ENSMUSG00000029821 Dfna5 A
ENSMUSG00000039095 En2 A
ENSMUSG00000029122 Evc A
ENSMUSG00000024691 Fam111a A
ENSMUSG00000001555 Fkbp10 A
ENSMUSG00000002732 Fkbp7 A
ENSMUSG00000031451 Gas6 A
ENSMUSG00000027316 Gfra4 A
ENSMUSG00000028005 Gucy1b3 A
ENSMUSG00000025534 Gusb A
ENSMUSG00000059325 Hopx A
ENSMUSG00000074811 Hps6 A
ENSMUSG00000060591 Ifitm2 A
ENSMUSG00000055980 Irs1 A
ENSMUSG00000041921 Metapl1 A
ENSMUSG00000039533 Mmd2 A
ENSMUSG00000055430 Nap1l5 A
ENSMUSG00000042684 Npl A
ENSMUSG00000003849 Nqo1 A
ENSMUSG00000029468 P2rx7 A
ENSMUSG00000048347 Pcdhb18 A
ENSMUSG00000045498 Pcdhb3 A
ENSMUSG00000051242 Pcdhb9 A
ENSMUSG00000019577 Pdk4 A
ENSMUSG00000036218 Pdzrn4 A
ENSMUSG00000026664 Phyh A
ENSMUSG00000060675 Pla2g16 A
ENSMUSG00000023913 Pla2g7 A
ENSMUSG00000028494 Plin2 A
ENSMUSG00000049409 Prokr1 A
ENSMUSG00000020415 Pttg1 A
ENSMUSG00000030559 Rab38 A
ENSMUSG00000026475 Rgs16 A
ENSMUSG00000021464 Ror2 A
ENSMUSG00000042312 S100a13 A
ENSMUSG00000042216 Sgsm1 A
ENSMUSG00000041540 Sox5 A
ENSMUSG00000024776 Stambpl1 A
ENSMUSG00000023885 Thbs2 A
ENSMUSG00000036975 Tmem177 A
ENSMUSG00000073968 Trim68 A
ENSMUSG00000058672 Tubb2a A
ENSMUSG00000062591 Tubb4 A
ENSMUSG00000035799 Twist1 A
ENSMUSG00000034777 Vax2 A
ENSMUSG00000024076 Vit A
ENSMUSG00000085906 AC020971.2 A+B
ENSMUSG00000072591 AC122789.1 A+B
ENSMUSG00000021814 Anxa7 A+B
ENSMUSG00000057789 Bak1 A+B
ENSMUSG00000030077 Chl1 A+B
ENSMUSG00000065979 Cpped1 A+B
ENSMUSG00000050248 Evc2 A+B
ENSMUSG00000028268 Gbp3 A+B
ENSMUSG00000034245 Hdac11 A+B
ENSMUSG00000008540 Mgst1 A+B
ENSMUSG00000046949 Nqo2 A+B
ENSMUSG00000046768 Rhoj A+B
ENSMUSG00000037455 1110021L09Rik B
ENSMUSG00000025466 1810014F10Rik B
ENSMUSG00000071632 2510002D24Rik B
ENSMUSG00000033111 3830406C13Rik B
ENSMUSG00000062822 4833420G17Rik B
ENSMUSG00000052688 5430435G22Rik B
ENSMUSG00000025971 9430016H08Rik B
ENSMUSG00000020620 Abca8b B
ENSMUSG00000028970 Abcb1b B
ENSMUSG00000046858 AC107766.1 B
ENSMUSG00000089955 AC107766.1 B
ENSMUSG00000085644 AC108401.1 B
ENSMUSG00000075536 AC113595.2 B
ENSMUSG00000078697 AC119848.1 B
ENSMUSG00000060647 AC121569.2 B
ENSMUSG00000089856 AC122789.1 B
ENSMUSG00000075444 AC123606.1 B
ENSMUSG00000073233 AC124134.1 B
ENSMUSG00000087651 AC125276.1 B
ENSMUSG00000079599 AC129184.1 B
ENSMUSG00000061461 AC134463.1 B
ENSMUSG00000079149 AC134581.1 B
ENSMUSG00000062862 AC138791.1 B
ENSMUSG00000086101 AC158956.1 B
ENSMUSG00000056938 Acbd4 B
ENSMUSG00000040272 Accs B
ENSMUSG00000017697 Ada B
ENSMUSG00000053441 Adamts19 B
ENSMUSG00000030000 Add2 B
ENSMUSG00000020473 Aebp1 B
ENSMUSG00000038729 Akap2 B
ENSMUSG00000090182 AL929021.1 B
ENSMUSG00000035561 Aldh1b1 B
ENSMUSG00000030088 Aldh1l1 B
ENSMUSG00000004849 Ap1s1 B
ENSMUSG00000009585 Apobec3 B
ENSMUSG00000032812 Arap1 B
ENSMUSG00000037509 Arhgef4 B
ENSMUSG00000062031 Athl1 B
ENSMUSG00000031441 Atp11a B
ENSMUSG00000007097 Atp1a2 B
ENSMUSG00000078349 AW011738 B
ENSMUSG00000080717 B230307C23Rik B
ENSMUSG00000042215 Bag2 B
ENSMUSG00000046598 Bdh1 B
ENSMUSG00000038286 Bphl B
ENSMUSG00000071317 Bves B
ENSMUSG00000024592 C330018D20Rik B
ENSMUSG00000021991 Cacna2d3 B
ENSMUSG00000035547 Capn5 B
ENSMUSG00000051483 Cbr1 B
ENSMUSG00000022665 Ccdc80 B
ENSMUSG00000025510 Cd151 B
ENSMUSG00000005087 Cd44 B
ENSMUSG00000026031 Cflar B
ENSMUSG00000029161 Cgref1 B
ENSMUSG00000056486 Chn1 B
ENSMUSG00000090258 Churc1 B
ENSMUSG00000006782 Cnp B
ENSMUSG00000044681 Cnpy1 B
ENSMUSG00000040690 Col16a1 B
ENSMUSG00000031502 Col4a1 B
ENSMUSG00000027570 Col9a3 B
ENSMUSG00000056941 Commd7 B
ENSMUSG00000051811 Cox6b2 B
ENSMUSG00000034796 Cpne7 B
ENSMUSG00000027408 Cpxm1 B
ENSMUSG00000042109 Csdc2 B
ENSMUSG00000028804 Csmd2 B
ENSMUSG00000005054 Cstb B
ENSMUSG00000028179 Cth B
ENSMUSG00000083282 Ctsf B
ENSMUSG00000031924 Cyb5b B
ENSMUSG00000034445 Cybasc3 B
ENSMUSG00000015224 Cyp2j9 B
ENSMUSG00000022150 Dab2 B
ENSMUSG00000045608 Dbx2 B
ENSMUSG00000039450 Dcxr B
ENSMUSG00000040296 Ddx58 B
ENSMUSG00000025815 Dhtkd1 B
ENSMUSG00000027560 Dok5 B
ENSMUSG00000047205 Dusp18 B
ENSMUSG00000034488 Edil3 B
ENSMUSG00000078135 Eid1 B
ENSMUSG00000048988 Elfn1 B
ENSMUSG00000029675 Eln B
ENSMUSG00000021728 Emb B
ENSMUSG00000022505 Emp2 B
ENSMUSG00000004267 Eno2 B
ENSMUSG00000015766 Eps8 B
ENSMUSG00000075703 Ept1 B
ENSMUSG00000027714 Exosc9 B
ENSMUSG00000052397 Ezr B
ENSMUSG00000029851 Fam115c B
ENSMUSG00000070044 Fam149a B
ENSMUSG00000078670 Fam174b B
ENSMUSG00000054942 Fam73a B
ENSMUSG00000024778 Fas B
ENSMUSG00000064080 Fbln2 B
ENSMUSG00000040913 Fbxw4 B
ENSMUSG00000003355 Fkbp11 B
ENSMUSG00000025175 Fn3k B
ENSMUSG00000081683 Fzd10 B
ENSMUSG00000034793 G6pc3 B
ENSMUSG00000025579 Gaa B
ENSMUSG00000018567 Gabarap B
ENSMUSG00000035473 Galm B
ENSMUSG00000015027 Galns B
ENSMUSG00000047261 Gap43 B
ENSMUSG00000027199 Gatm B
ENSMUSG00000028214 Gem B
ENSMUSG00000056966 Gjc3 B
ENSMUSG00000071543 Gm10336 B
ENSMUSG00000043004 Gng2 B
ENSMUSG00000029464 Gpn3 B
ENSMUSG00000069170 Gpr98 B
ENSMUSG00000049583 Grm5 B
ENSMUSG00000060803 Gstp1 B
ENSMUSG00000001665 Gstt3 B
ENSMUSG00000023079 Gtf2ird1 B
ENSMUSG00000019188 H13 B
ENSMUSG00000061232 H2-K1 B
ENSMUSG00000053835 H2-T24 B
ENSMUSG00000058189 Hist1h2bm B
ENSMUSG00000025188 Hps1 B
ENSMUSG00000041548 Hspb8 B
ENSMUSG00000058258 Idi1 B
ENSMUSG00000035551 Igfbpl1 B
ENSMUSG00000022969 Il10rb B
ENSMUSG00000002897 Il17ra B
ENSMUSG00000032763 Ilvbl B
ENSMUSG00000001504 Irx2 B
ENSMUSG00000015533 Itga2 B
ENSMUSG00000027009 Itga4 B
ENSMUSG00000025348 Itga7 B
ENSMUSG00000073859 Itpripl2 B
ENSMUSG00000025736 Jmjd8 B
ENSMUSG00000027895 Kcnc4 B
ENSMUSG00000044708 Kcnj10 B
ENSMUSG00000037624 Kcnk2 B
ENSMUSG00000063229 Ldha B
ENSMUSG00000033880 Lgals3bp B
ENSMUSG00000019906 Lin7a B
ENSMUSG00000000693 Loxl3 B
ENSMUSG00000025507 Lrdd B
ENSMUSG00000021579 Lrrc14b B
ENSMUSG00000039246 Lyplal1 B
ENSMUSG00000045854 Lyrm2 B
ENSMUSG00000037523 Mavs B
ENSMUSG00000042814 Mcts2 B
ENSMUSG00000030621 Me3 B
ENSMUSG00000030291 Med21 B
ENSMUSG00000028655 Mfsd2a B
ENSMUSG00000054612 Mgmt B
ENSMUSG00000019823 Mical1 B
ENSMUSG00000034121 Mks1 B
ENSMUSG00000020287 Mpg B
ENSMUSG00000031760 Mt3 B
ENSMUSG00000015222 Mtap2 B
ENSMUSG00000045636 Mtus1 B
ENSMUSG00000020814 Mxra7 B
ENSMUSG00000067818 Myl9 B
ENSMUSG00000031478 Nek3 B
ENSMUSG00000022454 Nell2 B
ENSMUSG00000037499 Nenf B
ENSMUSG00000039873 Neurl2 B
ENSMUSG00000020248 Nfyb B
ENSMUSG00000031773 Nlrc5 B
ENSMUSG00000026946 Nmi B
ENSMUSG00000022421 Nptxr B
ENSMUSG00000017176 Nt5c3l B
ENSMUSG00000024228 Nudt12 B
ENSMUSG00000029153 Ociad2 B
ENSMUSG00000029012 Orc5l B
ENSMUSG00000030774 Pak1 B
ENSMUSG00000090053 Palm2 B
ENSMUSG00000089945 Palm2-Akap2 B
ENSMUSG00000033377 Palmd B
ENSMUSG00000038507 Parp12 B
ENSMUSG00000022438 Parvb B
ENSMUSG00000001497 Pax9 B
ENSMUSG00000049100 Pcdh10 B
ENSMUSG00000007440 Pcdha11 B
ENSMUSG00000051486 Pcdhb11 B
ENSMUSG00000047307 Pcdhb13 B
ENSMUSG00000047910 Pcdhb16 B
ENSMUSG00000051599 Pcdhb2 B
ENSMUSG00000045689 Pcdhb4 B
ENSMUSG00000045876 Pcdhb8 B
ENSMUSG00000030513 Pcsk6 B
ENSMUSG00000078931 Pdf B
ENSMUSG00000031595 Pdgfrl B
ENSMUSG00000070526 Peg12 B
ENSMUSG00000042632 Pla2g6 B
ENSMUSG00000021822 Plau B
ENSMUSG00000024197 Plin3 B
ENSMUSG00000031775 Pllp B
ENSMUSG00000031570 Ppapdc1b B
ENSMUSG00000042133 Ppig B
ENSMUSG00000037826 Ppm1k B
ENSMUSG00000026778 Prkcq B
ENSMUSG00000039405 Prss23 B
ENSMUSG00000024337 Psmb9 B
ENSMUSG00000028378 Ptgr1 B
ENSMUSG00000072946 Ptgr2 B
ENSMUSG00000063235 Ptpmt1 B
ENSMUSG00000026204 Ptprn B
ENSMUSG00000004044 Ptrf B
ENSMUSG00000040511 Pvr B
ENSMUSG00000072566 Pvt1 B
ENSMUSG00000033684 Qsox1 B
ENSMUSG00000027953 Rag1ap1 B
ENSMUSG00000025921 Rdh10 B
ENSMUSG00000025350 Rdh5 B
ENSMUSG00000020037 Rfx4 B
ENSMUSG00000021719 Rgs7bp B
ENSMUSG00000042671 Rgs8 B
ENSMUSG00000048330 Ric3 B
ENSMUSG00000035226 Rims4 B
ENSMUSG00000086290 RP23-115D21.2 B
ENSMUSG00000044751 RP23-173F16.2 B
ENSMUSG00000075276 RP23-263O6.4 B
ENSMUSG00000047905 RP23-265P8.1 B
ENSMUSG00000086998 RP23-29H5.7 B
ENSMUSG00000086061 RP23-308N2.7 B
ENSMUSG00000087596 RP23-317F9.4 B
ENSMUSG00000086859 RP23-41E14.4 B
ENSMUSG00000041959 S100a10 B
ENSMUSG00000034173 Scand3 B
ENSMUSG00000025203 Scd2 B
ENSMUSG00000026504 Sdccag8 B
ENSMUSG00000000753 Serpinf1 B
ENSMUSG00000070436 Serpinh1 B
ENSMUSG00000024548 Setbp1 B
ENSMUSG00000022436 Sh3bp1 B
ENSMUSG00000030638 Sh3gl3 B
ENSMUSG00000024600 Slc27a6 B
ENSMUSG00000027661 Slc2a10 B
ENSMUSG00000049922 Slc35c1 B
ENSMUSG00000027894 Slc6a17 B
ENSMUSG00000025889 Snca B
ENSMUSG00000034891 Sncb B
ENSMUSG00000044349 Snhg11 B
ENSMUSG00000006050 Sra1 B
ENSMUSG00000070003 Ssbp4 B
ENSMUSG00000024172 St6gal2 B
ENSMUSG00000004043 Stat5a B
ENSMUSG00000033855 Ston1 B
ENSMUSG00000020903 Stx8 B
ENSMUSG00000028369 Svep1 B
ENSMUSG00000019769 Syne1 B
ENSMUSG00000000384 Tbrg4 B
ENSMUSG00000027868 Tbx15 B
ENSMUSG00000020034 Tcp11l2 B
ENSMUSG00000035686 Thrsp B
ENSMUSG00000031639 Tlr3 B
ENSMUSG00000025572 Tmc6 B
ENSMUSG00000026109 Tmeff2 B
ENSMUSG00000069763 Tmem100 B
ENSMUSG00000024666 Tmem138 B
ENSMUSG00000026939 Tmem141 B
ENSMUSG00000025933 Tmem14a B
ENSMUSG00000043140 Tmem186 B
ENSMUSG00000050777 Tmem37 B
ENSMUSG00000028822 Tmem50a B
ENSMUSG00000025505 Tmem80 B
ENSMUSG00000035413 Tmem98 B
ENSMUSG00000053475 Tnfaip6 B
ENSMUSG00000022074 Tnfrsf10b B
ENSMUSG00000090170 Tnfsf12 B
ENSMUSG00000000934 Top1mt B
ENSMUSG00000074607 Tox2 B
ENSMUSG00000019842 Traf3ip2 B
ENSMUSG00000044528 Tram1l1 B
ENSMUSG00000025413 Ttc4 B
ENSMUSG00000029201 Ugdh B
ENSMUSG00000005501 Usp40 B
ENSMUSG00000079490 Vmn2r-ps112 B
ENSMUSG00000034040 Wbscr17 B
ENSMUSG00000030170 Wnt5b B
ENSMUSG00000028329 Xpa B
ENSMUSG00000021287 Xrcc3 B
ENSMUSG00000087598 Zfp111 B
ENSMUSG00000042097 Zfp239 B
ENSMUSG00000028389 Zfp37 B
ENSMUSG00000059878 Zfp422 B
ENSMUSG00000045598 Zfp553 B
ENSMUSG00000023284 Zfp605 B
ENSMUSG00000067928 Zfp760 B
ENSMUSG00000054716 Zfp771 B
Appendix B
Epigenetic drug screen results
Table showing results from first two trials of the epigenetic drug screen. Compound name, target
category and specific target are shown. Drugs highlighted in blue showed weak activation in 1 or
2 trials, yellow indicate drugs which led to more convincing activation in 2 or more trails. Trial
1 was conducted for 4 days using 10μM drug. Growth and cell morphology characteristics are
noted. The expressed allele for each gene are listed. Highlighted in yellow are partial activation
of the previously silent allele, blue indicates very weak activation. x indicates sequencing traces
which were not of sufficient quality to determine allele information.
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Appendix C
Detailed experimental protocols
C.1 ESC to NPC differentiation protocol
259
Embryonic Stem Cell to Neural Progenitor Cell Differentiation Protocol Page 1 of 2 
 
 
Differentiation of mouse ESCs to NPCs 
 
10% N2B27 media: 
 
250ml   DMEM/F12 1x, (Gibco, common stock) 
250ml   Neurobasal medium (1x, Gibco 21103049) 
0.5ml   N2 supplement (100x, Gibco 17502-048, stored at -20) 
4ml (20mg)  Insulin (Sigma I-1882 made to 5mg/ml in PBS, stored at -20) 
0.667ml  BSA Fraction V Solution (7.5% Gibco 15260-001) 
1.0ml   B27 supplement (50x, Gibco 0080085SA, stored at -20) 
5ml   P/S 
sterile filter before use. Keep 4 degrees in dark. Use within 2 weeks. 
 
Alternatively of N2 supplement plus insulin (N2+) you can use home-made modified N2 
supplement. The only difference between Mod N2 and N2+ is the concentration of 
insulin: 
    1x  100x Mod N2 10ml Mod N2      100x N2 + 
Insulin (Sigma I-1882) 25mg/L 2.5mg/ml 25mg  0.5mg/ml 
Apotransferin (Sigma T1147) 100ug/ml 10mg/ml 100mg  10mg/ml 
Progesterone (Sigma P8783) 6ng/ml  600ng/ml 6ug  630ng/ml 
Putrescine (Sigma P5780) 16ug/ml 1.6mg/ml 16mg  1.611mg/ml 
Sodium selenite (Sigma P5261) 30nM 3uM  5.1882ug 3uM 
 
N2 expansion media: 
500ml  DMEM/F2    
333ul 7.5% BSA Fraction V  final 50ug/ml 
20ul 250ug/ml mEGF  final 10ng/ml 
20ul 250ug/ml mFGF  final 10ng/ml 
5ml P/S  
 
filter, make 50ml aliquots. Add to 50ml prior to use: 
50ul 1mg/ml laminin  final 1ug/ml 
500ul 100x N2 supplement  final 1x 
 
 
Protocol: 
1. Grow ES cells on MEF feeders until confluent 
2. Trypsinise, soak on gelatin to remove MEFs 1hr at 37 degrees 
3. Collect ESC, count cells 
4. Plate onto gelatin coated 10cm plate at different densities ranging from 0.5x106 
cells to 2.0x106 cells per 10cm plate in N2B27 media. Typically use 3 or 4 
different densities as differentiation efficiency varies. 
5. Differentiate cells for 6 days. Change media every 2 days. 
6. Trypsinise plate and count cells. Suspend between 1.5x106 and 3.0x106 cells total 
in uncoated T75 flask in N2 expansion media. 
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7. Aggregates will start to grow out in suspension over the next 4 days. 
8. Collect day 3 or 4 aggregates by mild centrifugation. 
9. Plate aggregates onto 1x 10cm gelatin coated plate in N2 expansion media. 
10. NPC should adhere within a few days. Once cells have settled, change N2 
expansion media every 2-3 days. Split as required. 
C.2 RNA-sequencing library preparation
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Long RNA-seq protocol (paired-end stranded library) 
Start with 10ug of total RNA. 
 
PolyA+ isolation (Qiagen Oligotex kit) 
* use DEPC-treated water 
* preheat Oligotex suspension to 37 degrees, mix by vortexing then keep at room temp 
* heat water bath or heating block to 70 degrees, heat 400ul of buffer OEB per sample 
* ensure that buffer OBB does not have precipitates by prewarming at 37 degrees for 10 
minutes then place at room temperature. 
* perform all steps at room temperature unless otherwise indicated. 
* all centrifugation steps should be performed in a microcentrifuge tube at max speed 
(14,000g to 18,000g) 
 
1. Pipet 10ug total RNA into an RNase-free 1.5ml microcentrifuge tube and adjust 
the volume of water to 250ul. 
2. Add 250ul buffer OBB, 15ul oligotex suspension. Mix thoroughly by vortexing or 
flicking the tube 
3. Incubate 3 minutes at 70 degrees to disrupt secondary structure 
4. Remove sample from waterbath/heating block and place at room temperature for 
12 minutes to allow hybridisation between oligo dT30 and polyA tails 
5. Centrifuge 2 minutes at 14,000-18,000g, room temperature. Collect and save the 
supernatant (polyA minus fraction). It doesn’t matter if not all of the supernatant 
is collected. 
6. Resuspend the pellet in 1ml buffer OW2 by pipetting. Make sure pellet is 
completely resuspended. Centrifuge 12,000g 2 minutes. Carefully remove 
supernatant. 
7. Wash again in 1ml buffer OW2. Be careful when removing supernatant, often it is 
necessary to remove all but ~100ul, spin down again and then remove the rest. 
8. Add 100ul preheated buffer OEB (70 degrees). Resuspend by pipetting, place 
back at 70 degrees for 10 seconds before centrifuging 2 minutes 12,000g room 
temp. 
9. Transfer supernatant containing polyA+ RNA to new microcentrifuge. 
10. Resuspend again with 100ul preheated buffer OEB. Add the supernatant to the 
polyA+ fraction. 
11. For second round of polyA+ purification repeat steps 1-10. Otherwise continue to 
ethanol precipitation. 
12. Spin polyA+ RNA in spin filter column for 1 minutes at 18,000g to remove any 
remaining oligotex suspension from the polyA+ RNA. Transfer flowthrough to a 
new tube as the Ambion tubes don’t close very well. 
13. Add 1ul glycoblue, 1/10V 3M sodium acetate pH5.5, 3V 100% EtOH. Incubate -
70 for at least 30 minutes 
14. Centrifuge 30 minutes 4 degrees 15,000g 
15. Wash 1x with 70% EtOH (-20degrees), remove EtOH. 
16. Either airdry or put in speedvac for 4 minutes to remove residual EtOH which can 
interfere with subsequent reactions. 
17. Resuspend pellect in 10ul H2O on ice for 5 minutes. 
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Ribominus treatment 
 
*use 10ul of polyA+ RNA from previous step or <10ug of total RNA. 
*set a waterbath or heat block to 70 degrees 
 
1. Add to 1-10ug of RNA, 10ul of ribominus probe, 100ul hybridsation buffer 
2. Incubate at 70 degrees for 5 minutes to denature the RNA. 
3. Cool sample slowly over 30 minutes by placing tube in 37 degree heat block to 
allow sequence specific hybridisation. 
4. Prepare beads during the incubation: 
a. Vortex ribominus beads thoroughtly, pipet 750ul into a sterile 1.5ml tube 
b. Place on magnet for 1 minute, remove supernatant. 
c. Add 750ul sterile DEPC water, vortex, place on magnet, discard 
supernatant 
d. Repeat wash with 750ul water 
e. Resuspend in 750ul hybridisation buffer and transfer 250ul to a new tube. 
f. Place the tube with 500ul on magnet for 1 minute, remove supernatant and 
resuspend in 200ul hybridisation buffer. 
g. Keep both tubes at 37 degrees until needed. 
5. After 37 degree incubation, transfer ~120ul RNA-probe sample to the prepared 
ribominus beads (200ul beads). Mix well 
6. Incubate 37 degrees for 15 minutes, gently mix occasionally. 
7. Briefly centrifuge, place on magnet for 1 minute. DO NOT DISCARD 
SUPERNATANT AS THIS CONTAINS THE RNA! 
8. Place the tube with 250ul beads on magent 1 minute, remove supernatant 
9. Transfer ribominus RNA from the first tube to the second tube of beads. Mix well 
by pipetting. 
10. Incubate 37 degrees for 15 minutes, gently mix occasionally. 
11. Place tube on magnetic separator for 1 minute, transfer the supernatant containing 
ribominus RNA to a small filter column and spin at max speed for 2 minutes to 
remove any residual magnetic particles. 
12. Transfer flow through to a new tube 
13. Add 1/10V 3M sodium acetate pH5.5, 3V 100% EtOH (glycoblue from polyA 
purification will still be present). Incubate -70 for at least 30 minutes 
14. Centrifuge 30 minutes 4 degrees 15,000g 
15. Wash 1x with 70% EtOH (-20degrees), remove EtOH. 
16. Either airdry or put in speedvac for 4 minutes to remove residual EtOH which can 
interfere with subsequent reactions. 
17. Resuspend pellect in 4ul H2O on ice for 5 minutes. 
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cDNA-1st strand synthesis 
*Add all of the polyA+ ribominus RNA from 10ug of total RNA. 
*if have 2 or more samples make up mastermixes for all steps 
 
1. To 4ul of RNA add: 
1.6ul  random primers (50ng/ul, invitrogen) 
2ul  polydT20 (50uM, invitrogen) 
1ul  NIST spike-ins 
2. Start PCR program: 
98 degrees  2 min 
70 degrees  5 min 
0.1deg/sec to 15 degrees 
PAUSE 
3. As soon as 15 degrees is reached (after ~15 minutes), add: 
4ul  Superscript III 1st strand buffer (5x, invitrogen) 
1ul  0.1M MgCl2 (diluted from 1M MgCl2 Ambion stock) 
1ul  10mM dNTPs (invitrogen) 
2ul  0.1M DTT 
1ul  RNase Inhibitor (Ambion 20U/ul) 
0.5ul H2O 
4. The reaction total should be 17.9ul 
5. Resume PCR program: 
15 degrees  30 min 
PAUSE 
6. After 30 min at 15 degrees, pause program and add: 
1.0ul actinomycin-D (120ng/ul in 10mM Tris pH7.6, dilute from 1mg/ml 
stock before use) 
1.1ul superscript III enzyme (invitrogen) 
7. The reaction total should be 20ul 
8. Resume PCR program (approx 1 hour 40 minutes) 
0.1deg/seec to 25 degrees 
25 degrees  10 min 
0.1deg/sec to 42 degrees 
42 degrees  45 min 
0.1 deg/sec to 50 degrees 
50 degrees  15 min 
75 degrees  15 min 
4 degrees hold 
9. Bring total reaction volume to 100ul with H2O. Add 5 volumes of buffer PB 
10. Add to minelute Qiagen spin column.  
11. Centrifuge 1 minute 10,000g 
12. Wash column 1x with buffer PE 
13. Centrifuge 1 minute 10,000g 
14. Remove flow through, centrifuge 1 minute 12,000g 
15. Add 16ul of EB to column, sit 1 minute at room temp, spin 12,000g. 
16. Elute again with 15ul EB. Pool sample (~30ul). 
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2nd strand synthesis 
* add enzymes last in order listed in protocol to prevent RNase H activity before DNA 
pol is present. 
* prepare reaction on ice 
 
1. Prepare 2nd strand mix: 
2ul  5x first strand buffer (invitrogen) 
15ul 5x second strand buffer (invitrogen) 
0.5ul 0.1M MgCl2 
1ul  0.1 M DTT 
2ul  dUNTP mix (10mM each of dATP, dCTP, dGTP, dUTP) 
0.5ul E. coli DNA ligase (10U/ul) 
2ul  E. coli DNA polymerase I (10U/ul) 
0.5ul RNase H (2U/ul) 
21.5ul RNase free H2O 
2. Add 45ul second strand mix to 30ul of purified 1st strand reaction, bringing total 
reaction volume to 75ul 
3. Incubate 2 hours at 16 degrees, hold at 4 degrees in PCR machine 
4. Bring total reaction volume to 100ul with H2O. Add 5 volumes of buffer PB 
5. Add to minelute Qiagen spin column.  
6. Centrifuge 1 minute 10,000g 
7. Wash column 1x with buffer PE 
8. Centrifuge 1 minute 10,000g 
9. Remove flow through, centrifuge 1 minute 12,000g 
10. Add 26ul of EB to column, sit 1 minute at room temp, spin 12,000g. 
11. Elute again with 25ul EB. Pool sample (~50ul). 
12. Save 1.5ul to run on bioanalyser DNA high-sensitivity chip (pre-fragmentation) 
 
Fragmentation of ds cDNA using Covaris 
* If machine is off: switch machine on, ensure chambers are filled with autoclaved DI 
water. Run degas program prior to fragmenting samples (~30 minutes) 
 
1. Transfer 50ul sample to covaris microtube using a pipette 
2. Place in machine by snapping into place 
3. Run program ‘degas100ulsnapcap60sec’ 
4. sonication takes 60 seconds 
5. run 1ul on DNA high-sensitivity chip (post-fragmentation). Fragmentation size 
should have a peak at 200-300. 
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End-Repair cDNA 
 
48ul  sample 
27ul  H2O 
10ul T4 DNA ligase buffer with 10mM ATP 
4ul 10mM dNTP mix 
5ul T4 DNA polymerase 3U/ul(NEB M0203) 
1ul  Klenow DNA polymerase 5U/ul(NEB M0210) 
5ul      T4 PNK 10U/ul(NEB M0201) 
100ul 
 
Incubate room temperature 30 minutes 
 
Add 500ul PB, clean-up using Qiagen minelute columns. Elute 2 x 16ul 
 
Addition of single A base 
 
32ul eluted cDNA 
5ul NEB buffer 2 
10ul 1mM dATP 
3ul    Klenow fragment 3’ to 5’ exo –5U/ul (NEB M0212) 
50ul 
 
Incubate 37 degrees, 30 minutes 
 
Bring volume to 100ul with 50ul H2O, Add 500ul PB, minelute columns, Elute 1 x 19ul 
 
Adapter Ligation 
 
19ul  eluted cDNA 
25ul 2x Rapid DNA ligase buffer (Enzymatics B101) 
1ul Illumina Paired-End adapter oligo mix 
5ul     DNA T4 ligase (Enzymatics 600U/ul) 
50ul 
 
Incubate room temperature 30 minutes 
 
Bring volume to 100ul with 50ul H2O, Add 500ul PB, minelute columns. Elute 1 x 15ul 
 
UNG treatment 
 
 15ul eluted cDNA 
 1.7ul 500mM KCl 
 1ul UNG (Roche N808-0096) 
 
Indubate 37 degrees 15 minutes, 95 degrees 10 minutes. Hold on ice. 
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Gel purification 
 
Add 10ul of loading dye to 17.7ul UNG treated sample 
 
Run on 2% ultra-pure agarose gel for 2 hours at 90V. Use 100bp ladder and have a spare 
lane between samples. 
Cut out 200bp band and another band at about 250bp. It is normal not to see anything on 
the gel, cut out gel anyway. Freeze larger slice. 
 
Weigh out gel slice (~120g). Add 3V buffer QG, dissolve 15-20 minutes at 55 degrees. 
Add 1V isopropanol. Load onto minelute column, spin through. Wash 1x 0.5ml buffer 
QG, 1x 0.75ml buffer PE. Dry spin x1. Eulte 2 x 15ul buffer EB 
 
PCR amplification 
 
Use 15ul of eluted cDNA from gel purification. Save other 15ul incase PCR does not 
work. 
 
 15ul eluted cDNA 
 1ul PE primer 1.0 (100uM HPLC purified) 
 1ul PE primer 2.0 (100uM HPLC purified) 
50ul 2x HF Phusion Mix (Finzymes) 
33ul    H2O (incase need to add more or less cDNA, can adjust this amount) 
100ul 
 
Cycle conditions: 
 98 degrees 1 min 
  
98 degrees 10s 
 60 degrees 30s  18 cycles 
 72 degrees 30s 
 
72 degrees 5 min 
hold at 4 degrees 
 
Add 500ul PB, minelute clean-up, elute 1x15ul 
 
Gel Purification 
 
Add 10ul of loading dye to 15ul eluted PCR product 
 
Run on 1% ultra-pure agarose gel for 2 hours at 90V. Use 100bp ladder and have a spare 
lane between samples. 
Cut out band about 100pb larger than cDNA band. 
Gel purify as above, elute 2x 25ul EB. 
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Dilute to 100ul with 50ul H2O. Add 10ul Sodium acetate, 330ul EtOH. Precipitate 30 
min at -80 degrees or overnight at -20. Centrifuge 30 min at max speed. Wash 1x in 70% 
EtOH. Airdry or speedvac for 4 min. Resuspend in 25ul H20. 
 
Library Quantitation 
 
Run Agilent DNA high sensitivity chip. Run 2 dilutions of sample at 1:20 and 1:30. At 
least one of the dilutions should be between max and half max of loading peak height. 
Calculate the peak size (should be consistent between dilutions) and take the average of 
the concentration. 
 
Dilute library to 10nM. 
 
Send 25ul or half of library, which ever is less, to sequencers. Keep remaining library as 
backup. 
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Reagents required – separate stocks of everything to prevent contamination!!! 
 
 
Oligotex mRNA midi kit (12 reactions) Qiagen Cat # 70042   $673 
Glycoblue (300 reactions)   Ambion Cat # AM9515  $65.25 
 
Ribominus kit (8 reactions)   Invitrogen Cat # A10837-08  $482 
 
Superscript III RT (2,000U)   Invitrogen Cat # 18080-093  $80 
Random primers     Invitrogen Cat # 48190-011  $138 
Oligo-dT20 primers    Invitrogen Cat # 18418-020  $130 
NIST spike-ins    from Gingeras lab   - 
RNAse Inhibitor    Ambion Cat # AM2690  $82 
1M MgCl2     Ambion Cat # AM9530G  $27.90 
10mM Tris-HCl pH7.6   Sigma Cat # T2444-100mL  $21.50 
Actinomycin-D (5mg)   Invitrogen 11805-017   $78.25 
 
5x second strand buffer   Invitrogen 10812-014   $110 
dUTP       Roche #11934554001   ? 
dNTPs      Roche # 11969064001  ? 
E. Coli DNA ligase    Invitrogen Cat # 18052-019  $39 
E. coli DNA polymerase I   Invitrogen Cat # 18010-017  $99.25 
RNase H     Invitrogen Cat # 18021-014  $128 
  
Bioanalyser high-sensitivity DNA chips Agilent Cat # 5067-4626  $453 
Bioanalyser RNA nano chip reagents  Agilent Cat # 5067-1512  $362 
 
Covaris microtube snap-cap (25 tubes) Covaris Cat #520045   $125 
   
T4 DNA ligase buffer with 10mM ATP 
T4 DNA polymerase (3U/ul)   NEB Cat # M2030 
Klenow DNA polumerase (5U/ul)  NEB Cat # M0210 
T4 PNK (10U/ul)    NEB Cat # M0201 
NEB buffer 2     NEB 
Klenow fragment 3’ to 5’ exo – (5U/ul) NEB Cat # M0212 
 
2x Rapid Ligation Buffer   Enzymatics B101 
T4 DNA ligase (600U/ul)   Enzymatics 12 2012 
 
Illumina Paired-end adapter Oligo Mix Illumina – got aliquot from Gingeras Lab 
Uracil N-Glycoslyase  (UNG)  AmpErase ABI N8080096   $143 
 
PE primer 1.0     Order HPLC purified from IDT 
PE primer 2.0     Order HPLC purified from IDT 
2x HF phusion mix    Finzymes 
 
C.3 Histone Chromatin immunoprecipitation protocol
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Histone ChIP protocol 
 
Sample fixation: 
1. Pre-warm glycine to ensure it is correctly resuspended prior to starting. 
2. Harvest cells and resuspend to 1 x 106 cells/ml in D-PBS. 1 x 10cm plate of NPCs 
will yield approximately 3 x 106 cells. 
3. Add 27μl of 37% formaldehyde per 1ml of cell suspension (final 1%). Mix by 
gentle inversion of the falcon tube. 
4. Incubate exactly 5 minutes at room temperature 
5. Add 200μl of 2.5M glycine per 1ml of cell suspension. Mix by gentle inversion of 
the falcon tube. 
6. Incubate 5 minutes at room temperature 
7. Spin down 3000g for 10 minutes at 4°C 
8. Resuspend in ice-cold TBS. 
9. Aliquot 5x106 cells per 1.5ml eppendorf tube. Each sample will be sufficient for 2 
ChIP plus input control. 
10. Spin down, 3000g for 3 minutes at 4°C 
11. Reuspend and incubate samples in 1ml Lysis buffer + protease inhibitors added, 
10 minutes on ice 
12. Spin down 1000g for 3 minutes at 4°C 
13. Wash nuclei in 0.5ml Lysis buffer + protease inhibitors 
14. Snap freeze pellet in liquid nitrogen. Store samples at -80°C for up to 6 months. 
 
Antibody+Bead preparation: 
1. Resuspend M-280 sheep anti-mouse or anti-rabbit beads (Invitrogen) and aliquot 
40μl per IP (approximately 2x107 beads). 
2. Add 400μl 0.5% BSA, 1x PBS per sample 
3. Place on magnetic stand for 1 minute. Remove supernatant 
4. Resuspend in 0.5ml 0.5% BSA, 1x PBS per sample. Incubate 30 minutes on 
rotator at 4°C. 
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5. Add antibodies or 5μl normal mouse/rabbit IgG (3mg/ml) in 500μl RIPA-150, 
0.5% BSA. 
6. Incubate 4-6  hours at 4°C with rotation. 
 
Chromatin immunoprecipitation: 
7. Fill sonicator bath with ice slurry to pre-cool machine at least 30 minutes prior to 
starting. 
8. Resuspend nuclei in 500μl Dilution Buffer I + protease inhibitors 
9. Incubate 5 minutes on ice 
10. Sonicate 20 cycles on maxium setting 30 seconds ON, 30 seconds OFF. Optimal 
setting depends on the cell type and fixation conditions and needs to be optimized. 
Use polystyrene 15ml falcon tubes (BD 352095) for sonication. Probes extend 
into the tube. Add a small amount of ice every 4 cycles to ensure samples stay 
cold. 
11. Spin down samples in 1.5ml low binding RNAse, DNAse free 1.5ml tubes 
maximum speed, 10 minutes at 4°C. 
12. During chromatin centrifugation step, wash antibody bound beads twice in 1ml 
RIPA-150, 0.5% BSA. 
13. Collect chromatin supernatant. Add 500μl Dilution Buffer II and 500μl RIPA-150 
+ protease inhibitors per sample. 
14. Add 500μl chromatin supernatant per IP. Make sure you keep 200μl chromatin 
aside as input control. Keep input at 4°C until required. 
15. Incubate chromatin with antibody bound beads overnight (at least 16 hours) at 
4°C with rotation 
16. Wash beads 2x in 1ml RIPA-150 + 0.5x protease inhibitors 
17. Wash beads 2x in 1ml RIPA-500 + 0.1mM PMSF 
18. Wash beads 1x in 1ml TE 
19. Elute in 100μl elution buffer (TE, 1% SDS) for 15 minutes at 65°C with shaking 
20. Collect supernatant 
21. Repeat elution with another 100μl elution buffer for 15 minutes at 65°C with 
shaking 
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22. Pool eluted samples (total 200μl). 
23. Add 200μl post-elution buffer to each sample (total 400μl) 
24. To the input, add 160μl H2O, 18μl 5M NaCl, 3.6μl 0.5M EDTA, 18μl 10% SDS 
25. Incubate samples and input overnight at 65°C in waterbath. Ensure tubes are 
sealed by wrapping with parafilm 
26. Add 2μl of 10mg/ml RNAse per sample (final 50μg/ml). Incubate 37°C for 30 
minutes 
27. Add 5μl of 20ml/ml proteinase K (finale 250μg/ml). Incubate 55°C for 1 hour. 
28. Clean-up either by phenol-chloroform extraction or using Qiagen PCR clean-up 
columns. 
29. Final volume 50μl. Use 2μl for Q-PCR 
30. Check chromatin smear by running 2-5μl of input on 2% agarose gel. Smear 
should be between 200-400bp. 
 
Lysis Buffer: 
 stock final concentration 10ml 
 1M Tris-HCl pH8.0 10mM 100μl 
 5M NaCl 10mM 20μl 
 10% NP40 0.5% 0.5ml 
 H2O  9.4ml 
 
Dilution Buffer I 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 50mM 250μl 
 0.5M EDTA 2mM 20μl 
 20% SDS 0.2% 50μl 
 5M NaCl 134mM 134μl 
 20% Triton X-100 0.88% 220μl 
 10% Na-Deoxycholate 0.088% 44μl 
 H2O  4.3ml 
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Dilution Buffer II 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 50mM 250μl 
 5M NaCl 167mM 167μl 
 20% Triton X-100 1.1% 275μl 
 10% Na-Deoxycholate 0.11% 55μl 
 H2O  4.25ml 
 
Elution Buffer 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 10mM 50μl 
 0.5M EDTA 1mM 10μl 
 10% SDS 1% 500μl 
 H2O  4.44ml 
 
Post-Elution Buffer 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 10mM 50μl 
 0.5M EDTA 9mM 90μl 
 5M NaCl 600mM 600μl 
 H2O  4.26ml 
 
RIPA Buffer 
 stock 100ml RIPA-150 100ml RIPA-500 
 1M Tris-HCl pH8.0 5ml 5ml 
 5M NaCl 3ml 10ml 
 0.5M EDTA 200μl 200μl 
 10% SDS 1ml 1ml 
 20% triton X-100 5ml 5ml 
 10% Na-deoxycholate 1ml 1ml 
 H2O up to 100ml up to 100ml 
C.4 RNA polymerase Chromatin immunoprecipitation protocol
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RNA polymerase II ChIP protocol 
 
Sample fixation: 
1. Pre-warm glycine to ensure it is correctly resuspended prior to starting. 
2. Harvest cells and resuspend to 1 x 106 cells/ml in D-PBS. 1 x 10cm plate of NPCs 
will yield approximately 3 x 106 cells. 
3. Add 27μl of 37% formaldehyde per 1ml of cell suspension (final 1%). Mix by 
gentle inversion of the falcon tube. 
4. Incubate exactly 5 minutes at room temperature 
5. Add 200μl of 2.5M glycine per 1ml of cell suspension. Mix by gentle inversion of 
the falcon tube. 
6. Incubate 5 minutes at room temperature 
7. Spin down 3000g for 10 minutes at 4°C 
8. Resuspend in ice-cold TBS. 
9. Aliquot 5x106 cells per 1.5ml eppendorf tube. Each sample will be sufficient for 2 
ChIP plus input control. 
10. Spin down, 3000g for 3 minutes at 4°C 
11. Reuspend and incubate samples in 1ml Lysis buffer + protease inhibitors added, 
10 minutes on ice 
12. Spin down 1000g for 3 minutes at 4°C 
13. Wash nuclei in 0.5ml Lysis buffer + protease inhibitors 
14. Snap freeze pellet in liquid nitrogen. Store samples at -80°C for up to 6 months. 
 
Antibody+Bead preparation: 
1. Resuspend M-280 sheep anti-mouse beads (Invitrogen) and aliquot 40μl per IP 
(approximately 2x107 beads). 
2. Add 400μl 0.5% BSA, 1x PBS per sample 
3. Place on magnetic stand for 1 minute. Remove supernatant 
4. Resuspend in 0.5ml 0.5% BSA, 1x PBS per sample. Incubate 30 minutes on 
rotator at 4°C. 
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5. Add 5μl mouse α RNApolII antibody (abcam 817) or 5μl normal mouse IgG 
(3mg/ml) in 500μl RIPA-150, 0.5% BSA. 
6. Incubate 4-6  hours at 4°C with rotation. 
 
Chromatin immunoprecipitation: 
7. Fill sonicator bath with ice slurry to pre-cool machine at least 30 minutes prior to 
starting. 
8. Resuspend nuclei in 500μl Sonication buffer + protease inhibitors 
9. Incubate 5 minutes on ice 
10. Sonicate 16 cycles on maximum setting 30 seconds ON, 30 seconds OFF. 
Optimal setting depends on the cell type and fixation conditions and needs to be 
optimized. Use polystyrene 15ml falcon tubes (BD 352095) for sonication. Probes 
extend into the tube. Add a small amount of ice every 4 cycles to ensure samples 
stay cold. 
11. Spin down samples in 1.5ml low binding RNAse, DNAse free 1.5ml tubes 
maximum speed, 10 minutes at 4°C. 
12. During chromatin centrifugation step, wash antibody bound beads twice in 1ml 
RIPA-150, 0.5% BSA. 
13. Collect chromatin supernatant. Add 1ml Sonication buffer + protease inhibitors 
per sample. 
14. Add 500μl chromatin supernatant per IP. Make sure you keep 200μl chromatin 
aside as input control. Keep input at 4°C until required. 
15. Incubate chromatin with antibody bound beads overnight (at least 16 hours) at 
4°C with rotation 
16. Wash beads 3x in 1ml Sonication Buffer + protease inhibitors 
17. Wash beads 1x in 1ml High Salt Sonication Buffer + 0.1mM PMSF 
18. Wash beads 1x in 1ml LiCl buffer 
19. Wash beads 1x in 1ml TE 
20. Elute in 100μl elution buffer (TE, 1% SDS) for 15 minutes at 65°C with shaking 
21. Collect supernatant 
22. Repeat elution with 100μl elution buffer for 15 minutes at 65°C with shaking 
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23. Pool eluted samples (total 200μl). 
24. Add 200μl post-elution buffer to each sample (total 400μl) 
25. To the input, add 160μl H2O, 18μl 5M NaCl, 3.6μl 0.5M EDTA, 18μl 10% SDS 
26. Incubate samples and input overnight at 65°C in water bath. Ensure tubes are 
sealed by wrapping with parafilm 
27. Add 2μl of 10mg/ml RNAse per sample (final 50μg/ml). Incubate 37°C, 30 min 
28. Add 5μl of 20ml/ml proteinase K (finale 250μg/ml). Incubate 55°C for 1 hour. 
29. Clean-up either by phenol-chloroform extraction or using Qiagen PCR clean-up 
columns. 
30. Final volume 50μl. Use 2μl for Q-PCR 
31. Check chromatin smear by running 2-5μl of input on 2% agarose gel. Smear 
should be between 200-400bp. 
 
Lysis Buffer: 
 stock final concentration 10ml 
 1M Tris-HCl pH8.0 10mM 100μl 
 5M NaCl 10mM 20μl 
 10% NP40 0.5% 0.5ml 
 H2O  9.4ml 
 
Sonication Buffer 
 stock final concentration 5ml 
 1M Tris-HCl pH7.5 50mM 250μl 
 5M NaCl 140mM 140μl 
 0.5M EDTA 1mM 10μl 
 0.2M EGTA 1mM 25μl 
 20% Triton X-100 1% 250μl 
 10% Na-deoxycholate 0.1% 50μl 
 20% SDS 0.1% 250μl 
 H2O  4.25ml 
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High Salt Sonication Buffer 
 stock final concentration 5ml 
 1M Tris-HCl pH7.5 50mM 250μl 
 5M NaCl 500mM 500μl 
 0.5M EDTA 1mM 10μl 
 0.2M EGTA 1mM 25μl 
 20% Triton X-100 1% 250μl 
 10% Na-deoxycholate 0.1% 50μl 
 20% SDS 0.1% 250μl 
 H2O  3.66ml 
 
LiCl buffer 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 20mM 100μl 
 0.5M EDTA 1mM 10μl 
 5M LiCl 250mM 250μl 
 10% NP-40 0.5% 500μl 
 10% Na-deoxycholate 0.5% 500μl 
 H2O  3.64ml 
 
Elution Buffer 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 50mM 250μl 
 0.5M EDTA pH8.0 10mM 100μl 
 20% SDS 1% 250μl 
 H2O  4.4ml 
 
 
C.5 ChIP-sequencing protocol
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ChIP-Seq protocol 
 
Sample fixation: 
1. Pre-warm glycine to ensure it is correctly resuspended prior to starting. 
2. Harvest cells and resuspend to 1 x 106 cells/ml in D-PBS. 1 x 10cm plate of NPCs 
will yield approximately 3 x 106 cells. 
3. Add 27μl of 37% formaldehyde per 1ml of cell suspension (final 1%). Mix by 
gentle inversion of the falcon tube. 
4. Incubate exactly 5 minutes at room temperature 
5. Add 200μl of 2.5M glycine per 1ml of cell suspension. Mix by gentle inversion of 
the falcon tube. 
6. Incubate 5 minutes at room temperature 
7. Spin down 3000g for 10 minutes at 4°C 
8. Resuspend in ice-cold TBS. 
9. Aliquot 5x106 cells per 1.5ml eppendorf tube. Each sample will be sufficient for 2 
ChIP plus input control. 
10. Spin down, 3000g for 3 minutes at 4°C 
11. Reuspend and incubate samples in 1ml Lysis buffer + protease inhibitors added, 
10 minutes on ice 
12. Spin down 1000g for 3 minutes at 4°C 
13. Wash nuclei in 0.5ml Lysis buffer + protease inhibitors 
14. Snap freeze pellet in liquid nitrogen. Store samples at -80°C for up to 6 months. 
 
Antibody+Bead preparation: 
1. Resuspend M-280 sheep anti-mouse or anti-rabbit beads (Invitrogen) and aliquot 
80μl per IP (approximately 4x107 beads). 
2. Add 400μl 0.5% BSA, 1x PBS per sample 
3. Place on magnetic stand for 1 minute. Remove supernatant 
4. Resuspend in 0.5ml 0.5% BSA, 1x PBS per sample. Incubate 30 minutes on 
rotator at 4°C. 
5. Add 4mg antibodies or in 500μl RIPA-150, 0.5% BSA. 
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6. Incubate 4-6  hours at 4°C with rotation. 
 
Chromatin immunoprecipitation: 
7. Fill sonicator bath with ice slurry to pre-cool machine at least 30 minutes prior to 
starting. 
8. Resuspend nuclei in 500μl Dilution Buffer I + protease inhibitors. Will need 2 
tubes each owith 5x106 cells per IP. 
9. Incubate 5 minutes on ice 
10. Sonicate 24 cycles on maxium setting 30 seconds ON, 30 seconds OFF. Optimal 
setting depends on the cell type and fixation conditions and needs to be optimized. 
Use polystyrene 15ml falcon tubes (BD 352095) for sonication. Probes extend 
into the tube. Add a small amount of ice every 4 cycles to ensure samples stay 
cold. 
11. Spin down samples in 1.5ml low binding RNAse, DNAse free 1.5ml tubes 
maximum speed, 10 minutes at 4°C. 
12. During chromatin centrifugation step, wash antibody bound beads twice in 1ml 
RIPA-150, 0.5% BSA. 
13. Collect chromatin supernatant. Add 500μl Dilution Buffer II and 500μl RIPA-150 
+ protease inhibitors per sample. 
14. Add 2x1.5ml chromatin supernatant per IP. You will have two tubes per IP. 
15. Incubate chromatin with antibody bound beads overnight (at least 16 hours) at 
4°C with rotation 
16. Wash beads 2x in 1ml RIPA-150 + 0.5x protease inhibitors 
17. Wash beads 2x in 1ml RIPA-500 + 0.1mM PMSF 
18. Wash beads 1x in 1ml TE 
19. Elute in 100μl elution buffer (TE, 1% SDS) for 15 minutes at 65°C with shaking. 
Pool the two tubes together with the first 100μl wash. 
20. Collect supernatant 
21. Repeat elution with another 100μl elution buffer for 15 minutes at 65°C with 
shaking 
22. Pool eluted samples (total 200μl). 
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23. Add 200μl post-elution buffer to each sample (total 400μl) 
24. Incubate samples and input overnight at 65°C in waterbath. Ensure tubes are 
sealed by wrapping with parafilm 
25. Add 2μl of 10mg/ml RNAse per sample (final 50μg/ml). Incubate 37°C for 30 
minutes 
26. Add 5μl of 20ml/ml proteinase K (finale 250μg/ml). Incubate 55°C for 1 hour. 
27. Clean-up either by phenol-chloroform extraction or using Qiagen PCR clean-up 
columns. 
28. Final volume 30μl. 
29. Check chromatin smear by running High Sensitivity DNA chip (Bioanalyser). 
Will need 5-10ng DNA within 200-600bp range. 
30. Add 31μl resuspension buffer from Illumina TruSeq mRNA preparation kit. All 
reagents from here on come from this kit. 
31. Perform end repair. Add 40μl End Repair Mix. Incubate 30 minutes at 30°C 
32. Clean-up using 140μl AmpureX beads. Resuspend in 17.5μl Resuspension buffer 
33. Perform  A-tail reaction. Add 12.5μl End Repair Mix. Incubate 37°C for 30 min. 
34. Ligate adapters. Add 2.5μl resuspension buffer, 2.5μl ligation mix and 2.5μl 
adapter. Incubate 10 minutes at 30°C 
35. Add 5μl stop ligation buffer. Bring the 42.5μl to a total volume of 100μl by 
adding 57.5μl H2O. 
36. Clean-up with Qiagen PCR purification columns. Elute 30μl elution buffer 
37. Run on 2% agarose gel for 2 hours at 90V. Ensure there is a spare lane between 
samples. 
38. Gel purify band at 200bp range. Collect 300bp gel piece as back-up. Elute 30μl 
elution buffer. 
39. PCR amplify with 7.5μl primer cocktail and 37.5μl PCR mix. 15 cycles. 
40. Clean-up with Ampure beads adding 75μl to 75μl PCR reaction 
41. Resuspend in a total 22.5μl resuspension buffer 
42. Transfer 20μl to a new tube. 
43. Run 1:10 and 1:20 dilutions on High Sensitivity DNA chip (Agilent bioanalyser). 
Peak of library should be around 300bp. Dilute to 10nM and sequence (SR36). 
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Lysis Buffer: 
 stock final concentration 10ml 
 1M Tris-HCl pH8.0 10mM 100μl 
 5M NaCl 10mM 20μl 
 10% NP40 0.5% 0.5ml 
 H2O  9.4ml 
 
Dilution Buffer I 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 50mM 250μl 
 0.5M EDTA 2mM 20μl 
 20% SDS 0.2% 50μl 
 5M NaCl 134mM 134μl 
 20% Triton X-100 0.88% 220μl 
 10% Na-Deoxycholate 0.088% 44μl 
 H2O  4.3ml 
 
Dilution Buffer II 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 50mM 250μl 
 5M NaCl 167mM 167μl 
 20% Triton X-100 1.1% 275μl 
 10% Na-Deoxycholate 0.11% 55μl 
 H2O  4.25ml 
 
Elution Buffer 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 10mM 50μl 
 0.5M EDTA 1mM 10μl 
 10% SDS 1% 500μl 
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 H2O  4.44ml 
 
Post-Elution Buffer 
 stock final concentration 5ml 
 1M Tris-HCl pH8.0 10mM 50μl 
 0.5M EDTA 9mM 90μl 
 5M NaCl 600mM 600μl 
 H2O  4.26ml 
 
RIPA Buffer 
 stock 100ml RIPA-150 100ml RIPA-500 
 1M Tris-HCl pH8.0 5ml 5ml 
 5M NaCl 3ml 10ml 
 0.5M EDTA 200μl 200μl 
 10% SDS 1ml 1ml 
 20% triton X-100 5ml 5ml 
 10% Na-deoxycholate 1ml 1ml 
 H2O up to 100ml up to 100ml 	  
C.6 Nick Translation protocol
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Nick Translation Protocol 
Reagents from Nick Translation Kit (Abbott Molecular Cat. 32-801300 or homemade 
reagents) 
Labeled dUTP from Enzo life sciences 
 
1. Make reaction mixture: 
 22-xµl water 
 xµl  DNA (2µg total) 
 2.5µl  0.2mM labeled dUTP 
 5µl  0.1mM dTTP 
 10µl  dNTP mix 
 5µl  10x nick translation buffer 
2. mix well, add 5µl nick translation enzyme 
 
3. PCR reaction: 
15°C 10 hours 
70°C 10 min 
hold at 4°C 
 
4. transfer to 1.5ml eppendorf and add: 
1µl  0.5M EDTA 
1µl  linear acrylamide 
5µl  3M NaOAc 
125µl  100% EtOH (ice cold) 
 
5. precipitate at -20°C over night or -80°C 2 hours 
 
6. centrifuge max speed 1 hr 4°C 
 
7. remove supernatant 
 
8. wash 2x with 1ml 75% EtOH 
 
9. air dry pellet 15 min 37°C incubator 
 
10. resuspend 50ul H2O. Place on shaking 37°C heat block to completely resuspended. 
 
11. Run 5ul on 2% agarose gel. Smear pattern should be between 50-400nt. 
 
12. Store at -20°C in dark. Use 3-5ul per FISH reaction 
C.7 RNA-DNA FISH protocol
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DAY 1 
 
RNA FISH Hybridization: 
 
1) Fix cells in 2% PFA for 20 min at room temperature 
 
2) Wash in 1x PBS, 3 x 10min. 
 
3) Permeablize cells in 1xPBS/0.5% Triton X-100/5mM VRC, 5 minutes on ice.  
 
4) Wash in 1x PBS, 3 x 10min 
 
5) Equilibrate in 2x SSC, 10 min @ room temperature 
 
6) Probe preparation: 
a. Place 2ul probe (~40ng), 5ul each Cot1 DNA, yeast tRNA, and ssDNA  in a tube, 
and dehydrate in Speed-Vac. (~20min) 
b. Meanwhile, prepare 2x Hybridization Buffer: 4xSSC, 20% Dextran Sulfate in 
H2O. Mix and keep on 37°C heating block.  
c. Remove probe from Speed-Vac and add 10ul formamide to resuspend. Place on 
the 37°C heating block, with shaking, for at least 30 min.  
 
7) Denature the probe for 10 min @ 90-92°C. Then, incubate on ice for at least 2 minutes.  
 
8) Add 10ul 2X Hybridization Buffer to the denatured probe and mix well.  
 
9) Spot 20ul probe mixture onto a clean slide, and place the coversip, cell side down, onto 
the probe.  
 
10)  Seal with rubber cement, and hybridize overnight at 37°C in a humid chamber.  
 
 
DAY 2 
 
Before you start: 
 
- Turn the water bath up to 80°C. Put an empty coplin jar into the 80°C water bath to pre-
heat. 
- Set one heating block to 92-95°C. 
- Place an empty coplin jar on ice to chill. 
- Warm 50% Formamide/2X SSC solution to 37°C in a coplin jar.  
- Warm some 2X SSC and 1X SSC to 37°C.  (10 ml per coplin jar) 
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Post-hybridization washes: 
 
1) Remove rubber cement from coverslips, and add some 2X SSC to the sides of the 
coverslip to help loosen it from the slide.  
 
2) Transfer the coverslips to the coplin jar containing 50% formamide/2X SSC (pH 7.0), 
incubate at 37°C for 30 minutes. If a shaking water bath is available, gently agitate the 
coplin jars during the incubation.  
 
2) Wash in 2X SSC, 15 minutes at 37°C. 
 
3) Wash in 1X SSC, 15 minutes at 37°C.  
 
4) Equilibrate the coverslips in 4X SSC, 5 minutes at room temp.  
 
5) Incubate with DAPI stain (1:10,000 in 4X SSC) for 3 minutes at room temp.  
 
6) Wash in 4X SSC, 2 x 5 minutes at room temp.  
 
7) Mount coverslips on clean slides, using 15ml mounting medium. Blot excess mounting 
medium with a paper towel, and then seal coverslips with nail polish. 
 
8) Image cells, be sure to save coordinates of images on microscope to return to the same 
cells. 
 
 
 
DAY 3: 
 
Coverslip Preparation: 
 
1) Mark position of coverslip on slide with black marker. Remove nailpolish and carefully 
remove coverslip from slide. Use of 1x PBS can assist coverslip removal. Make a small 
break in one corner and mark the slide appropriately such that you can correctly orient 
the slide following DNA-FISH. 
 
2) Wash slide 3 times in 1xPBS, 5 minutes each, to remove mounting medium. 
 
3) Fix cells in 4% PFA, 10min @ room temp.  
 
2) Wash in 1X PBS, 3 x 10 min.  
 
3) Add 0.1mg/ml RNAse A in 1X PBS, incubate at 37°C x 1.5 hour.  
 
4) During RNase treatment, start probe preparation, as described below.  
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Probe Preparation (Keep probe out of direct light): 
 
1) For each slide to be hybridized, add the following to a 1.5 ml tube: 
 
5ml mouse Cot1 DNA (~10mg) 
5ml salmon sperm DNA 
5ml yeast tRNA 
2-5ml nick translated probe (40-50ng) 
Total volume: ~20ml 
 
2) Dehydrate probe in Speed-Vac. (~30 min) 
 
3) Add 10ml formamide to each tube to resuspend probe.  
 
4) Place tubes in the shaking incubator @ 37°C for at least 30 minutes to resuspend. 
 
5) Make 2X Hybridization Buffer, 10ml for each slide: 
20% Dextran Sulfate 
4X SSC 
dH2O 
 
6) Keep 2X Hybridization Buffer in shaking incubator at 37°C until coverslips are ready for 
hybridization.  
 
 
Denaturation of Cellular DNA Before Hybridization: 
 
1) After RNase treatment is complete, transfer coverslips to coplin jars containing 2X SSC.  
 
2) Wash in 2X SSC, 2 x 5 min at RT, then 5 min at 42°C.  
 
3) Make formamide solution: 70% formamide, 2X SSC.  
 
4) Microwave the formamide solution until just boiling. (~20 sec) 
 
5) Transfer the hot solution to the coplin jar that is already in the 80°C water bath, and 
monitor the temperature of the solution in the coplin jar with a thermometer.  
 
6) When the temperature of the solution goes down to 80°C, transfer the coverslips in to the 
coplin jar in the 80°C water bath. 
 
7) Denature the coverslips in the 80°C bath for 2-10 minutes (depending on cell type).  
 
8) Just before the denaturation step is complete, add ice-cold (-20°C) 70% ethanol to the 
coplin jar that was pre-chilled on ice.  
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9) QUICKLY transfer coverslips to the coplin jar containing 70% ethanol. Incubate on ice for 
5 minutes.  
 
10) Dehydrate the coverslips through an ethanol series: 95% ethanol x 5 minutes, then 100% 
ethanol for at least 5 minutes. The coverslips can stay in 100% ethanol until the probes are 
ready for hybridization. 
 
 
Final Probe Preparation and Hybridization: 
 
1) Just before the cells are ready for hybridization, denature the probe (resuspended in 
formamide) in the 92-95°C heating block for 10 minutes.  
 
2) Transfer probes directly to ice, and incubate for at least 2 minutes.  
 
3) Add 10ml pre-warmed 2X Hybridization Buffer to the denatured probe, mix well, and spot 
the probe on a clean slide. (~20ml total, final concentrations in probe: 10% dextran sulfate, 
50% formamide, 2X SSC) 
 
4) Remove the denatured coverslip from the 100% ethanol, blot with Whatman paper, and 
briefly air dry.  
 
5) Turn the coverslip, cell side down, onto the probe on the slide.  
 
6) Seal the coverslip with rubber cement, place the slides in a humid chamber, and incubate at 
37°C overnight.  
 
 
 
DAY 4 
 
Before you begin: 
 
- Warm 50% Formamide/2X SSC solution to 37°C in a coplin jar.  
- Warm some 2X SSC and 1X SSC to 37°C.  (10 ml per coplin jar) 
 
Post-hybridization washes: 
 
1) Remove rubber cement from coverslips, and add some 2X SSC to the sides of the coverslip to 
help loosen it from the slide.  
 
2) Transfer the coverslips to the coplin jar containing 50% formamide/2X SSC (pH 7.0), 
incubate at 37°C for 30 minutes. If a shaking water bath is available, gently agitate the coplin 
jars during the incubation.  
 
3) Wash in 2X SSC, 15 minutes at 37°C. 
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4) Wash in 1X SSC, 15 minutes at 37°C.  
 
5) Equilibrate the coverslips in 4X SSC, 5 minutes at room temp.  
 
6) Incubate with DAPI stain (1:10,000 in 4X SSC) for 3 minutes at room temp.  
 
7) Wash in 4X SSC, 2 x 5 minutes at room temp.  
 
8) Mount coverslips on original slides using marks as a guide, using 15ml mounting medium. 
Blot excess mounting medium with a paper towel, and then seal coverslips with nail polish. 
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Introduction
Although chromatin was first described 130 years ago [1],
the organization and dynamics of chromatin in the inter-
phase nucleus in vivo, and how this organization relates to
transcriptional regulation, is still not fully understood.
Here we review recent advances in electron microscopy
and light microscopy, as well as biochemical and molecu-
lar biology approaches that have shed new light on this
fundamental question in biology.
Higher order chromatin structure
DNA in the eukaryotic cell nucleus exists as a complex
with histone proteins. 147 bp of DNA are wrapped in 1.7
negatively supercoiled turns around the nucleosome core
particle comprised of two H3-H4 and two H2A–H2B
histone dimers. Nucleosomes are separated from each
other by 10–80 bp linker DNA associated with linker
histone H1 (reviewed in [2]). This DNA–nucleosome
complex forms a 10 nm diameter fiber resembling ‘beads
on a string’ [3,4] (Figure 1e). The 10 nm chromatin fiber
has been shown in vitro to form a higher order helical fiber
30 nm in diameter (Figure 1d) containing 6–11 nucleo-
somes per turn [5,6] which has been proposed to form
even higher order chromatin fibers in interphase [7], and a
200–300 nm chromonema structure in mitotic chromo-
somes [8,9]. Two models have been proposed to describe
the 30 nm fiber (Figure 1d). First, an interdigitated one-
start solenoid structure where each nucleosome interacts
with its fifth or sixth neighbor [10]. Secondly, a two-start
zigzag ribbon where every second nucleosome interacts
[11,12]. In a molecular tweezer experiment using 25-
nucleosome repeat arrays in vitro, it has been determined
that the extension characteristics and force of 4 pN
required to fully extend the array from a 30 nm to a
10 nm fiber is consistent with a solenoid structure [13].
While it has been extensively studied in vitro, evidence
for the existence of the 30 nm fiber in vivo is limited. It
has been proposed that the 30 nm fiber is the preferred
structure in chromatin preparations with low chromatin
concentrations and low ionic strength where intra-mol-
ecular nucleosome interactions are favored over inter-
molecular interactions (reviewed in [14,15]). Moreover,
alcohol dehydration and embedding procedures used in
electron microscopy sample preparations, as well as the
‘Widom 601 nucleosome positioning’ sequence used for
some of these studies probably favor the formation of the
30 nm fiber in vitro (reviewed in [14]), all factors which
call into question its existence in vivo.
In interphase cells, the 30 nm fiber has so far only been
observed in two specialized systems: starfish spermato-
zoids [16], and chicken erythrocyte nuclei [16,17]. In
contrast to the majority of cells, these two model systems
are largely transcriptionally inactive, they contain a more
highly charged histone H1 isoform, low abundance of
non-histone chromatin proteins, and a longer nucleosome
repeat length [18], suggesting that the 30 nm fiber might
be involved in heterochromatic transcriptional repression
and compaction [17]. However, this compaction may not
be sufficient for transcriptional silencing, as the structure
of the 30 nm fiber in avian erythrocyte nuclei is loose
enough to permit the access of even large proteins to the
chromatin fiber [17,19]. Interestingly, in mouse rod
photoreceptor cells which have concentric areas of vary-
ing chromatin compaction, the central and most compact
area shows an amorphous phase with no chromatin fibers,
whereas the more peripheral layer with intermediate
levels of chromatin compaction shows a 30 nm fiber,
and the least condensed region shows only the 10 nm
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fiber [20]. This suggests that chromatin within these cells
can exist in multiple distinct structures.
In order to study the decompaction and transcriptional
activation of condensed chromatin from human cells that
mimics in vivo characteristics, Reinberg and colleagues
reconstituted 5 kb of DNA surrounding the RAR/RXR
responsive PEPCK promoter with native histones iso-
lated from HeLa cells, as well as histone H1, the core
histone chaperone RSF, and the histone H1 chaperone
NAP-1 [21]. This resulted in a highly compacted 30 nm
chromatin fiber which became decondensed upon tran-
scriptional activation. By contrast, mitotic HeLa S3
chromosomes observed in a close-to-native state by
small-angle X-ray scattering and cryo-electron micro-
scopy (cryo-EM) of vitreous sections, fail to show a higher
order chromatin structure beyond the 10 nm fiber
[22,23]. Similarly, cryo-EM of rodent and plant inter-
phase chromatin has been shown to be homogeneous and
disorganized [24]. Furthermore, chromatin organization
was studied by a combination of electron spectroscopic
imaging and electron tomography, which does not involve
contrast agents and creates a three dimensional image of
chromatin in situ [25]. Using this technique, open chro-
matin or condensed chromatin within chromocenters in
mouse embryonic fibroblasts, as well as in mouse spleen
lymphocytes and liver tissue cells showed the 10 nm fiber,
but did not exhibit any evidence for a 30 nm or higher
order chromatin organization [25]. Therefore, rather
than being ordered into a 30 nm fiber, chromatin has
been described as a dynamic disordered and interdigi-
tated state comparable with a ‘polymer melt’, where
nucleosomes that are not linear neighbors on the DNA
strand interact within a chromatin region [14,22,23]
(Figure 1d). It has been proposed that these regions
represent drops of viscous fluid in which the radial pos-
ition of genes within these drops may influence their
transcriptional activity [14]. This fluid and irregular chro-
matin arrangement might permit a more dynamic and
flexible organization of the genome than the rigid 30 nm
fiber would provide [14,22], and would consequently
facilitate dynamic processes such as transcription, DNA
replication, DNA repair and enhancer-promoter inter-
actions [22]. Furthermore, the irregular spacing and
concentration of nucleosomes seen in vivo has been
shown to be incompatible with the 30 nm fiber [26],
further supporting the polymer melt model.
In recent years, considerable effort has been made to
study chromatin in conditions that are close to the living
state and an increasing amount of data suggests that
chromatin organization above the 10 nm fiber probably
does not exist in most mammalian cells. New super-
resolution imaging techniques are promising tools to
further evaluate the organization and dynamics of chro-
matin in living cells in the near future.
Genome-wide chromatin interactions
The development of the Chromosome Conformation
Capture (3C) and 3C-related genome-wide techniques
(circularized chromosome conformation capture (4C),
carbon copy chromosome conformation capture (5C),
Hi-C) has given us an insight into the structure and
long-range interactions of chromatin at the molecular
level in vivo (reviewed in [27,28]). In yeast, 3C analysis
of transcriptionally active chromatin shows local vari-
ations in chromatin compaction, and does not support
the presence of a 30 nm fiber [29]. A seminal study by
Dekker and colleagues provided a model of the local
chromatin environment of normal human lymphoblasts
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Chromatin organization in the mammalian nucleus. (a) Chromosomes are organized in chromosome territories. (b) Chromosome territories are
comprised of fractal globules, and fractal globules from adjacent chromosome territories can interdigitate. (c) Chromatin fibers interact (i) within a
fractal globule (frequent), (ii) between fractal globules of the same chromosome territory (rare), or (iii) between adjacent chromosome territories (very
rare). (d) Chromatin may form a 30 nm fiber with a solenoid zigzag, or polymer melt organization (see text). (e) Chromatin is resolved as a 10 nm ‘beads
on a string’ fiber consisting of nucleosomes.
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on the megabase scale as a fractal globule, where chro-
matin partitions into adjacent regions with minimal inter-
digitation [30] (Figure 1b), consistent with the diffusion
and binding properties caused by molecular crowding of
chromatin binding proteins [31,32]. The fractal globules
ultimately associate on the chromosome level to form
chromosome territories [30] (Figure 1a, b), which can be
observed in interphase nuclei using light microscopy
techniques. In addition, the fractal globule model
suggests a mechanism for the interaction of genomic sites
that are distant within a chromosome or on different
chromosomes, which might lead to chromosomal translo-
cations in cancer. Interestingly, the three dimensional
chromatin structure revealed by Hi-C experiments
directly correlates with chromosomal rearrangements
and somatic copy number variations reported in human
cancer cells [33]. Similarly, the translocation frequency of
the Igh and Myc loci which are located on different
chromosomes in mouse B lymphocytes directly correlates
to their contact frequency in a 4C-seq experiment [34].
Furthermore, the actual observed intra-and inter-chro-
mosomal translocation frequency has been shown to
correlate with the contact probability in a Hi-C exper-
iment in G1 arrested mouse pro-B cells [35].
Within the fractal globule, chromatin is organized into
discrete domains. A Hi-C analysis in mouse ES cells
identified 2200 topological domains in which chromatin
with a median size of 880 kb occupying about 91% of the
genome interacts locally [36]. These topological
domains are enriched in housekeeping genes and SINE
elements, and are separated by topological boundary
regions with characteristics of insulator elements, such
as CTCF-binding and a segregation of the heterochro-
matic H3K9me3 mark [36]. This organization of the
topological domains is conserved between different
human cell types, as well as between human and mouse
[36]. A follow up study by the same group using the
ChIP-seq technique found a significant overlap of topo-
logical domains with cis-regulatory enhancer-promoter
units in 19 embryonic and adult mouse tissues and cell
types [37]. Similarly, a 4.5 Mb region encompassing Xist
on the X chromosome in mouse ES cells was shown to
partition into discrete topologically associating domains
(TADs) that are 200 kb to 1 Mb in size, and are present on
both the active and inactive X chromosome in male and
female ES cells [38]. While they are enriched in, they do
not require H3K27me3, H3K9me2 nor lamina-associated
domains (LADs) for their maintenance [38]. Within a
TAD, genes are transcriptionally co-regulated, and while
the TADs as a whole do not change, the internal TAD
contacts rearrange upon ES cell differentiation support-
ing the link between chromatin structure and transcrip-
tion [38]. Similarly, a study of the active and inactive
X-chromosome in human SATO3 lymphoblast cells
revealed that transcription disrupts intrachromosomal
interactions, leading to local chromatin decompaction
at promoters [39]. A 5C study as part of the ENCODE
project analyzed the interactions of transcriptional start
sites (TSS) in 44 regions representing 1% of the genome
in three human cell lines [40]. More than 1000 mostly
asymmetric long-range interactions with distal elements
resembling promoters and enhancers were identified
within these regions [40]. However, in contrast to another
study [37], 60% of the interactions were found in only
one of the three cell lines analyzed indicating a cell-type
specific chromatin folding [40]. Therefore, it remains to
be determined how conserved these long-range inter-
actions are between cell types or species. In addition to
intra-chromosomal contacts, tethered chromosome con-
formation capture (TCC) experiments in human lympho-
blastoid cells revealed that inter-chromosomal contacts
are indiscriminate between chromosome territories and
their contact probability is a function of their transcrip-
tional activity and position within the territory [41]. Con-
sequently, inter-chromosomal contacts are about 70 times
less frequent than intra-chromosomal contacts and may
be present only in a fraction of cells where both inter-
acting regions are accessible [41] (Figure 1).
The fractal globule model has provided exciting initial
insights into genome-wide short-range and long-range
gene interactions involved in transcriptional regulation
and chromosomal translocations in cancer. However, cur-
rent 3C methodology surveys chromatin topology within
dynamic populations of cells. At the single cell level,
chromatin interactions are likely to be dynamic, some
being stochastic, and their frequency may depend on the
cell cycle and additional factors. Therefore, an examin-
ation of chromatin topology of single cells is needed to
assess cell-to-cell differences as well as changes during
the cell cycle and stages of differentiation in order to fully
understand the relationship of gene interactions to cel-
lular function.
Gene position in relation to chromosome
territories
From the higher order fractal globule structure, chromatin
is further organized into chromosome territories, where
each chromosome, rather than being intertwined,
occupies its own distinct region of the nucleus (reviewed
in [42,43]). In order to study the contacts and interdigita-
tion of chromosome territories, Bickmore and colleagues
used fluorescently-labeled pooled sequence-capture
probes to show that the exons of mouse chromosome 2
predominantly localize at the surface of the chromosome
territory [44]. This is consistent with genes looping out of
their chromosome territory and allows for interactions
with regions of other chromosomes. Pulse-labeling exper-
iments have revealed that only 1% of chromatin from
different chromosomes co-localize in interphase cells
[45]. Thus it is likely that these inter-chromosomal inter-
actions occur transiently and/or that these are rare events,
as has also been proposed by genome-wide mapping of
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chromosome interactions [41] (Figure 1). The importance
of inter-chromosomal interactions for gene regulation still
remains to be elucidated, but it has been proposed that
some co-regulated genes can colocalize in interchromatin
granules or transcription factories [46–48]. However, it
remains to be demonstrated if looping out from a chromo-
some territory is an active process preceding transcription,
or if it is a consequence of gene activation (Figure 2).
Treatment with the histone deacetylase inhibitor TSA
results in increased chromatin mobility [49] and an increase
in inter-chromosomal co-localization [45], suggesting that
gene activation may not be a consequence of gene move-
ment and co-localization, and that the two processes might
indeed be independent from each other (Figure 2c).
Gene position in relation to the nuclear
periphery
Beyond the organization of chromatin in chromosome
territories, the radial position of genes within the nucleus
has been implicated in gene regulation. In particular, it
has been suggested that the low transcriptional activity of
perinuclear heterochromatin is a consequence of nuclear
lamina-mediated gene silencing [50]. The nuclear lamina
which is comprised of a meshwork of type V intermediate
filament proteins (lamins) and other associated proteins
(reviewed in [51]) provides the interface between the
inner nuclear membrane, nuclear pore complex and the
nearby chromatin. Associations of large regions of chro-
matin, termed lamin associated domains (LADs) with the
nuclear lamina is generally associated with transcriptional
repression [52], however relocation to the periphery is not
always sufficient for gene silencing [53], nor is it necessary
as many inactive loci are located within the nucleoplasm
away from the nuclear periphery. Nonetheless the associ-
ation with, and disassociation of gene loci from the
nuclear lamina and corresponding changes in transcrip-
tional status, for example during embryonic stem cell
differentiation [52], implicates this nuclear compartment
in the regulation of gene expression.
Recent studies have advanced our understanding of how
genes relocate to and from the nuclear periphery. In S.
cerevisiae the INO1 gene relocates to the nuclear pore
complex (NPC) upon transcriptional activation [54]. This
relocation is controlled by two upstream 8 bp and 20 bp
DNA elements termed ‘DNA zip codes’ which are suffi-
cient for relocation and clustering at the NPC [55],
suggesting that the genome itself encodes for its spatial
organization. DNA elements can also mediate gene repo-
sitioning in mammalian cells. The IgH and Cyp3a loci are
located within LADs that dissociate from the nuclear
lamina in cell types in which these genes are actively
transcribed [56]. Integration of BACs containing these
genomic regions into a control locus relocates the locus to
the nuclear periphery [57]. Through a series of trunca-
tion experiments, Singh and colleagues identified a 4–
6 kb minimal sequence element at these loci that is
sufficient to target the surrounding DNA region to the
nuclear periphery and consequently attenuate transcrip-
tion of a reporter gene [57]. This sequence element is
enriched with the GAGA motif, which when inserted as 10
copies in a 400 bp array, is sufficient to target a DNA locus
to the lamina. The sequestration at the lamina could be
partially inhibited through knockdown of either the zinc
finger protein cKrox, which binds the GAGA motif, or the
histone deacetylase HDAC3 [57]. Therefore, chromatin
modifications, in addition to the DNA sequence
elements, may also be involved in positioning genes at
the nuclear periphery. This is further supported by find-
ings implicating histone deactylases in targeting the
cystic fibrosis transmembrane conductance regulator
(CFTR) gene to the nuclear periphery in non-expressing
cells [58]. In addition to histone acetylation levels,
histone H3 lysine 9 methylation has also been suggested
to influence DNA positioning at the nuclear lamina in
C. elegans embryos [59]. An RNAi screen identified 29
factors that, when knocked-down, led to activation of a
92 Genome architecture and expression
Figure 2
Activation preceeds movement
Activation depends on prior movement
Activation and movement are independent events
(a)
(b)
(c)
Current Opinion in Genetics & Development
Transcriptional activity influences chromatin topology. (a) Transcriptional
activation of a gene may precede its movement within the nucleus. (b)
An inactive gene may get activated subsequent to its movement to a site
that is favorable to transcriptional activation. (c) Transcriptional
activation and gene movement may be independent of each other. Red,
inactive gene; green, active gene.
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peripheral repressed reporter array. Interestingly, only 2
of these factors resulted in additional movement of the
array into the nucleoplasm, demonstrating that move-
ment is not required for gene activation. Conversely,
movement of a reporter gene under an inactive promoter
from the periphery was not accompanied by transcrip-
tional activation [59]. Therefore, while there is a cor-
relation between gene expression levels and nuclear
periphery positioning, the two processes are not necess-
arily dependent on each other. Additional characteriz-
ation of the factors that are required for gene positioning
relative to the nuclear periphery and other nuclear struc-
tures represents an interesting area for future research.
Transcription dependent gene movement
When considering gene positioning, either relative to
topological associated domains, chromatin territories, or
a nuclear structure such as the lamina, an important
consideration is whether changes in gene position occur
before or following changes in gene expression (Figure 2).
For example, the HOX gene cluster in mammals change
during differentiation from a single domain marked by
H3K27me3 to a bimodal domain in which the active Hox
genes occupy a separate region rich in H3K4me3 distinct
from the inactive regions [60]. However, it is unknown
whether the structural changes that accompany gene
activation are necessary for transcription to occur, or
whether they are a secondary event stabilizing the gene
expression program in the cells. The two alleles of the
imprinted Kcnq1 locus have recently been shown to associ-
ate in early embryogenesis at sites of high RNA polymer-
ase II occupancy [61]. This suggests a role for gene
transcription in mediating the pairing, however cause
and effect again remain unknown. Similarly, the long
noncoding RNAs TUG1 and MALAT1/NEAT2 have
been implicated in the relocation of growth control genes
between Polycomb bodies and interchromatin granule
clusters [62]. Long range chromosomal interactions be-
tween the ifrrg cytokine gene and its receptor genes
ifrrgR1 and ifrrgR2 are also associated with gene expres-
sion [63]. This interaction persists following inhibition of
transcription with the RNA polymerase II inhibitor a-
amanitin, implying that gene transcription is not required
to maintain the intergenic interactions. However, it
remains to be determined whether transcription is
required for their establishment. Along these lines, chro-
matin looping may directly affect transcription, rather than
being the result of transcriptional co-regulation. This was
shown by zinc-finger mediated tethering of the GATA1
associated protein Ldb1, or merely its self-association
domain, to the b-globin promoter in erythroid cells
[64]. This led to the formation of a chromatin loop
between the promoter and the locus control region
(LCR), and to expression of the b-globin gene in the
absence of GATA1 [64]. In order to untangle the inter-
connection of gene transcription and gene movement, live
cell systems, in which one can follow the activation or
silencing of individual endogenous genes with respect to
their chromosome territory or a nuclear compartment, will
be required. These types of experiments will be critical to
extending our understanding of the role of nuclear organ-
ization in the regulation of gene expression.
Outlook
In recent years, light microscopy and electron microscopy
approaches, as well as the emergence of genome-wide
3C-related studies have broadened our understanding of
the three-dimensional organization of chromatin within
the nuclear space, and how it relates to transcriptional
regulation. However, many fundamental questions
remain unanswered. Although increasing evidence from
experiments that are close to the native chromatin state
do not support the 40 year old concept of higher order
chromatin structure, there is still a lack of understanding
with regard to the structure of chromatin in the living cell,
and whether or not a 30 nm fiber or even higher order
chromatin organization exists in live interphase mamma-
lian cells. Chromatin may have very different structures
within a cell depending on multiple factors, such as the
radial position within the nucleus, the cell cycle stage, the
differentiation state of the cell, transcriptional activity,
nucleosome occupancy, DNA and histone modifications,
histone variants, long-range chromatin interactions, or any
combination of these factors.
Although 3C-related techniques have provided signifi-
cant insight into genome-wide chromatin association fre-
quencies within a population of cells, these techniques
currently do not tell us how dynamic such interactions are
in and among single cells. It remains to be determined
what the frequency and duration of these interactions are,
how they relate to the cell cycle and differentiation, and if
they are the cause or consequence of transcriptional
regulation.
While recent advances in imaging and molecular
approaches have provided significant insights into chro-
matin organization and gene interactions, ongoing studies
examining individual living and fixed cells will provide
the basis for further advances.
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